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Abstract
ABSTRACT
Alterations in metabolism and heart rate variability (HRV) and endothelial dysfunction as 
well as sleep deprivation and shift work have been associated with an increased risk for 
cardiovascular disease. The aim of the current study was to investigate the effect of one 
night of total sleep deprivation (TSD) (as a proxy for the first night of shift work) and 
recovery sleep on metabolic and cardiovascular function and alertness and mood under 
controlled laboratory conditions in experienced shift workers compared with non-shift 
workers.
Eleven shift workers (SW) (shift work > 5 years) and 14 non-shift workers (NSW), 
matched for age, BMI and cholesterol, followed a 7-day regular sleep-wake cycle prior to 
the laboratory session, consisting of adaptation sleep, baseline sleep, TSD (30.5 h), a 4- 
h nap and recovery sleep. All interventions were relative to wake up time (body posture, 
food intake and light controlled throughout).
After TSD, basal plasma triacylglycerol (TAG) levels and postprandial glucose clearance 
decreased and the morning peak in HRV variance increased. After recovery sleep, TAG 
and insulin responses increased and non-esterified fatty acid (NEFA) responses and 
HRV variance decreased. These data suggest shifts in insulin sensitivity and 
sympathetic/parasympathetic balance after TSD and recovery sleep. Mood and alertness 
deteriorated after TSD but the recovery periods provided effective recuperation. There 
were no differences in screening parameters and circadian phase between SW and 
NSW. However, SW felt more alert, cheerful, elated and calmer and showed a lower 
HRV variance and higher sympathetic activity as well as a trend for lower endothelial 
function throughout the study and a smaller increase in insulin and decrease in NEFA 
responses after recovery sleep. Further research is needed to unravel the mechanisms 
underlying these group differences and to clarify why some changes in metabolic and 
cardiovascular function take place after TSD while others are observed following 
recovery sleep.
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Chapter 1 Introduction
CHAPTER 1 INTRODUCTION
1.1 Metabolic syndrome and cardiovascular disease
Cardiovascular disease (CVD) is the primary cause of morbidity and mortality nowadays; 
nearly half of all deaths (49%) in Europe are from CVD; 55% of the deaths in women and 
43% of the deaths in men (British Heart Foundation Statistics 2009). Therefore, it is not 
surprising that this is a major research area.
CVD has traditionally been seen as a disease of lipid metabolism. The metabolic 
parameters reported to be associated with CVD are clustered in the ‘metabolic 
syndrome’. Depending on the guidelines applied (from the US, Europe or global), 
different combinations of the following criteria have to be met to be diagnosed with 
metabolic syndrome: glucose intolerance/insulin resistance, central obesity,
hypertension, elevated triacylglycerol (TAG) levels, decreased high-density lipoprotein 
(HDL) levels (Grundy et al. 2004; Shaw et al. 2005) (Table 1.1) and increased 
cholesterol levels (above 5 mmol/L) (Betteridge et al. 1993; British Cardiac Society et al.
2005). Glucose intolerance and insulin resistance, required to be present by the World 
Health Organisation (WHO) and European Group for the study of Insulin Resistance 
(EGIR), are subsequent phases preceding diabetes. The time course of diabetes 
development is characterised by maintenance of normal to mildly elevated glucose levels 
due to increased insulin secretion (glucose intolerance/insulin insensitivity or resistance), 
followed by failure of the (3-cells to produce more insulin to keep glucose levels within the 
homeostatic range (diabetes) (DeFronzo 1988; Reaven 2002) (Figure 1.1). Other 
authors suggest lower cut off values than 1.7 or 2 mmol/L for TAGs and report that an 
elevation above TAG levels of 1.5 mmol/L is associated with smaller and denser low- 
density lipoprotein (LDL), which may increase the risk for CVD (Griffin et al. 1994). Some 
of the risk factors for the metabolic syndrome also fall into another cluster of risk factors, 
such as the atherogenic lipoprotein phenotype, characterised by abnormal TAGs, HDL 
cholesterol and the presence of small dense LDL (Austin etal. 1988).
A downstream marker which would functionally integrate the above markers of CVD is 
endothelial function. Indeed, rhythmicity in endothelial function may well explain several 
processes occurring in CVD (Walters etal. 2003).
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Table 1.1. Definitions of the metabolic syndrome: global, US and Europe.
NCEP ATP WHO EGIR
Three of the following:
1. Fasting plasm a glucose >6 1 
mmol/l (>11-0 mg/l)
2. Central obesity W aist 
circum ference > 10 20  mm (m en), 
> 880  mm (women)
3. Hypertension Blood pressure 
>13 0 /85  m m hg
4. Hypertriglyceridaem ia  
Triacylglycerols > 1 7  m mol/l HDL 
<1-0 mmol/l (m en), < 1 3  mmol/l 
(wom en)
D iabetes or impaired glucose 
to lerance or insulin resistance 
(under clam p conditions) and 
two of the following:
1. Microalbum inuria Urinary 
albumin excretion rate >20  
pg/m in or Albumin:creatinine 
>30 mg/g
2. Central obesity BMI >30  
kg/m^ and/or W H R  >0-9 (m en), 
>0-85  (wom en)
3. Hypertension Blood pressure 
> 1 4 0 /9 0  m mHg
4. Dyslipidaem ia Triacylglycerols 
>1 -7 mmol/l and/or H D L <0-9  
mmol/l (m en), <1-0 mmol/l 
(wom en)
(Definition for non-diabetics 
only) Insulin resistance or 
fasting hyperinsulinaem ia and 
two of the following:
1. Fasting plasm a glucose >6-1 
mmol/l
2. Central obesity W aist 
circum ference >940 mm (m en), 
>800 mm (wom en)
3. Hypertension Blood pressure 
>14 0 /90  m m Hg and/or 
Medication
4. Dyslipidaem ia Triacylglcerols 
>2-0 mmol/l or HDL <1-0  
mmol/l or Treated  for 
dyslipidaem ia
BMI, body mass index; EGIR, European Group for the Study of Insulin Resistance; HDL, high- 
density lipoprotein; NCEP ATP III, National Cholesterol Education Programme Adult Treatment 
Panel III; W HR, waist hip ratio. Adapted from: Shaw etal. (2005).
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Figure 1.1. Progression of blood glucose and insulin levels in patients with type II 
diabetes.
Adapted from Champe eta l. (2008).
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A fairly new, non-invasive technique to assess endothelial function, measurement of 
flow-mediated dilatation (FMD) (section 1.5.2.1) by ultrasound recordings (Celermajer et 
al. 1992), has been used within our research group (Hampton at al. 2010; Walters at al. 
2006) and others groups (e.g. Bots at al. 2005; Charakida at al. 2005; Clarkson at al. 
1997; Donald at al. 2006; Fathi at al. 2004; Sorensen at al. 1995). The assessment of 
FMD compares the diameter of the brachial artery at rest and at the peak during shear 
stress-induced dilatation (e.g. Charakida at al. 2005; Clarkson at al. 1997; Fathi at al. 
2004; Sorensen at al. 1995). It has been shown that FMD is lower in populations with 
diabetes or coronary heart disease (CHD) than in healthy populations but that there is a 
large overlap between these groups (Bots et al. 2005). Moens at al. (2005) suggested 
that a FMD in healthy subjects is above 7%, whereas in patients with CVD the FMD is 0- 
5%. However, this technique requires a defined protocol to achieve optimal 
reproducibility (Donald atal. 2006).
Another functional integrator of cardiovascular function is heart rate variability (HRV) 
(section 1.5.3.1), defined as ‘the oscillation in the interval between consecutive heart 
beats as well as the oscillations between consecutive instantaneous heart rates’ (Task 
Force of the European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology 1996). It is commonly assessed by time domain measures derived 
from an electrocardiogram (ECG), e.g. the SDNN, the standard deviation (SD) of the 
normal-to-normal (NN) interval between QRS complexes. Mainly sympathetic, but 
possibly also parasympathetic modulation, is thought to be reflected in the low frequency 
(LF) power in the frequency domain, while parasympathetic activity is the major 
component of high frequency (HF) power. The balance between these autonomic 
systems is reflected by the LF/HF ratio. A lower variance (e.g. lower SDNN) in the ECG 
and in some studies a shift towards higher sympathetic activation have been associated 
with CVD (Buccelletti atal. 2009; Koskinen atal. 2009; Manfrini atal. 2008; Perciaccante 
at al. 2006; Rabbone atal. 2009; Task Force of the European Society of Cardiology and 
the North American Society of Pacing and Electrophysiology 1996; Thayer atal. 2010).
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1.2 General epidemiology of sleep duration and metabolic and 
cardiovascular function
1.2.1 Sleep duration
The first obvious question to ask in a study on sleep deprivation is: how many people are 
sleep deprived? Some statistics have shown that over 15% of Americans sleep less than 
6 h a night (Kripke et al. 2002). In agreement with this, another poll revealed that 15% of 
respondents (18 years and older) slept less than 6 h on weekdays and 10% slept less 
than 6 h on weekends over the past year (The National Sleep Foundation 2002). 
Although these percentages provide interesting information about the distribution of 
sleep durations, they do not necessarily give an indication about the average sleep 
duration in a population. The first study reported a modal sleep duration of 8 h and 
almost half of the sample slept more than 7.5 h (Kripke at al. 2002). The second poll 
showed that, on average, the respondents slept 6.9 h on weekdays and 7.5 h on 
weekends (The National Sleep Foundation 2002).
Whereas many studies on sleep duration use subjective self-reported sleep parameters, 
a few more objective studies have been carried out. As part of the Coronary Artery Risk 
Development in Young Adults (CARDIA) study, wrist activity monitoring was used in 669 
participants as an objective and non-invasive way to assess various sleep parameters 
(Lauderdale at al. 2006). Although mean time in bed was 7.5 h, average sleep duration 
was only 6.1 h. Sleep duration (and other parameters) showed race-gender differences, 
even after adjustment for factors such as socioeconomic status (Lauderdale at al. 2006). 
The downside of this study, however, was that sleep parameters were only measured 
during 2 weekdays and 1 weekend day. Therefore, it cannot be assumed that the results 
reflect subjects’ normal sleep patterns.
It may also be of interest to look at sleep need. Percentages of reported insufficient sleep 
seem to be high in adolescents (15% of the 13 year olds to 25% of the 17 year olds) and 
again there are differences depending on gender and ethnicity (Dorofaeff & Denny
2006). However, insufficient sleep is something else than sleep duration as these 
adolescents had a much longer sleep duration that the adults in the studies above, with 
an average of 8 h and 40 min during the week and 9 h and 23 min during the weekend 
(Dorofaeff & Denny 2006). Another study on adolescents, showed similar numbers, but 
also stated that 91.6% of the 12-18 year old students slept less than (but still) 9.2 h per 
night and that this was related to the amount of extracurricular activities of these
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students (LoessI et al. 2008). These studies indicate that it is not possible to simply 
define sleep deprivation as a set number of hours sleep, but that it is likely to depend on 
individual characteristics, such as age.
Furthermore, it has been suggested that we nowadays sleep less and less. It has been 
reported that the percentage of Americans of 18 years and older sleeping less than 6 h 
in a 24 h period increased over the years, with roughly 15-25% in 1984 and 20-35% in 
2004 (Centers for Disease Control and Prevention 2005). However, a British study 
conducted in 2003 using face-to-face interviews in adults aged 16 years and older in the 
general population via NOP Omnibus Surveys, showed an average sleep duration of
7.04 h (Groeger et al. 2004). The authors state that there are not many good historical 
data for comparison but the reliable data suggest ‘that we are not sleeping less than we 
did but, perhaps, less than we now need’. In agreement with this, the British Time Use 
Survey using Office for National Statistics Omnibus Surveys, investigated time spent on 
main activities in 2005 in those over 16 years and showed that on average people slept 8 
h on weekdays and 8.8 h during the weekend or 8.2 h on average (Lader et al. 2006). In 
agreement with this. The American Time Use Survey 2003-2005 in respondents older 
than 14 years using phone interviews showed that Americans slept (including napping) 
on average 8.3 h on weekdays and 9.3 h in weekends (Basner et al. 2007). Other 
authors also suggest that we may not need more sleep, but more free time (Anderson & 
Horne 2008).
In summary, different studies show different results on the average sleep duration in a 
population. This can be due to differences in the populations studied e.g. age, gender 
and ethnicity (see also section 1.8) and prevalence of sleep disorders and diseases. It 
could also be related to the specific questions asked such as sleep on weekdays 
compared to sleep on weekend days.
1.2.2 Sleep duration, metabolic and cardiovascular function
The previous section gave an idea about the prevalence of different sleep durations in 
the population. However, for how many people is short sleep duration associated with 
adverse effects on cardiovascular and metabolic function? When answering this 
question, specific conditions such as obesity, hypertension or diabetes can be 
considered as subsets of risk factors for CVD. The metabolic syndrome, for instance, is
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one of the well known clusters of symptoms associated with increased risk for CVD 
(Shaw et al. 2005) (see section 1.1).
Indeed, recently, various reviews have elaborated on the effects of sleep duration on 
metabolism, obesity, diabetes and CVD, although the majority of these reviews come 
from the same group of researchers (Copinschi 2005; Crispim et al. 2007; Knutson et al. 
2007; Martins et al. 2008; Mullington et al. 2009; Schultes et al. 2005; Spiegel et al. 
2005; Spiegel et al. 2009; Trenell et al. 2007; Van Cauter et al. 2007; Van Cauter & 
Knutson 2008; Wolk et al. 2005). Generally taken, it is thought that there is a U-shaped 
association between sleep duration and all-cause mortality. This U-shaped relationship is 
also found in most, if not all, studies on sleep deprivation and metabolic/cardiovascular 
function (Alvarez & Ayas 2004; Gangwisch et al. 2006; Sabanayagam & Shankar 2010; 
Taheri et al. 2004). Sleep deprivation, per se or alongside a medical condition or sleep 
disorder such as sleep apnoea, is indeed associated with metabolic syndrome and CVD 
(Spiegel etal. 2009).
In a population of men and women with and without sleep apnea/hypopnea in The Sleep 
Heart Health Study it was shown that those with a habitual sleep duration of less than 6 
h were at higher risk for diabetes mellitus and an impaired glucose tolerance test 
(Gottlieb et al. 2005). Other aspects of cardiovascular function have also been 
investigated, for example in the same study but in a larger subject group, it was shown 
that in those sleeping less than 7 h, the prevalence of hypertension was increased after 
adjustments were made, also for the prevalence of diabetes mellitus and CVD (Gottlieb 
et al. 2006). In agreement with this, a recent national health and nutrition study in a 
population without sleep disorders has shown that sleeping 5 h or less increased the risk 
for hypertension but only in those aged 32-59 years, not in the oldest age group, even 
after strict adjustments for factors like alcohol consumption, obesity and diabetes 
(Gangwisch et al. 2006). Recent results from the National Health Interview Survey in 
over 31,000 American adults showed that a self-reported sleep duration of < 7 h (or < 5 h 
in the multivariable model) was associated with a higher risk for CVD even when 
multivariable adjusted (Sabanayagam & Shankar 2010).
As is the case for the studies above, most epidemiological data include self-reported 
sleep duration, creating another type of limitation of these studies. The only study to my 
knowledge using polysomnography (PSG) as an objective method to assess sleep 
duration showed that amongst people with an habitual sleep of less than 8 h, shorter 
sleep was associated with a higher body mass index (BMI) and if sleep was less than 5
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h, with low leptin levels (Taheri et al. 2004). Unfortunately, PSG was only carried out for 
1 overnight and showed higher grehlin levels in those who slept less than 5 h on this 
night. Both leptin and grehlin results were adjusted for age, sex and BMI. The 
observation that there may be an independent link between weight gain and short sleep 
was also shown by a recent meta-analysis (Patel & Hu 2008). However, the association 
was less clear in adults than in children. A study on the heritability of sleep duration and 
obesity indicated that self-imposed sleep restriction is associated with elevated BMI, 
independent of genetics and a common living environment (Watson at ai. 2010).
Despite the outcomes from these large studies, some researchers still doubt whether this 
statistical significance actually implies a clinical risk as very short sleep (5 h) is not so 
common and most short sleepers are not obese and do not suffer from the metabolic 
syndrome (Horne 2008). Moreover, many epidemiological studies assess cardiovascular 
and metabolic function in short sleepers with sleep (-associated) disorders which makes 
it difficult to assess the effects of sleep deprivation per se, even after adjustments have 
been made. Another factor which compromises interpretation of the results is the already 
mentioned U-shaped association between sleep duration and various risks. This 
indicates that sleeping more than 8 or 9 h might also be associated with negative health 
effects (Youngstedt & Kripke 2004). Indeed some of the previously cited studies on sleep 
deprivation show aversive health effects of sleeping longer than 8 or 9 h (Gottlieb et al. 
2005; Gottlieb et al. 2006; Sabanayagam & Shankar 2010; Taheri et al. 2004). This 
emphasises that it is very difficult to tease out the various interactions and cause- 
consequence relationships in epidemiological studies.
There are no epidemiological studies on the association between sleep deprivation and 
FMD and HRV, apart from studies on the relation between sleep problems and 
cardiovascular function (e.g. primary insomnia is associated with lower variance within 
HRV (Spiegelhalder et al. 2010).
1.3 General epidemiology of shift work and metabolic and cardiovascular 
function
1.3.1 Shift work
One of the reasons for the short sleep duration reported in previous sections may be the 
demand for shift work. In today’s 24/7 society sleep is under high pressure. Self-selected
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as well as imposed work-related and social requirements put a heavy burden on sleep 
timing, duration and quality. The high demand for shift work is illustrated by national 
statistics showing that in 2009 14.5% of the UK working population (2,892,5000) (ONS 
Labour Force Survey 2010) was involved in some type of shift work (4,206,000) (ONS 
Labour Force Survey 2009) (see Table 1.2).
An EU wide study showed slightly higher numbers in 2000 (Boisard et al. 2002). The 
survey on working conditions carried out in 15 EU countries showed that almost half of 
the working population was engaged in ‘evening or night shifts’, ‘shift work’ or ‘alternating 
shifts’ and that 18.8% of the employees had at least 1 night shift a month.
Not only the general definition of shift work may vary, but also within shift work it is 
difficult to make subgroups as there is an infinite number of combinations of shifts and 
shift schedules (Costa 2003; Foster & Wulff 2005) also indicated by the fairly large ‘other 
type of shift work’ group in Table 1.2. For instance, in 126 train drivers and 104 traffic 
controllers, 4 combinations of schedules ending in a night shift and 4 ending in a morning 
shift were possible within 48 hours of irregular shift work (Sallinen et al. 2003). 
Obviously, these shift schedules strongly influence sleep (see also section 1.7) and 
napping schedules. One study found that sleep duration and napping before the shift 
were dependent on the combination and the timing of the shifts (Sallinen et al. 2003). In 
agreement with this, the timing of the shifts and speed of shift rotation affected sleep 
length and sleepiness in counter clockwise and clockwise rotating shift schedules (Cruz 
et al. 2003; Hanna et al. 1998; Pilcher et al. 2000). Sleep before a shift was usually 
significantly shortened, while the occurrence and length of napping before or after a shift 
was highly dependent on the shift work pattern and other circumstances (Akerstedt 
2003). In addition, a wide range of shift work durations has been studied (section 1.3.2).
1.3.2 Shift work, metabolic and cardiovascular function
Previous research has suggested that shift work might not be without risk and it is 
thought to have consequences for mental and physical health (Costa, 2003). A major 
concern has been the association of shift work with CVD, which is the primary cause of 
morbidity and causality nowadays (section 1.1). This is association is supported by 
animal research showing that ‘chronic circadian desynchronisation (reversal of the light- 
dark cycle) decreased survival by 11% in hamsters with cardiomyopathic heart disease’ 
(Penev et al. 1998).
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Table 1.2. Shift patterns^ for people In employment*
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009
Three-shift working 677 599 542 501 543 501 504 480 454 415 400
Continentai shifts 154 148 164 136 136 136 124 106 108 100 99
Two-shift system eariy/late-double day 1,351 1,338 1,249 1,265 1,284 1,265 1,168 1,229 1,242 1,188 1,178
Sometimes nights sometimes days 525 561 549 551 616 551 561 624 646 625 557
Spiit shifts 162 159 163 165 151 165 188 173 182 188 160
Morning shifts 108 99 97 106 115 106 125 114 123 116 111
Evening or twiiight shifts 243 258 241 256 226 256 250 223 242 227 211
Night shifts 440 445 430 428 418 428 412 422 386 388 349
Weekend shifts 47 40 47 74 54 74 67 59 73 78 70
Other type of shift work 837 951 977 1,009 987 1,009 960 1,012 993 1,022 1,071
Totai shift work 4,546 4,600 4,461 4,493 4,532 4,493 4,361 4,444 4,451 4,350 4,206
* Applies to all respondents in employment who may do shift work. Values are numbers of people 
in thousands.
Three-shift working, day divided into three working periods: morning, afternoon and night; 
continental shifts, continuous three-shift system that rotates rapidly; split shifts, full shifts divided 
into two distinct parts with a gap of several hours in between; morning shift, if full-time: most 
commonly 0:600-14:00 h; evening shift, if full-time: most commonly 15:00-24:00 h; night shift, if 
full-time: most commonly 18:00-06:00 h, and usually continuing after midnight; weekend shift, 
work during Fridays, Saturdays, Sundays (06:00-18:00 h), when there is no other work; other type 
of shift work, only when none of the above apply.
Adapted from: ONS Labour Force Survey (2009).
A comprehensive meta analysis has shown that shift work is associated with a broad 
range of changes in metabolic and cardiovascular factors; especially higher levels of 
TAGs and total cholesterol tended to be more prominent in studies of better quality 
(Boggild & Knutsson 1999). The authors concluded that SW have an estimated 
increased risk of CVD of 40%. Because of the completeness of this analysis, only later 
studies confirming these data or adding some new perspectives will be discussed 
hereafter.
 ^ In addition to the definitions in Table 1.2 more details on the shift patters are as follows: three-shift working, this kind of 
shift work usually, but not always, involves one or more weeks of mornings, followed by one or more weeks of afternoons, 
followed by one or more weeks of nights; continental shifts, e.g. three mornings, then two afternoons, then two nights; two- 
shift system, earlies and lates or double day shifts. Usually there is a break between shift changes; two-shift system, 
normally two shifts of eight hours each, e.g. 06:00-14:00 h and 14:00-22:00 h. Shifts are usually alternated weekly or over 
longer intervals; split shifts, used in industries where peak demands are met at different times of the day e.g. catering, 
passenger transport and service industries; morning shift, this code is used if the morning shift is the only shift worked or 
worked part time during the morning; evening shift, also used for a  part-time shift 17:00-21:00 h or 18:00-22:00 h. Part- 
time evening shifts are usually called twilight shifts; night shift, this code is used only for permanent night work.
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CHD was indeed significantly higher in a recent cohort of rotating SW (13.5%) compared 
with daytime workers (7.1%) (on average almost 15 years of work before the diagnosis) 
(Ellingsen et al. 2007). Prevalence of coronary artery disease (CAD)/myocardial 
infarction (Ml) or hypertension/brain strokes was about twice as high in SW than in NSW. 
When investigating CVD risk factors, a later population based cross-sectional study 
assessing health at 30, 40, 50 and 60 years of age again indicated a higher prevalence 
of decreased HDL-cholesterol (< 0.9 mmol/L in men, < 1.0 mmol/L in women) (at 30 
years of age) in SW, increased TAGs (> 1.7 mmol/L) (in 40 year old men and women 
and in 60 year old women), but also increased BMI (> 30) (in almost all groups) 
compared to day workers (Karlsson et al. 2001). Female SW had higher total cholesterol 
levels (except for women who were 30 years old) and impaired glucose tolerance (at 60 
years). Other cross-sectional data from a sub-population within the work, lipids and 
fibrinogen (WOLF) study showed significantly higher fasting insulin (8.2 mU/L compared 
to 7.5 mU/L in day workers) (~ 49.2 pmol/l compared to 45 pmol/L), a higher percentage 
of hypertriglyceridaemia (> 1.7 mmol/L), increased waist-hip ratio (WHR) (> 0.9) and 
lower HDL-cholesterol (< 0.9 mmol/L), but similar prevalence of hyperglycaemia (> 7 
mmol/L) amongst SW (Karlsson et al. 2003). These results were presented for all age 
groups (and both genders) together but there appeared to be some differences between 
those older than 50 years compared to the younger group. Shift work duration was not 
reported, only that subjects had to be permanently employed. In addition, the study did 
not assess at what circadian time blood samples were taken, but that they were taken 
earlier in SW than in day workers. This is important as differences in circadian phase and 
not shift work itself may result in changes in the parameters (see section 1.4). Other 
population-based cross-sectional data showed some additional changes in SW, such as 
increased BMI (27.1), WHR (0.95), diastolic blood pressure (78 mmHg) and morning 
blood concentrations of fasting insulin (65.5 pmol/L), HOMA (2.1), TAGs (1.7 mmol/L) 
and uric acid and a higher leukocyte count (independent of other factors) (Sookoian et 
al. 2007). Like in many other studies on SW, it was not stated what the history of shift 
work was and when these blood samples were taken in relation to the shifts.
A cross-sectional study which actually included the duration of shift work, also compared 
male SW in manufacturing industry (average age 29.1 years) and female nurses 
(average age 28.5 years) to day workers and assessed shift work duration (Ha & Park 
2005). A longer shift duration resulted in increased blood pressure in men, but 
decreased diastolic blood pressure in women, increased cholesterol in men but 
decreased in women and an increased WHR in women. There were no effects on fasting 
blood glucose levels. The authors proposed that the difference between male and
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females could be due to the so-called ‘healthy-worker effect’ in nurses; i.e. those who are 
healthier can cope for longer with aversive conditions and therefore measurements taken 
in these subjects are ‘healthier’. Gender differences could also be related to a sex- 
hormone effect.
In a very recent cross-sectional study, a well-defined cohort of rotating SW (on a 
schedule with 1 or 2 mornings, afternoons and nights and 3 or 4 days off) were 
compared to day workers (both groups had worked according to their schedules for 10 or 
more years) (Esquirol et al. 2009). Blood samples were taken from 198 men, at the start 
of a morning shift in the rotating SW and during the morning in day workers. Significantly 
higher TAGs (167.07 mg/dL ~ 1.9 mmol/L), free fatty acids (FFAs) (15.64 mg/dL ~ 0.55 
mmol/L), fasting glucose (91.7mg/dL ~ 5 mmol/L) and HDL cholesterol (47.84 mg/dL ~
1.2 mmolL) were reported in SW compared to day workers.
Prospective studies also show that the effect of shift work is not universal. At baseline 
309 male current rotating SW were at higher risk for CVD compared to 1220 NSW but 
they were not suffering from the metabolic syndrome (De Bacquer et al. 2009). However 
after a mean follow up time of 6.6 years and separated by age and years of rotating shift 
work, it appeared that rotating SW older than 45 years (n = 205) were at risk for the 
metabolic syndrome (OR 1.36 - 1.82), whereas this only held for SW younger than 45 
years if they had worked rotating shifts for more than 10 years (n = 67, OR = 1.61). This 
study showed that SW were at higher risk for CVD even after adjustment for initial 
confounding factors. However, the authors did not provide information about the shift 
work history especially before the baseline measurement. In addition, the group of SW 
assessed at follow up was not the same as the SW at baseline as some SW had left their 
jobs which may indicate the ‘healthy worker effect’. In agreement with this, a prospective 
study in a cohort of nurses showed that those nurses who slept 5 h or less, had an 
increased risk of CHD, non-fatal Ml or fatal CHD, of around 90%, even after adjustment 
for smoking, BMI and other confounders (Ayas et al. 2003b). In the same cohort, the 
authors also observed an increased risk of diabetes of around 50% for short sleepers 
(Ayas et al. 2003a). This association remained after adjustment for various factors but 
the relation to short sleep disappeared after controlling for BMI. However, when severe 
diabetes was focussed on, the risk remained significant.
By contrast a recent meta-analysis concluded that ‘there was limited epidemiological 
evidence for a causal relation between shift work and ischaemic heart disease (IHD)’ 
(Frost etal. 2009). The authors reviewed 7 papers on death from IHD, 6 on the incidence
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and 1 which reported both. Two mortality studies showed an increased risk, whereas 6 
studies found a risk around 1. Six out of 7 studies including both fatal and non-fatal 
incidence data showed a slightly higher risk. However, not all studies were of high quality 
and had properly described exposure to shift work or controlled for confounders. In 
addition, in a recent study investigating the effect of shift work on hypercholesterolaemia 
(> 5.7 mmol/L), the authors concluded that they did not observe a consistent link 
between shift work and cholesterol levels (Dochi et al. 2008). The relationship was only 
significant after adjustment for many factors but not after adjustment for age or a few 
other factors. In agreement with this, a cohort study showed that SW had a significantly 
higher BMI and WHR than day workers but total cholesterol, LDL and LDL/HDL were 
only non-significantly higher in the SW. Working shifts for one year, showed only an 
aversive effect on smoking, whereas BMI and the LDLVHDL ratio decreased in SW, 
which was a significantly different change compared to day workers (van Amelsvoort et 
al. 2004).
HRV has been assessed in SW (Togo & Takahashi 2009), but not in many 
epidemiological studies. Some studies with larger subject numbers observed a lower 
mean SDNN for all 5 min segments in the recordings (SDNN index) during sleep and 
work in 103 SW compared to 32 day workers (van Amelsvoort et al. 2000) and a higher 
normalised low frequency power (LF norm, (LF/(LF+HF) or LF/(total power)) when night 
shift days were compared to morning shifts days in 65 SW especially in irregular shift 
systems (Van Amelsvoort et al. 2001a). LF norm and LF/HF were higher after 2 day 
shifts in rotating nurses compared to nurses who had been on day shifts (Ishii et al. 
2005) or on day shifts for at least a year (Ishii et al. 2004). However, van Amelsvoort et 
al. (2001b) did not find any significant differences in HR, SDNN index and HF when they 
compared 49 SW with 22 day workers (partly from the same population) after a 1 year 
follow up. In addition, another study observed no significant differences in LFnorm and 
LF/HF between 153 male SW and 87 male day workers (Murata et al. 2005). There is 
only one study to date assessing FMD in SW, but this is a smaller scale field study and 
will therefore be discussed together with other studies on HRV in Section 1.7.
In summary, the above studies have shown some inconsistent results. This indicates that 
caution should be taken when drawing conclusions about the risks of shift work as the 
effects may depend on various factors. From most studies it is not entirely clear what the 
best predictor for CVD risk is, namely duration, type or timing of shift work. This results 
largely from the fact that most studies simply do not report these aspects in much detail
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or mention wide shift work ranges or average shift work durations. To illustrate this, the 
studies on FMD and HRV mentioned in section 1.3.2 and 1.7 included subjects with shift 
work duration ranges from 0.5 -  37 years (Ishii et al. 2005; Mitani et al. 2006; Munakata 
et al. 2001) and averages from 3 - 1 7  years (Amir et al. 2004; Chung et al. 2009; Furlan 
et al. 2000; Murata et al. 2005; Su et al. 2008). Such ranges and differences in shift work 
durations were also found in the data on metabolic syndrome and CVD (De Bacquer et 
al. 2009; Ha & Park 2005; van Amelsvoort et al. 2004) summarised in this section. It is, 
therefore, unclear after how many years changes in metabolic and cardiovascular 
function would start to become overt. Some studies suggest no relationship with the 
duration of shift work at all while others indicate a linear relationship (Boggild & Knutsson
1999). This statement was also reinforced by a recent editorial of Boggild (2009), who 
proposes that future epidemiological studies should accurately describe the type of shift 
work, shift work schedules, amount of shift work per month or year and number of years 
in shift work. He also suggested that differences between studies could be due to the 
control group used for comparison, selection into, out of shift work, the ‘healthy-worker 
effect’ (Knutsson 2004) and confusion about the difference between confounding 
variables (which are not affected by shift work and can be adjusted for) and mediating 
factors (which can be affected by shift work and do not necessarily have to be adjusted 
for, e.g. cholesterol). This decision is not always easy to make as some factors, such as 
smoking, can fall into either of the groups (Boggild 2009; Nabe-Nielsen etal. 2008).
1.4 Sleep and circadian rhythms
1.4.1 Regulation of sieep
There are many brain areas involved in the regulation of sleep and wakefulness, but the 
core components are thought to be located in the hypothalamus. According to the widely 
accepted “flip-flop switch" model, this is where the actual transition between sleep and 
wakefulness takes place (Saper et a i 2005). Briefly summarised, the model proposes a 
mutual inhibition between monoaminergic cell groups in the brain stem, which are part of 
the ascending arousal system and the ventrolateral preoptic nucleus (VLPO) in the 
hypothalamus, promoting sleep. During wakefulness, monoaminergic cells inhibit the 
VLPO, thereby removing their own inhibition as well as suppression of the orexin 
neurons, which results in the prevention of sleep. During sleep, however, the VLPO 
inhibits the orexin neurons and the monoaminergic cells which in turn, causes 
disinhibition of the VLPO cells.
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For a long time it had been thought that sleep was a simple, uniform process. However 
in the 1980’s, it was proposed that sleep is regulated by 2 separate but interacting 
processes; the 2 process model (Beersma 1998; Borbely 1982; Daan etal. 1984) (Figure
1.2). This model proposes that sleep is driven by a homeostatic component, inducing 
higher sleep pressure after prolonged wakefulness (process S), as well as an 
endogenous oscillator with a clear day/night rhythm (process C). The homeostatic 
component (sleep or process S in the model) is usually compared to an hour glass. As 
wakefulness is extended, sleep pressure builds up, but at some point, the turning point, 
sleep occurs and the sleep pressure dissipates again.
Figure 1.2. Schematic representation of the two-process model of sieep regulation.
Process S (solid line) and process 0  (dotted line) interact to regulate sleep (S) and wakefulness 
(W). Adapted from Beersma (1998).
1.4.2 Regulation o f circadian rhythms
The endogenously generated circadian rhythms have a period around (circa) a day 
(dian). Circadian rhythms are generated by ‘an internal clock’, located in the 
suprachiasmatic nuclei (SON) of the hypothalamus (Ralph at al. 1990) and are present 
even in the absence of external time cues or ‘zeitgebers’. The most important cue for the 
human circadian system is light (Duffy & Wright 2005), which synchronises the internal 
rhythms to the 24 h day. Circadian rhythms are most frequently described in melatonin, 
cortisol, body temperature and sleep/wakefulness (Czeisler at al. 1999) but they also 
drive the cycles of many other processes in the body, such as metabolic activity and 
cardiovascular function (section 1.5). This is important to bear in mind since for many 
functions assessed, the outcome will be (partly) dependent on the time with respect to 
the internal clock (i.e. circadian time or phase). Although the clock located in the SCN is 
regarded as the ‘master clock’ it is also known that there are oscillators in peripheral
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tissues, so-called peripheral clocks. These are thought to be synchronised to each other 
and to the master clock (Maywood et al. 2007) and play and important role in metabolic 
function (section 1.5.1.2).
A way to asses the timing of the clock in the SON is by assessing the timing of a 
characteristic point within a circadian rhythm, a circadian phase marker. The most 
reliable phase marker is thought to be melatonin (Arendt 2003; Klerman et al. 2002), a 
hormone which is produced by the pineal gland in the brain in response to signals from 
the SCN. It can be measured in plasma and saliva, of which the latter was done in this 
project (section.5.2.1). Assessment of melatonin profiles has to be performed in 
controlled conditions and the collection of samples and analysis of the data requires 
time. Therefore, an a priori circadian phase assessment can simply be done by looking 
at wake up time. In volunteers with a regular sleep-wake cycle wake up time is closely 
related to a reproducible circadian phase assessed by melatonin (Burgess et al. 2003; 
Revel I et al. 2005).
Circadian rhythms are only reliably investigated under certain conditions. The first type of 
protocol discussed in following sections is a constant routine (CR) protocol first proposed 
by Mills et al. (1978). In this protocol external factors known to influence the clock are 
minimised (i.e. no sleep, constant posture, dim light and regular or constant nutrition 
(Duffy & Dijk 2002)). The second type is a forced desynchrony (FD) protocol (Kleitman & 
Kleitman 1953) where subjects are usually put on a sleep-wake (or more correct: rest- 
activity) schedule with a cycle length longer (around 28 h) or shorter (around 20 h) than 
24 h but still with 1/3 of the cycle spent asleep. This imposed sleep-wake cycle has a 
period which deviates too much from the endogenous period (which is a little longer than 
24 h in most people (Czeisler et al. 1999)) to remain entrained and will cause circadian 
rhythms to ‘free-run’ (Blatter & Cajochen 2007; Hiddinga et al. 1997; Wright et al. 2001). 
Both methods have an ‘unmasking effect’; a OR protocol (high sleep pressure) allows 
assessment of phase while a FD protocol (low sleep pressure) was originally designed 
for assessment of endogenous period. A FD protocol has the extra advantage that 
processes can be evaluated at different circadian phases but with the same time elapsed 
awake (and for this reason does not induce sleep deprivation).
Therefore, only studies using these OR and FD protocols are taken into consideration 
when assessing circadian rhythmicity of all parameters in section 1.5.
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1.4.3 Output pathways o f sleep and circadian rhythms
The above sections described how sleep and circadian rhythms originate and interact. 
This section focuses on how they control various processes in the body. It is suggested 
that the SON regulates its output to the periphery via a dual control mechanism 
(Kalsbeek et al. 2006a). In essence, this means that signals from the SCN are conveyed 
both via (neuro)endocrine and neuronal (autonomic) (and intermediate) pathways. These 
separated, but integrated polysynaptic pathways control multiple outputs such as the 
classical examples of cortisol, melatonin and body temperature, but likely also metabolic 
and cardiovascular function via balancing inhibitory (GABA) and excitatory (glutamate) 
pathways (Buys et al. 2006; Kalsbeek et al. 2006a; Kalsbeek et al. 2006b; Scheer et al. 
2003; Scheer etal. 2001) (Figure 1.3).
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Figure 1.3. Review scheme of the various SCN outputs.
Three main types of SON outputs can be discerned: connections with endocrine, preautonomic, 
and intermediate neurons. From: Kalsbeek et al. (2006a).
Misalignment of those endogenous biological rhythms with externally imposed schedules 
(e.g. in night shift work where individuals are often active during the rising phase of 
melatonin and eat during decreased metabolic activity) is one of the explanations for the 
above mentioned observations in SW (section 1.3.2) (Boggild & Knutsson 1999; 
Knutsson & Boggild 2000).
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Indeed, it has been shown that SW have a different dietary intake, with a higher energy 
intake in SW older than 30 years, especially in those with midnight shifts, compared to 
day workers (Morikawa et al. 2008). In addition, rotating shift workers have been shown 
to have a higher meal frequency, fewer calories at breakfast and more at the 
intermediate meals (Esquirol et al. 2009). Moreover, a high energy intake at dinner (time 
not specified) appeared to contribute to metabolic syndrome. However, after the 
adjustment for dietary intake the association with shift work remained present. In 
addition, altered metabolic responses have been observed when the same meal was 
provided during the night compared to during the day in simulated night shifts and non­
adapted SW (section 1.7). Secondly, lifestyle factors such as smoking and alcohol are 
said to be involved in the changes in metabolic and cardiovascular function observed in 
SW. And thirdly, disturbances in the homeostatic component of sleep (increased sleep 
pressure after prolonged wakefulness) may contribute to the observed alterations 
(Knutsson & Boggild 2000).
Although, there are some proposals as to how the SCN transfers messages to the 
periphery (e.g. via autonomic innervation), it is less clear how sleep affects the rest of the 
body. Some mechanistic links have been proposed between sleep and energy balance, 
but these mainly focus on feeding and appetite (Horne 2009; Tsujino & Sakurai 2009; 
Vanitallie 2006). As the function of the autonomic nervous system is all about the 
balance between activity and rest, an interaction between sleep and the autonomic 
nervous system is logical.
The autonomic nervous system is involved in involuntary actions, thereby affecting 
cardiovascular and metabolic function in various ways. It controls blood vessel diameter, 
heart rate, digestion and pancreatic, hepatic and intestinal function (Figure 1.4). The 
output is determined by the balance between parasympathetic and the sympathetic 
innervations. The parasympathetic system is active during periods of quiescence (‘rest 
and digest’) whereas the sympathetic nervous system is associated with active periods 
(‘fight-or-flight reaction’) (Hall & Nicolelis 2001). There are several central networks 
thought to coordinate these autonomic functions, of which the hypothalamus is a 
particularly important one. It is thought to ‘integrate autonomic response and endocrine 
function with behaviour’ (Iversen et al. 2000). In addition, autonomic outputs may affect 
each other, e.g. decreased insulin sensitivity and an increased insulin response have 
been linked to a higher heart rate (Facchini etal. 1996).
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Figure 1.4. The sympathetic and parasympathetic branches of the autonomic nervous 
system regulate metabolic and cardiovascular function.
From : Hall & N icole lis  (2 0 0 1 ).
As mentioned earlier, it is likely that there are interactions between sleep and the 
autonomic nervous system. Therefore, it is not surprising that brain areas involved in 
sleep are close to those regulating autonomic processes such as cardiovascular and 
metabolic function. For example, the hypothalamus contains the key components 
regulating the transition between sleep and wakefulness (1.4.1) but it also integrates
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autonomic responses. The preoptic area of the hypothalamus for instance, regulates 
blood pressure, while the tuberomamillary nucleus in the posterior part of the 
hypothalamus contains histamine producing cells involved in wakefulness and arousal 
(Iversen et al. 2000). Other anatomical studies have shown that neurons with differential 
activity during sleep and wakefulness have projections from the lamina terminalis and 
ventrolateral preoptic area to the lateral hypothalamic area (LHA) and paraventricular 
nucleus (PVN), which are regions involved in sympathetic activity during arousal 
(Uschakov et al. 2006).
The wake promoting factor orexin/hypocretin (Saper et al. 2005) in the lateral 
hypothalamus is possibly the most logical candidate for a common substrate for both 
sleep and metabolism, also mentioned by others (Horne 2009; Tsujino & Sakurai 2009; 
Vanitallie 2006). Neurons from the hypothalamus project to fat tissue, the liver and the 
pancreas (Kreier et al. 2006) and orexin has been shown to stimulate sympathetic 
neurons innervating these tissues (van den Top et al. 2003), which would lead to, for 
example, increased glucose mobilisation and altered insulin sensitivity (Shiuchi et al. 
2009; Yi et al. 2009). In addition, orexin has been suggested to stimulate sympathetic 
neurons in the raphe nuclei in the medulla innervating brown adipose tissue resulting in 
thermogenesis (Berthoud et al. 2005). Orexin containing neurons have also been shown 
to project to thyrotropin releasing hormone expressing neurons which are involved in 
vagally mediated gastrointestinal, pancreatic and hepatic functions and to extend into the 
ventral medulla thereby affecting heart rate (Berthoud etal. 2005).
An increase in cerebrospinal fluid orexin levels in both squirrel monkeys and rats as well 
as hypothalamic prepro-orexin mRNA levels in rats was regulated by circadian inputs as 
well as sleep pressure after sleep deprivation (Deboer et al. 2004; Martins et al. 2010; 
Zeitzer et al. 2007). In addition, the orexin system showed synaptic potentiation after 
prolonged wakefulness (Tononi & Cirelli 2007). Although the exact mechanism has not 
yet been defined, these studies indicate that an altered expression of and response to 
orexin during and after sleep deprivation may affect the balance between sympathetic 
and parasympathetic innervations, resulting in alterations in metabolic and 
cardiovascular function.
The interaction between sleep and metabolic and cardiovascular function may also occur 
via other neurotransmitters or neuromodulators such as adenosine. Adenosine 
accumulates during prolonged wakefulness in the basal forebrain and promotes the 
transition from wakefulness to slow wave sleep (SWS), but is also involved in brain
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energy metabolism (Porkka-Heiskanen et al. 2003). In addition, elevated levels of 
adenosine inhibit cholinergic neurons in the preoptic nucleus (Arrigoni et al. 2006) and 
impair performance on the rat psychomotor vigilance test (PVT) (Christie et al. 2008). 
However, it is not clear what role adenosine would play in transferring messages from 
the brain to the periphery.
1.5 Assessed parameters
1.5.1 Metabolism
1.5.1.1 Normal physiology of metabolism
The body takes up fuels in the form of macronutrients: carbohydrate, fat and protein, 
which are either oxidised or stored (Frayn & Akanji 2003). In the next sections the normal 
physiology of some subtypes of some metabolites such as glucose, TAGs and NEFAs, 
and their relation to lipoproteins, cholesterol and insulin will be described. Although these 
components will be discussed separately, they cannot be seen as independent, as their 
functioning is highly inter-linked. The connection between the tissues is mainly regulated 
by nervous and hormone systems. The tissues themselves are innervated by 
parasympathetic (from the prevertebral ganglia), sympathetic nerves (from the dorsal 
vagal nucleus) and enteric nerves (Iversen etal. 2000).
So called ‘substrate fluxes’ from and to the tissues are different in the fasting and 
postprandial states (Figure 1.5). Below, mainly the postprandial processes are described 
although the general mechanisms hold for both conditions (Frayn & Akanji 2003).
1.5.1.1.1 Glucose
The body obtains glucose as part of a meal and can produce glucose endogenously from 
stores in the liver. The blood concentrations of glucose depend on the nutritional state 
but are strictly regulated. During an overnight (10 h) fast (the post-absorptive state), 
circulating glucose is mainly the result of glycogen break down (glycogenolysis) and 
gluconeogenesis (from lactate, pyruvate and glycerol), in the liver. The steady state 
fasting concentration is 3 - 6 mmol/L (Frayn & Akanji 2003; Nussey & Whitehead 2001) 
in healthy subjects but will vary with age and other factors such as weight.
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Figure 1.5. Metabolism in the fasting and fed state.
From: Bender (2008).
When a meal is eaten, the glucose concentration rises but is tightly regulated and returns 
to fasting levels fairly quickly. Glucose absorbed from the diet is first converted (a 
process termed glycolysis) to lactate in non-hepatic tissue (for example, the gut) and, in 
the liver, is converted to pyruvate. This end-prodoct (and the intermediates) can be 
syntehsised back into glucose (glyconeogenesis), for example by using lactate as a 
substrate. After a meal, some of the circulating glucose is immediately used by the 
splanchnic (hepatic plus gastrointenstinal) tissues and muscle and adipose tissue. Most 
of the circulating glucose, however, is stored as glycogen in muscle and liver or 
converted to TAGs in adipocytes (DePronzo 1988; Nussey & Whitehead 2001; Randall 
etal. 1996).
1.5.1.1.2 TAGs, NEFAs and lipoproteins
TAGs belong to the category of simple lipids (esters of fatty acids with various alcohols), 
while NEFAs are derived lipids (hydrolysis products of simple or compound lipids). TAGs 
are primarily used as energy for the body rather than as structural components and are 
the major source of energy (and the principal component of dietary lipids) in a Western 
diet (Frayn & Akanji 2003; Griffin 2009). There are various processes in the digestion of
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fats, composing a chain of reception, émulsification, lipolysis, solubilisation and 
absorption of lipids (Griffin 2009) (Figure 1.6). The major processes in lipid homeostasis 
are lipogenesis and lipolysis. Lipogenesis is the synthesis of lipids (e.g. TAGs) from their 
constituent free fatty acids (FFAs) or NEFAs; lipolysis results in the production of NEFAs 
from lipids (Griffin 2009; Vernon etal. 1999).
After an overnight fast, NEFAs are produced by lipolyis of TAGs in adipose tissue and 
their concentration is around 0.5 -  1 mmol/L. They can be used by tissues such as liver 
and skeletal muscle as a source of energy via beta oxidation or taken up by the liver and 
adipocytes to be converted into TAGs. In the fasting state TAGs are again secreted from 
the liver as very low-density lipoprotein (VLDL) with a typical concentration of 0.5 -  1.5 
mmol/L (Frayn & Akanji 2003) (Figure 1.6). The rate of production of VLDL is determined 
by the delivery of fatty acids (FAs) to the liver, mainly from the circulation in the form of 
NEFAs (Griffin 2009).
Following ingestion of dietary fat, short and medium chain length FFAs go via the portal 
circulation (bound to albumins) to the liver. However, long-chain FAs, such as TAGs, and 
cholesterol have to be solubilised in order to be transported in watery medium like blood. 
Therefore, lipids and cholesterol associate with mixed micelles and are taken up by the 
enterocytes where re-esterification into TAGs takes place (Figure 1.6). Subsequently, the 
water soluble apolipoproteins are formed. TAG-rich apolipoproteins (chylomicrons (CMs), 
of which the size depends on the fat content of the meal), are released via lymphatic 
vessels into the blood, resulting in postprandial lipaemia. When measuring serum TAG, 
in fact TAG associated with TAG-rich lipoproteins are measured. In normal subjects, in 
the morning, these peak between 3 and 4 hours postprandially and return to basal levels 
after 5-6 hours. Sometimes, a TAG peak can appear within 30 minutes after ingestion of 
fat. This is thought to be preformed lipid from a previous meal, released into the 
circulation by the new arrival of fat. This is why day time postprandial responses can by 
bi- or polyphasic, whereas those after an overnight fast are usually monophasic (Griffin 
2009).
Subsequently, TAG in TAG-rich CM from the intestines and in VLDL from the liver (to a 
lesser extend in postprandial conditions since chylomicron TAG is preferred substrate) 
can be lipolysed into FFAs by endothelial lipoprotein lipase (LPL) (in peripheral tissues 
such as adipose tissue and skeletal muscle) or hepatic lipase (ML) (Frayn & Akanji 2003;
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Griffin 2009; Vernon et al. 1999). Moreover, hormone sensitive lipase (HSL) is 
suppressed by insulin resulting in a decreased release of NEFAs from the adipocytes 
(Frayn & Akanji 2003). In addition, both liver and fat tissues can synthesise FFA da novo 
from acetyl-CoA resulting from catabolism of carbohydrates (Nussey & Whitehead 2001 ; 
Vernon et al. 1999). However, this process has only a small contribution for humans on a 
Western diet (Griffin 2009).
Not only chylomicrons and VLDL, but also LDL and HDL belong to the group of 
lipoproteins, whose function is to produce, transport and release TAGs and remove 
cholesterol from the circulation (Figure 1.6).
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Figure 1.6. Metabolism of TAGs, NEFAs and lipoproteins.
T h e  m ain  lipids in lipoproteins are  free  and esterified  cho lestero l (G) and trig lyceride  (T O  or T A G ). 
T h e  m etabo lism  of T A G , low -density  lipoprotein  (LD L ) cho lestero l and  h igh-density  lipoprotein  
(H D L ) is show n. In T A G  m etabo lism , hydro lysed  d ie ta ry  fats e n te r intestinal cells  (en tero cy tes ) v ia  
fatty acid  (FA ) transporters . R econstitu ted  T A G  is p ac k a g e d  with 0  es te r into chylom icrons (C M s ). 
C M s  c ircu late  until they  in teract with lipoprotein  lipase (LP L). T h e  re leased  free  FA s (or N E F A s )  
e n te r p eriphera l cells and  are  resyn thesised  into T A G  in ad ipocytes. T A G  can  in turn be  
hydrolysed by h orm o ne sensitive lipase (H S L ). In liver cells (h ep ato cy tes ), T A G  is p ac k a g e d  with  
cho lestero l into very  low -density  lipoprotein  (V L D L ). T h e  T A G  con ta in ed  in V L D L  is a lso  
hydro lysed by LPL, re leasing  FA s and  V L D L  rem n an ts  (ID L ) that a re  hydro lysed  by h ep atic  lipase  
(H L ), th e reb y  y ielding LDL. LD L transports  cho lestero l from  the liver (w h e re  cho lestero l is 
recycled  or syn thes ized  de novo) to the periphery . H D L  m ed ia tes  reverse  cho les tero l transp ort by  
u ptake of cho lestero l and  then enters  h ep a to cy tes . A d ap ted  from  H e g e le  (2 0 0 9 ).
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All lipoproteins, apart from HDL, are derived from TAG-rich particles, which deliver FFAs 
lipolysed from TAGs to the tissues (Griffin 2009; Nussey & Whitehead 2001). This 
happens by means of a delipidation cascade in which TAG-rich chylomicrons and VLDL 
undergo lipolysis, resulting in the formation of cholesterol rich remnants and ultimately 
LDL (Figure 1.6). The more lipid is lost, the smaller, but heavier and denser the particle 
(Frayn & Akanji 2003; Griffin 2009). HDL particles are produced by the liver and the gut 
and increase their size when they obtain cholesterol from TAG-rich proteins and 
peripheral tissues. HDLs are the only particles which can remove cholesterol from the 
circulation. This is done in the form of cholesterol esters (CEs) in HDL which is 
transported to the liver. Intra-cellular cholesterol can either be synthesised by the liver 
cells or obtained by uptake and degradation of LDL particles. LDL is mainly taken up by 
the LDL-receptors of cells and uptake decreases with a higher intracellular cholesterol 
level (Griffin 2009).
Thus, the levels of serum TAGs and lipoprotein function are highly interlinked. When 
serum TAG levels and thus TAG-rich lipoprotein concentrations are increased, a net 
transfer of TAGs into HDL and LDL takes place. The high TAG concentration makes 
them sensitive to HL resulting in smaller, denser particles. Small, dense HDL is rapidly 
catabolised by the liver, leading to lower serum HDL levels and impaired CE transport 
(lower HDL cholesterol). Small, dense LDL is removed less effectively by its receptor and 
is more likely to be oxidised in the arterial wall (Griffin 2009). These observations in 
TAGs, LDL and HDL cholesterol are known as the atherogenic lipoprotein phenotype 
(ALP) (see also section 1.1) (Griffin 2009).
1.5.1.1.3 Insulin
Insulin forms an important link within this interconnected system as it plays a role in the 
synthesis and removal of TAGs, NEFAs and glucose. Insulin is secreted by the p cells of 
the islets of Langerhans in the pancreas. The major stimulus for this secretion is an 
elevation in blood glucose concentration, for example after consumption of a meal. The 
main target tissues for insulin are liver, muscle, adipose tissue and to a minor extent the 
kidneys (Evans etal. 2004; Frayn & Akanji 2003; Randall etal. 1996) (Figure 1.7).
Insulin mainly has an anabolic function. It controls glucose homeostasis through 
suppression of endogenous glucose production and glycogen breakdown and stimulation
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of glycogen synthesis and glycolysis by the liver as well as stimulation of glucose uptake 
by the splanchnic tissues, muscle and adipose tissue (DeFronzo 1988; Frayn & Akanji 
2003; Randall et al. 1996). This process is influenced by feedback from adipocytokines 
such as adiponectin, tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6).
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Figure 1.7. The role of Insulin and Its target tissues In glucose and llpid homeostasis.
Glucose derived from diet or endogenous sources stimulates insulin secretion. Insulin promotes 
glucose uptake by skeletal muscle and fat, opposes hepatic glycogenolysis and gluconeogenesis, 
and inhibits fat lipolysis. Free fatty acids liberated from adipose tissue contribute to insulin 
resistance in skeletal muscle and liver. Additional fat-derived signals, including TNF-a, resistin 
and adiponectin, modulate insulin sensitivity and fatty acid metabolism in muscle and liver. 
Adapted from Evans eta l. (2004).
Tissues which are sensitive to insulin are the liver and adipose tissue. Insulin inhibits 
intracellular lipolysis of stored TAG in adipose tissue by inhibiting HSL and oxidation of 
FAs in the liver (Evans at al. 2004; Frayn & Akanji 2003; Griffin 2009) and it stimulates 
LPL in adipose tissue, thereby activating removal of TAGs from the plasma (Frayn & 
Akanji 2003; Griffin 2009; Moustaid at al. 1996). It also stimulates TAG synthesis by the 
liver and adipose tissue and da novo lipogenisis by the liver (Frayn & Akanji 2003). In 
addition, insulin suppresses VLDL release from the liver (also due to a decreased NEFA 
release) and stimulates cholesterol synthesis. Therefore, in cases of insulin resistance.
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lipolysis of TAG-rich particles is impaired and mobilisation of NEFAs and VLDL release 
are less suppressed, contributing to postprandial lipidaemia (Griffin 2009).
Other factors that affect the regulation of macronutrient metabolism are glucagon, 
catecholamenines (epinephrine and norepinephrine), cortisol, growth hormone (GH), 
insulin-like growth factors, thyroid hormones and leptin (Frayn & Akanji 2003).
1.5.1.2 Metabolism, sleep and circadian rhythms
As discussed in section 1.4.3, circadian rhythms underlie cyclic processes in many bodily 
functions. This is also the case for metabolic function (Green et al. 2008; Laposky et al. 
2008). Other evidence indicating that the SCN and circadian rhythms are linked to 
metabolism comes from polymorphisms in clock genes that have been associated with 
alterations in the endogenous rhythmic regulation of metabolism in mice (Turek et al. 
2005) and humans (Monteleone et al. 2008; Scott et al. 2008; Sookoian et al. 2008; 
Woon et al. 2007). Metabolic activity has indeed been shown to have both a circadian 
and sleep-homeostatic component, but the extent to which either of these contribute may 
vary depending on the parameter and study looked at (Laposky etal. 2008; Morgan etal. 
2003).
A controlled study in eight healthy men, with constant dextrose infusion during nocturnal 
sleep, nocturnal sleep deprivation and diurnal sleep, showed 3 acrophases for glucose 
during these 3 parts of the protocol (2.5 to 5 h after sleep onset) but lower elevation 
during sleep restriction suggesting that circadian and sleep influences are superimposed 
(Van Cauter et al. 1991). The insulin secretion rate (ISR) and insulin levels paralleled 
these changes. Although ISR levels at the acrophase were equally high during sleep and 
sleep deprivation, no consistent acrophase for insulin was observed during sleep 
deprivation. The authors suggested that constant nocturnal insulin concentrations 
despite a rise in the secretion rate indicated circadian variation in insulin clearance, with 
a higher insulin disposal rate at night. Results of this study are in agreement with a later 
study which also showed a stable circadian rhythm in glucose levels during a CR but a 
more variable, though significant, rhythm in insulin (Shea et al. 2005). Both parameters 
showed a peak around the normal time of awakening. A study using a FD protocol with 
ORs before and after FD and hourly nutrition, showed that glucose and TAGs (and 
insulin non-significantly) are modulated by sleep and the endogenous clock (Morgan et
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al. 1998). NEFAs were too variable to assess. Other studies have indicated diurnal 
rhythms in insulin sensitivity. For instance a study by the same group, although not a CR 
protocol, demonstrated lower postprandial LPL acitivity around 23:30 h than 11:30 h 
suggesting decreased sensitivity of lipid clearance to insulin in the evening 
(Arasaradnam et al. 2002). Furthermore, these researchers showed that glucose levels 
after an insulin tolerance test (ITT) decreased slower at 20:30 h than at 8:30 h (Morgan 
et al. 1999). This coincided with higher fasting NEFA levels but a steeper decline in post- 
ITT NEFA levels in the evening than in the morning. The authors suggested that the 
glucose data are indicative of peripheral insulin insensitivity. By contrast the post-ITT 
NEFA levels suggest an increased sensitivity of HSL to insulin in the evening, 
suppressing the release of NEFAs. The authors propose that the combination of these 
data indicates a dissociation between the diurnal effects of insulin on carbohydrate and 
lipid metabolism and a NEFA-induced insulin resistance in the evening.
The presence of circadian rhythms (also in other aspects of metabolism such as energy 
expenditure or carbohydrate oxidation) does not only depend on the study and 
investigated parameter but also on the exact composition of the meal and pre-meals. 
When men where provided with 6 isocaloric meals across a 24 day, either high in fat or 
high in carbohydrates, circadian patterns were observed in glucose and NEFAs, but in 
TAGs only with the high fat diet (Holmback et al. 2002). Therefore, the possible effect of 
circadian rhythms in metabolic activity will also play a role, but to what extent remains 
unclear.
1.5.2 Endothelial function
1.5.2.1 Normal physiology of endothelial function
The endothelium is the layer of cells in the tunica intima, lining the lumen of all blood 
vessels. In order to deliver the appropriate amount of blood to a tissue, arteries have to 
be able to dilate and constrict. Arteries expand in response to various stimuli such as 
hormones, carbon dioxide, lactic acid and nerve impulses (Chiras 1999). The latter have 
a parasympathetic and sympathetic component. The sympathetic nervous system 
increases peripheral resistance by constricting small arterioles (increasing blood 
pressure), whereas parasympathetic stimulation has a smaller contribution and induces 
vasodilatation by mediators such as nitric oxide (NO) (Iversen etal. 2000).
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Arteries can also dilate simply due to the flow of blood itself (Nussey & Whitehead 2001) 
(Figure 1.8). This is called FMD and is an endothelium-dependent process. It is mainly 
brought about by shear-induced endothelial NO production, due to a temporary increase 
in blood flow: reactive hyperaemia (Fathi etal. 2004; Moens et al. 2005). A lower FMD is 
associated with deteriorated endothelial function (section 1.1).
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Figure 1.8. The genesis of FMD, in response to different changes in shear stress.
* very short-term changes; ** changes taking place over slightly longer periods (minutes); *** 
changes taking place over a longer time (many minutes or hours).
EDHF, endothelium-derived hyperpolarizing factor; eNOS, endothelial nitric oxide (NO) synthase; 
Kc, calcium-activated potassium channel; PGI2, prostacycline. Adapted from Moens eta l. (2005).
1.5.2.2 Endothelial function, sleep and circadian rhythms
As endothelial function is considered a predictor for CVD (section 1.1), changes in 
rhythms in endothelial function were assessed in relation to cardiovascular risk (Shaw et 
al. 2001). In addition, most studies investigated diurnal variation in factors linked to 
endothelial function other than FMD, such as thrombotic factors (Walters et al. 2003). 
Not much is known about circadian rhythms in endothelial function measured by FMD.
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There is only one study to date indicating that endothelial function assessed by FMD in 
CR conditions was lower in the morning and higher in the evening (Walters et al. 2006). 
FMD was also measured without CR conditions at 21:00 h, 6:00 h and 11:00 h but in 
supine position and after at least 4 h fast. (Otto et al., 2004). In agreement with the data 
from Walters et al. (2006) this protocol showed that FMD was decreased in the early 
morning compared to 11:00 and 21:00 h. Endogenously generated rhythms in vascular 
function might result directly from the activity of the SCN i.e. due to cycles in 
parasympathetic and sympathetic activity or indirectly via circadian rhythms in other 
factors which influence endothelial function. Examples of such interactions are melatonin 
acting on vascular melatonin receptors or increased blood flow, insulin and endothelin-1 
stimulating vasoactive mediators like NO and endothelium-derived hyperpolarizing factor 
(EDHF) which affect platelet aggregation, vessel relaxation and cell adhesion molecules 
like E-selectin (adapted from Walters etal. 2003).
1.5.3 Heart rate variability
1.5.3.1 Normal physiology of heart rate variability
HRV is defined as ‘the oscillation in the interval between consecutive heart beats as well 
as the oscillations between consecutive instantaneous heart rates’ (section 1.1) (Task 
Force of the European Society of Cardiology and the North American Society of Pacing 
and Electrophysiology 1996). The heart beat originates from the sinoatrial node (SA 
node), which is capable of spontaneous depolarisation, called the pacemaker potential. 
The generated action potential spreads through the atria via gap junctions and travels 
through the atrioventricular node (AV node) via the bundle of His into the Purkinje fibers 
in the ventricular walls. This causes the ventricles to contract and blood to be pumped 
into the circulation (Fox 1996). Heart rate and force of contraction are influenced by the 
balance between activity of parasympathetic nerves (from the ventrolateral nucleus 
ambiguus) and sympathetic nerves (from the cervical ganglia), mainly through 
stimulation by (nor)epinephrine and inhibition by acetylcholine (Iversen etal. 2000).
The depolarisation and repolarisation of all myocardial cells combined produce a 
potential difference between two electrodes placed on the surface of the heart (or 
anywhere else on the body) which can be displayed in an EGG. The different phases of 
the cardiac cycle are known as P, ORS and T waves (Figure 1.9) (Levick 2003). The 
exact shape of the EGG depends on the orientation of the heart, the position of the 
electrodes and any other conditions such as individual physiology or medical conditions
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(Levick 2003; Swanton 1986). In order to assess HRV, it is common practice as a first 
step to detect ORS complexes from the EGG, which mainly reflect ventricular 
depolarisation. Subsequently, various HRV parameters can be derived of which the most 
commonly used ones are SDNN and LF/HF (section 1.1).
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Figure 1.9. The basic pattern of eiectricai activity across the heart inciuding the schematic 
representation of a QRS compiex.
From: Ashley and Niebauer (2004).
1.5.3.2 Heart rate variability, sleep and circadian rhythms
Biological rhythms are found in cardiovascular function (Walters et al. 2003) (section
1.5.2.2). However, it is less clear what the relative contribution of circadian rhythms and 
exogenous factors (e.g. changing body posture) is. In rats there is a clear circadian 
rhythm in heart rate that is not caused by activity (Scheer et ai. 2001). This rhythmicity is 
only present when the SON is intact and it is thought to be regulated by a multisynaptic 
pathway containing neurons projecting from the SCN to the PVN and on to preganglionic 
sympathetic and parasympathetic nuclei of the heart (Scheer et ai. 2003; Scheer et al.
2001). In agreement with this, studies in humans have shown that circadian rhythms are 
likely to be present in some of the HRV parameters. A circadian rhythm was shown in 
SDNN with a peak between 4:45 and 7:00 h (Bonnemeier et al. 2003; Vandewalle et al. 
2007; Viola et al. 2002) although the study of Bonnemeier did not use a CR protocol. In 
addition, peaks were seen at 6:15 h for LF and 5:16 h for HF (Vandewalle et al. 2007),
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but not in other HRV parameters such as LF/HF (Vandewalle et al. 2007; Viola et al.
2002).
1.5.4 Sleep, alertness and mood
For a long time, it has been thought that sleep is a simple, uniform process. However, 
after the introduction of the electroencephalogram (EEG) in the 1920’s which allowed 
visualisation of electrical activity of the cerebral cortex (Saper 2000) by recording voltage 
differences between electrodes on the scalp, it became clear that sleep is comprised of 
different stages characterised by differences in the frequencies and amplitudes of the 
voltage differences in the EEG. Later, other measurements such as respiratory effort, the 
EGG, eye movements in the electrooculogram (EOG) and muscle tone in the 
electromyogram (EMG) were included in polysomnography (PSG), which was given its 
name in 1974 (Dement 2005). Initiation, depth and termination of sleep are regulated 
both by circadian rhythms and sleep pressure (section 1.4.1). Although the function of 
sleep is still largely unknown, inadequate quality, quantity and timing of sleep can have 
consequences for metabolic and cardiovascular function (sections 1.2.2 and 1.3.2). In 
addition, both alertness and mood are influenced by sleep; section 1.6 discusses that 
sleep deprivation has a large impact, especially on alertness. As assessment of the 
effects of sleep deprivation and shift work on mood and alertness are not the main focus 
of this thesis, these will only be briefly discussed in this and following sections.
The alert state is defined as ‘the change that occurs when a person awakens or when a 
person who could not respond to commands becomes able to respond to commands.’ 
Furthermore, ‘alertness is thought to be a family of states that differ by the degree of 
alertness (heightened attention, indifference, inattention, sleepiness)’ (Kandel 2000a). 
More specifically, alertness is referred to as ‘selective and sustained attention’, whereas 
the term sleepiness may be used for ‘the desire to sleep’ (Roehrs et al. 2005). 
Performance, a term which is often mentioned when discussing alertness and 
sleepiness, refers to ‘cognitive functions ranging in complexity from psychomotor 
vigilance and working memory to logical reasoning and complex thought’. There are 
numerous ways of assessing objective and subjective alertness (Roehrs et al. 2005), of 
which the subjective Karolinska Sleepiness Scale (KSS) (Akerstedt & Gillberg 1990) and 
9-digit rating scale and objective psychomotor vigilance test (PVT) (Dinges & Powell 
1985) were used in this project.
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The neural basis of alertness lies, generally speaking, in activation of the thalamus and 
cortex by neurons of the brain stem and its reticular formation. The major 
neurotransmitter systems, e.g. cholinergic, dopaminergic, serotonergic and 
noradrenergic neurons are involved in the regulation of alertness (Kandel 2000a). In 
accordance with this, good performance on the PVT involves the sustained-attention 
network and cortical and subcortical motor areas, whereas slow reaction times (RTs) 
have been associated with higher activation of ‘default mode’ brain areas, indicating 
inattention (Drummond et al. 2005). A positron emission tomography (PET) study in 
sleep deprived subjects also indicated that the thalamus and prefrontal and posterior 
parietal cortices may play a role in alertness and cognitive performance (Thomas at ai.
2000).
Mood, ‘in clinical descriptions of emotional states ... refers to a sustained emotional state 
lasting weeks or more, while the term affect (or affective response) refers to the 
immediate or momentary state of a person’ (Kandel 2000b). In this thesis these terms 
will, although not strictly correct, be used interchangeably. Amongst the normal affective 
responses are some parameters assessed in this project, such as elation and 
depression (Kandel 2000b) Calmness and cheerfulness may possibly strictly speaking 
not be affective responses but are here regarded as aspects of mood. As holds for 
alertness, aspects of mood have a neural and physiological basis. In the mood disorder 
familial unipolar and bipolar depression, for example, activity of the subgenual region of 
the frontal cortex is affected and antidepressants act on the serotonergic and 
noradrenergic pathways. In severe depression there are disturbances in the 
hypothalamus-pituitary-adrenal (HPA) axis with an excessive secretion of 
adrenocorticotropic hormone (ACTH) having extensive physiological consequences 
(Kandel 2000b).
1.5.4.1 Sleep, alertness, mood and circadian rhythms
One of the earliest studies into circadian rhythms in alertness used a OR protocol (40 h 
wakefulness) to assess this phenomenon and a FD protocol (9.33 h sleep, 18.67 h 
wakefulness for approximately 4 weeks) (Dijk at ai. 1992) to separate the effects of 
circadian modulation from prior wakefulness (section 1.4.2). Both protocols showed that 
subjective alertness (by visual analogues scale (VAS)) and calculation performance 
closely followed the rhythm in core body temperature (CBT). Both alertness and 
performance increased for the first 3 h after waking, then remained stable for 13-14.h
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and subsequently decreased with minimum alertness and performance around or just 
after, respectively, the CBT minimum usually approximately 2 h before habitual wake up 
time. The data also showed that the effect of prior wakefulness was strongest around the 
CBT minimum and weakest around the CBT maximum. A later study using a FD 
protocol for only 12 days showed similar results (Wright et al. 2002). Effects of time 
awake and circadian phase were shown on subjective alertness (VAS) and most of the 
PVT parameters: slowest 10% reaction time (SRT), fastest 10% reaction time (FRT) and 
lapses (RT > 500 ms) but not median reaction time (median RT). Lowest alertness and 
performance levels were observed around the CBT minimum. A FD protocol with lower 
sleep pressure (shorter rest-activity cycle of 20 h for 4 weeks) also showed an effect of 
time awake on and circadian modulation of median RT, lapses and KSS (Wyatt et al. 
1999). In addition, circadian modulation increased with more hours of prior wakefulness. 
These findings were also confirmed in a CR protocol, which demonstrated that subjective 
alertness (KSS) and PVT performance (mean reaction time (RT), median RT, SRT and 
FRT) were constant during the first 16 h after waking but then deteriorated and were 
worst 2-4 h after the melatonin peak (which is around 4 h before habitual wake up time) 
(Cajochen et al. 1999). Largest changes were revealed by SRT and the smallest 
differences by FRT. A stable performance during approximately 16 h of wakefulness and 
a deterioration after that was also seen in young and postmenopausal women (Urrila et 
a/. 2007).
In agreement with these observations, a longer FD protocol (6 weeks) investigating 
objective alertness showed that all 3 assessed PVT parameters, mean RT, lapses and 
SRT were regulated in a circadian manner (Lee et al. 2009). The protocol also showed 
effects of time awake on the PVT parameters. In addition, mean RT and lapses showed 
a stronger circadian modulation of the effect of wakefulness at 60-, just after the CBT 
minimum at 0-. In contrast to the previous studies, mean RT and SRT increased from 6 h 
awake, not 16 h, whereas lapses increased continuously. A worsening PVT performance 
across the 6 weeks, even when returning to ‘normal’ circadian phase, indicated a build 
up of sleep debt despite a normal sleep-wake ratio. .
Also by using a ‘nap protocol’ (10 cycles of 75 min scheduled sleep and 150 min 
scheduled wakefulness) in order to create identical time elapsed awake between 
measurements in addition to elimination of the effects of sleep deprivation, it was shown 
that subjective sleepiness (KSS) displayed a circadian rhythm (Cajochen et al. 2001). 
Maximum sleepiness was observed just after the CBT minimum. When objective 
alertness in the nap protocol was compared with a CR protocol, it was confirmed that
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lapses, SRT and FRT showed circadian modulation and that lapses and SRT were 
affected by prolonged wakefulness (they increased between 23.75 and 35/38.75 h of 
sleep deprivation in the CR protocol) (Graw et al. 2004). However, FRT appeared not to 
be sensitive to sleep deprivation.
Another nap or ultra short sleep/wake protocol (around 18 cycles of 1 h sleep, 2 h wake) 
also showed circadian rhythms in sleepiness (Stanford Sleepiness Scale (SSS)) and 
PVT parameters (mean RT, median RT, FRT and 1/SRT (SRRT)) as well as in mood 
(Profile of Mood States Questionnaire (POMS), and total mood disturbance (TMD) (Kline 
et al. 2010)). In accordance with previous findings, a trough in PVT performance and, in 
this study in, mood was observed between 0- (intra-aural body temperature minimum) 
and 30- and largest sleepiness around the temperature minimum (330 - 60°). FD 
protocols also showed a circadian rhythm in mood (VAS scales for cheerfulness and 
happiness) but the authors state that ‘the time at which the circadian variation of mood 
reached its trough depended on the duration of prior wakefulness’ (Boivin etal. 1997).
These studies indicate that mood and both subjective and objective alertness/sleepiness 
are modulated by the circadian as well as the homeostatic component. It appears that 
during the first 16 h of wakefulness subjective and objective alertness are fairly stable 
but deteriorate if wakefulness is prolonged beyond this, resulting in an alertness dip 
around the minimum body temperature and worst performance just after. The circadian 
dip in alertness has been shown to be worsened as wakefulness is more prolonged and 
sleep deprivation gets more severe.
1.5.4.2 Correlation between subjective and objective sleepiness
As people generally feel they are slower and less accurate when they are sleepy, it is 
striking that measures of subjective and objective sleepiness do not correlate as well as 
expected. When a dose-response relationship between hours of sleep in the previous 
night and either sleepiness (SSS) or PVT performance was investigated, it also 
appeared that although both improved in a saturating exponential manner with more 
sleep, subjective sleepiness improved more slowly than PVT performance (Jewett et al. 
1999). Another study found significant differences between subjects in the number of 
lapses during 40 h sleep deprivation whereas sleepiness levels according to the SSS 
were not different (Van Dongen et al. 2004). These results indicated that there is no clear 
correlation between subjective and objective sleepiness. Similarly, sleep onset latency
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on the multiple wakefulness test for objective alertness decreased substantially in the 
worst performers whereas their SSS scores were not affected (Frey et al. 2004). In 
agreement with this, Fanzen et al. (2008) also observed independence between lapses 
and speed on one hand and subjective sleepiness on the other hand (Franzen et al.
2008). In addition, the VAS for global vigor score has been shown not to correlate with 
computerised RT and lapses under CR conditions (Leproult etal. 2003).
1.6 Laboratory studies on sleep deprivation
Whereas the previous sections described epidemiological studies on sleep duration, this 
section describes laboratory studies on healthy individuals experimentally subjected to 
sleep deprivation. Only human studies assessing the same parameters as the current 
study are included in Table 1.3 and Table 1.4 and are discussed in the subsequent 
sections. Studies on alertness and mood are not included in the tables as this was not a 
major topic within this thesis. In addition, processes ocurring during s\eep deprivation are 
not discussed here as they are discussed in the sleep/circadian sections of each 
parameter.
1.6.1 Total Sleep Deprivation (TSD)
In studies on TSD, subjects are kept awake for at least one complete night. The main 
studies on the effects of TSD on metabolic and cardiovascular function are summarised 
in Table 1.3.
Table 1.3. Overview of laboratory studies on the effects of total sleep deprivation on 
cardiovascular and metabolic function.
Study Sub
Jects
Protocol Parameters
measured
Changes after TSD
Base
line
TSD Reco
very
Ewing
(1991)
8 M DN 48 h D N /
2
nights
-N N 50
-HR
At night 
-N N 50 i  
- H R Î
Effect of rec sleep not 
reported
Gonzaliz 
-Ortiz et
28, 14 
exp and
DN 24 h 
TSD
no In both groups: 
-BP
-SSG  of 1ST Î
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Study Sub
Jects
Protocol Parameters
measured
Changes after TSD
Base TSD 
line
Reco
very
al.
(2000)
14
control
plus
within
subject
compari
son
in exp
/
norm
al
sleep
in
contre
I
-creatinine 
-uric acid 
-total chol 
-HDL  
-TAG  
-VLDL
Before and after TSD: 
-modified 1ST 
-cort
Gould et 
al.
(2009)
5 M
Han et 
al.
(1992)
64 M
Pagani 12F, 12
et al. M
(2009)
no 60 h no -LF/HF
-KSS
-navigation 
performance 
-task load and effort 
-EO G  (non-wake 
epochs)
7 h /1  76-80 no -actigraphy in 36 M
night h -electrolytes
-kidney and liver
function
-cort
-thyroid function
-glue
-lipids
7 24  h no -H R V
nights -AP
-NN
-baroreflex 
-performance 
-tiredness (11-digit 
scale)
-stress
-cort
-KSST
-phosphorus f
-A S T Î
-ALTT
-morning cort î  
-evening cort |
-morning T 3  j  from PSD
day 1 to 2
-TAGS i
- H D L Î
-apo B/A1 I
-tiredness t  
-stress Î  
-R T and S R T  t  
- N N |
-B R S î
Sauvet 12 M 8 h / 2  40h 8 h / 1  -PSG
etal. nights night -ICAM-1
(2009) -E-selectin
-VCAM-1
-hsCRP
-IL-6
-IL-p
-TN F-a
-(nor)epinephrine
-cort
-microvascular
reactivity: endothelium
(in)dependent
vasodilatation by SNP
and Ach
-BP
-H R V
-PSG
-reactivity i  at 12:00 for 
Ach and at 12:00 and 
18:00 for SNP  
-E-selectin î
-HR T, LFnorm j ,  HFnorm  
I  at 15:00 and 18:00 
-SBP t a t  15:00 
-ICAM -1, IL-6 and 
norepinephrine t  only 
after rec
-subjects remained awake  
during TSD
Schmid 
et al.
1 0 M 1
night
no Basal and HGG: 
-ins
-C-peptide:basal i  but 
attenuated decrease
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Study Sub
jects
Protocol Parameters
measured
Changes after TSD
Base TSD 
line
Reco
very
(2007) comp -glue during HGC
ared -glucagon -glucagon: basal and HGC
t o 7 h -C-peptide I  but stronger increase
sleep -(nor)epinephrine during end of HG C when
(cross -ACTH normalised to basal
over) -cort -basal cort |
-GH -normalised HCG GH |
-lactate -overall NEFA J,, sign at
-P-hydroxybutyrate end of HGC
-NEFAs -basal hunger |
-hunger -subjects remained awake
-PSG during TSD
Van 8 M 8 h / 2 28 h 8 h -glue -no change in glue after
Cauter nights day -ins TSD
et al. time -C-peptide
(1991) -cort
-G H
-ISR
Van 10 M DN 60 h 7 h / 1 -O G TT -O G TT ins T
Helder night
et al. 
(1993)
Vendra  
et al. 
(1986)
7 M DN h/ 
3
nights
120 h DN h
/ 4
nights
-muscle total chol, free -rhythm in plasma TAG
Zhong ef 19 M, 2 
al. F
(2005)
no 12, 14 
and 
36 h
no
chol, non-collagen 
protein, LCAT  
-serum total chol, 
TAGs, total protein, 
haematocrit
-SBP
-DBP
-MAP
-HR
-(LF/HF) HRV
-(LF/HF) BPV
-BRS
-NN
-RT
-ESS
dampened 
-serum chol had no 
rhythm but level |  
-LCAT i
-muscle total and 
free chol J,
All reversed by rec
-Changes in physiology 
dependent on supine or 
seated position and on 
amount of TS D  
-R T  Î  
-E S S î
Abbreviations and symbols used: i  = decreased or smaller, |  = increased or larger, Ach, 
acetylcholine; ACTH, adrenocorticotropic hormone; AP, arterial pressure; apo, apolipoprotein; 
AST, amino transferase; ALT, alanine amino transferase; BP, blood pressure; BRS, barorefelx 
sensitivity; chol, cholesterol; cort, cortisol; DBP, diastolic blood pressure; DN, data not available; 
EOG, electrooculogram; ESS, Epworth Sleepiness Scale; F, female; GH, growth hormone; glue, 
glucose; HDL, high-density lipoprotein; HF norm, normalised high frequency power (HF/(LF+HF)) 
in the electrocardiogram (ECG); HGC, hypoglycaemic clamp; HR, heart rate; HRV, heart rate 
variability; hs-CRP, high-sensitivity c-reactive protein; ICAM-1, intercellular adhesion molecule-1; 
IL-6, interleukin-6; IL- p, interleukin- P; ins, insulin; ISR, insulin secretion rate; 1ST, insulin
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suppression test; KSS, Karoiinska Sleepiness Scale; LCAT, lecithin cholesterol acetyltransferase; 
HRV LF/HF, low frequency power/high freq power in the ECG; (LF/HF) BPV, (low/high frequency 
modulation of) blood pressure variation; LF norm, normalised low frequency power (LF/(LF+HF)) 
in the ECG; M, male; MAP, mean arterial blood pressure; NEFA, non-esterified fatty acid; NN 
interval, normal-to-normal interval (between adjacent QRS complexes in the ECG); NN50, NN 
intervals longer than 50 ms in the ECG; OG TT, oral glucose tolerance test; PSG, 
polysomnography; rec, recovery; RT, reaction time; SBP, systolic blood pressure; SNP, sodium 
nitroprusside; SSG, steady state glucose; T3, triiodothyronine; TNF-a, tumor necrosis factor-a; 
TSD, total sleep deprivation; TAG, triacylglycerol; BRS, baroreflex sensitivity; VCAM-1, vascuiar 
cell adhesion molecule-1 ; VLDL, very low-density lipoprotein, ‘no’ for the baseline nights indicates 
that no adaptation /  baseline nights were spent in the laboratory; this does not mean that regular 
sleep/wake cycles at home have not been adopted prior to the laboratory study.
1.6.1.1 Metabolic and cardiovascular function
The effects of TSD on metabolic and cardiocasular function are summarised in Table 1.3 
An early protocol with isocaloric meals every 3 hours showed that 3 to 5 days of TSD 
resulted in a significant dampening of the TAG rhythm (Vendra et al. 1986). This 
dampening was reversed on day 3 of the recovery period (but no data were provided for 
the recovery day 1 and 2). Serum total cholesterol did not show a rhythm but the levels 
were significantly lower during day 4 and 5 of sleep deprivation. During recovery sleep, 
levels remained lower but not significantly so. In agreement with this, another study 
showed that 76-80 h TSD resulted in a significant decrease of TAG levels from 165 ±12 
to 143 ± 14 mg/d I (~ 1.9 to 1.6 mmol/L), but a significant increase in HDL from 46.4 ± 4.4 
to 54.6 ± 4.2 mg/dl (~ 1.2 to 1.4 mmol/L) (Han et al. 1992). In this study, however, food 
intake was ad libitum and body posture was not controlled.
Although there are differences in glucose levels during nocturnal sleep and wakefulness 
(section 1.5.1.2), mean glucose levels between 8:00 and 11:00 in the morning were not 
different after a TSD night compared with a night with sleep (Van Cauter et al. 1991). In 
addition, the total plasma glucose response to an oral glucose tolerance test (OGTT) 
was not different but the insulin response was higher after 60 h of TSD (VanHelder et al. 
1993). On the other hand, steady state glucose levels assessed by a modified insulin 
suppression test (1ST) were 18% higher after 24 h TSD compared to after a night of 
normal sleep within the same subjects, while metabolic characteristics such as TAGs 
and cholesterol were not different between the sleep deprived and the control group 
(Gonzalez-Ortiz et al. 2000). However, the timing and duration of ‘normal sleep’ in this
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study were not described and subjects were allowed to move freely. Another study did 
not find any effects on glucose and insulin levels but observed an overall decrease in 
NEFA levels at hypoglycaemic clamp (HGC) after sleep deprivation compared to 7 h 
sleep (Schmid et al. 2007).
The effects on cardiovascular function highly depend on whether the subjects were 
supine or seated. In both conditions, NN intervals decreased over the course of sleep 
deprivation (Zhong et al. 2005). Heart rate decreased after 12 and 36 hours in a supine 
position but increased after 24 hours in a seated position. LF and HF did not change in 
the supine position while in a seated position, LF increased after 12 and 24 hours, HF 
decreased after 12 hours and the LF/HF ratio increased after 12 hours (Zhong et al. 
2005). These assessments were made within subjects and not compared to a baseline 
night, so they may be due to circadian rhythms in HR and HRV (section 1.5.3.2). 
However the authors state that no changes were observed in 6 control subjects who 
underwent the same measurements, but then slept at home (Zhong et al. 2005). Others 
have observed a lower NN50 during 48 h sleep deprivation (Ewing et al. 1991) and a 
longer NN interval after one night TSD (Pagani et al. 2009). Another study also showed 
increased LFnorm but decreased HF norm (normalised high frequency power 
(HF/(LF+HF)) after 40 hours of total sleep deprivation in 12 men, but only at 15:00 h and 
18:00 h compared to the same time on the day before (after normal sleep) (Sauvet et al.
2009). By contrast, one study reported no difference in LF/HF throughout a 60 h sleep 
deprivation period (Gould et al. 2009). Sauvet and coworkers (2009) also assessed 
microvascular reactivity by endothelium-independent vasodilatation (skin blood flow 
measurements after sodium nitroprusside solution administration) and endothelium- 
dependent vasodilatation (skin blood flow measurements after acetylcholine 
administration). Endothelial function by endothelium-dependent vasodilatation was lower 
at 12:00 h after sleep deprivation (and lower at 12:00 h compared to 18:00 h both after 
baseline sleep and TSD). Endothelial function by endothelium-independent dilatation 
was lower after sleep deprivation at both times.
The data suggest that one night of total sleep deprivation is sufficient to impair metabolic 
and cardiovascular function. However, the effects appear to depend on the parameter 
measured and the time at which the parameter was assessed throughout the course of 
and after TSD.
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1.6.1.2 Alertness and mood
As the relationship between sleep deprivation and alertness and mood has not been 
addressed in sections 1.2.2 and 1.3.2, this will be introduced briefly in this section. 
Studies into the circadian and homeostatic modulation of alertness and mood in 
discussed in section 1.5.4.1 have already shown that alertness and mood are affected by 
prolonged wakefulness. The studies in this section and section 1.6.2 focus on the sleep- 
deprived versus non-sleep deprived condition and the effect of recovery sleep. There is 
ample research outside CR and FD settings showing that sleep deprivation affects 
alertness (Rogers et al. 2003). Amongst the various aspects which are covered by the 
term alertness, vigilant attention is commonly investigated as it is thought to be important 
for all other cognitive tasks and is very sensitive to sleep deprivation (Lim & Dinges
2008). A meta-analysis by the same authors showed that the largest effects of 24 -  48 h 
TSD were observed on simple attention, such as lapses and RT often assessed by the 
PVT developed by their group (Lim & Dinges 2010).
Although it is clear that sleep deprivation results in decreased alertness, the impact on 
mood seems to be bidirectional. There are not that many studies on the effects of 
restricted sleep on mood in healthy volunteers but in most people, sleep deprivation has 
been shown to increase negative mood (Pilcher & Huffcutt 1996). On the other hand, 
sleep deprivation has been reported to be a very effective treatment for depression 
(Giedke & Schwarzler 2002; Hemmeter etal. 2010; Ringel & Szuba 2001).
The following studies are some examples to illustrate what has been stated in these 
reviews. An experiment which compared sleep deprived to non-sleep deprived subjects 
observed a negative effect of 1 night of TSD on subjective mood and alertness (by VAS 
and Positive and Negative Affect Schedule (PANAS)) (but no effect on negative affect on 
the PANAS) (Franzen et al. 2008). One night TSD also decreased objective 
physiological alertness and increased the harmonic mean RT and frequency of lapses 
(Franzen et al. 2008) as well as simple RT and sleepiness on a 0-10 point scale or the 
Epworth Sleepiness Scale (ESS) (Pagani et al. 2009; Zhong et al. 2005). Furthermore, 
deterioration in subjective sleepiness (VAS) and RT (PVT) following 40 h sleep 
deprivation did return to baseline after 1 night with 9 h recovery sleep but not after 5 
nights 6 h sleep (Jay etal. 2007). Additional findings from this group showed that 2 TSD 
nights resulted in a recovery for SSS after 1 night of 9 h recovery sleep but PVT 
performance did not even recover after 2 nights (Lamond et al. 2007). Moreover, 2 or 
more nights of TSD in healthy individuals increased sleepiness and induced changes in
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some aspects of mood, such as anxiety and depression but not in others (Gould et al. 
2009; Kahn-Greene et al. 2007). Taken overall, these studies indicate that TSD impairs 
alertness and some aspects of mood.
1.6.2 Partial Sleep Deprivation (PSD)
While during TSD, volunteers do not sleep at all, during partial sleep deprivation (PSD) 
volunteers are kept awake only part of the night or for several consecutive nights. Table
1.4 summarises the most relevant studies on PSD.
Table 1.4. Overview of laboratory studies on the effects of partial sleep deprivation on 
cardiovascular and metabolic function.
Study Sub
Jects
Protocol Parameters
measured
Change after PSD
Base
line
PSD Reco
very
Buxton  
at al. 
(2010)
20 M 10 h /  
3
nights
5 h / 7
nights
10 h /  
1
night
-IV G TT  (SI, AIRg, DI, 
Kg, Sg)
-HEG  (ins resistance)
-R M R
-cort
-(nor)epinephrine
-KSS
-lapses
-IV G TT  SI, DI, Kg i  
-HEG ins resistance j  
-cort Î
-(nor)epinephrine j  
-KSS Î  
-lapses Î
effect of rec sleep not 
reported
Donga at 
al. (2010)
5 M / 6  F 8.5 h 8.5 h
comp
ared
to 4 h
(cross
over)
no -glue, NEFA, ins, 
glucagon and cort 
during basal and 
clamped state 
-HEG  
-PSG
-E G P T  
-Rd i  
-G IR  I
-N EFA  t  during clamp 
-226 min sleep
Kerkhofs
atal.
(2007)
10 F 1
night
4 h / 3
nights
8 h / 1
night
-leukocytes 
-total chol 
-LDL  
-H D L  
-TAG
-Apo A and B
-hsGRP
-more
-white blood cells
-monocytes
-neutrophils
-total chol
-LDL
Î
-effects of rec sleep not 
reported
Muenter 
at al. 
(2000)
6 M / 4 F 2
nights
4 h / 4
nights
no -R M S S D
-baroreflex
-SBP
-HR
-S B P î
- H R |
-orthostatic control
Nedeltche 6F/5M  no 5.5  /  no -weight 
va et al. 8.5h -O G TT
(2009) for 14 -IV G TT
-weight f  in both conditions 
-2 h glue & AUC 3 h O G TT
Î
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Study Sub
jects
Protocol Parameters
measured
Change after PSD
Base PSD 
line
Reco
very
nights
Schmid et 
al. (2009)
1 0 M 4.5 h
comp
ared
to 7 h
(cross
over)
no
-cort
-GH
-(nor)epinephrine
-PSG
-PSG
Basal and under HGC:
-glue
-ins
-C-peptide
-glucagon
-(nor)epinephrine
-ACTH
-cort
-GH
-reduced ins sensitivity and 
Î  glue effectiveness at 
basal ins
-dampened and delayed  
cort rhthm when looking at 
best fit curve
-lower GH during 1®* 4  h of 
night, only in M 
-overall epinephrine j ,  night 
time (nor)epinephrine t  
-5 h 11 min sleep
-4.5 h sleep but time in 
SW S the same  
-basal and HG C glucagon I  
-basal and initial HG C  
ACTH and cort i
Spiegel et 
al. (1999)
11 M 8 h / 3  4 h / 6  12 h /  
nights nights 7
nights
Spiegel et 
al. (2004)
11 M 8 h / 3  4 h / 6  12h/6 
nights nights days 
( 8 h  
/?nigh 
ts 1 
year 
later)
-sleep
-G C R  (after IVGTT) ~ 
Rd
-G E ~ S g
-ins resistance (after 
IVGTT)
-glue and ins after
meals
-LF/HF
-thyrotropin
-thyroxin index
-cort
-SSS
Compared to rec but 
not to baseline
-sleep
-leptin
-rNN
-cort
TSH
-glue
-ins
-HO M A
-subjective stress 
Compared to recovery 
but not to baseline
-3 h 49 min sleep, 
awakenings and REMj., 
nREM t  
-G C R i  
-G E I
-ins response to glue 
(IVG TT) i
-glue and ins after breakfast 
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study Sub
Jects
Protocol Parameters
measured
Change after PSD
Base PSD Reco
line very
Van 8 M 8 h / 2 8 h in 8 h / 2 -glue in experimental group
Leeuwen control / nights contr. nights -ms -ins Î
et al. 15 M in 4 h in -IGF-1 -ins/gluc t
(2010) exp e x p / -leptin -leptin t
5 -satiety after recovery glue i ,  IGF-1
nights and leptin t
Abbreviations and symbols used: I  = decreased or smaller, |  = increased or larger, ACTH, 
adrenocorticotropic hormone; AIRq, insulin response; apo, apolipoprotein; AUC, area under the 
curve; chol, cholesterol; cort, cortisol; DI, disposition index; EGP, endogenous glucose 
production; F, female; GCR, glucose clearance rate; GE, glucose effectiveness; GH, growth 
hormone; GIR, glucose infusion rate; glue, glucose; HDL, high-density lipoprotein; HEC, 
hyperinsulinémie euglycemic clamp; HGC, hypoglycaemic clamp; HOMA, homeostatic model 
assessment; HR, heart rate; hsCRP, high sensitivity c-reactive protein; IGF-1, insulin-like growth 
factor-1 ; ins, insulin; IVGTT, intravenous glucose tolerance test; KSS, Karoiinska Sleepiness 
Scale; Kq, glucose tolerance; LDL, low-density lipoprotein; LF/HF, low frequency power/high freq 
power in the electrocardiogram (ECG); M, male; NEFA, non-esterified fatty acid; NN interval, 
normal-to-normal interval (between adjacent QRS complexes in the ECG); nREM, non-rapid eye 
movememt sleep; OGTT, oral glucose tolerance test; PSG, polysomnography; Rd, rate of glucose 
disposal; rec, recovery; REM, rapid eye movememt sleep; RMR, resting metabolic rate; RMSSD, 
square root of the mean of the sum of the squares of differences between NN intervals in the 
ECG; rNN, autocorrelation coefficient of NN intervals; SBP, systolic blood pressure; Sq, glucose 
effectiveness; SI, insulin sensitivity; SSG, steady state glucose; SSS, Stanford Sleepiness Scale; 
SWS, slow wave sleep; PSD, partial sleep deprivation; TAG, triacylglycerol; TSH, thyrotropin, ‘no’ 
for the baseline nights indicates that no adaptation / baseline nights were spent in the laboratory; 
this does not mean that regular sleep/wake cycles at home have not been adopted prior to the 
laboratory study.
1.6.2.1 Metabolic function and heart rate variability
The effects of PSD on metabolic and cardiocasular function are summarised in Table 
1.4. There is only a small number of published studies which have investigated the 
effects of PSD on metabolic function. Spiegel et al. (1999) studied 11 young men who 
had 3 baseline nights (bl 1-3) with 8 h time in bed, 6 nights with 4 h (centred around the 
normal midpoint of sleep, PSD 1-6), followed by 7 recovery nights with 12 h in bed (recl- 
7). Subjects had to stay in bed in the clinic during the last 2 days of each of the 3
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conditions and they consumed carbohydrate rich (62%) meals every 5 h (i.e. at 9:00, 
14:00 and 19:00 h). On PSD5 and rec5, an intravenous glucose tolerance test (IVGTT) 
was carried out at 9:00 h (and thus the breakfast was omitted) and on PSD6 and rec6 24 
hour profiles of glucose and hormone concentrations were obtained. NN intervals and 
sleepiness were also recorded. Glucose clearance after the IVGTT was 40% slower and 
the acute insulin response to glucose was 30% lower after sleep deprivation compared 
to recovery sleep. After the breakfast, the glucose response was higher despite a slightly 
higher insulin response after sleep deprivation compared to recovery sleep. According to 
Nedeltcheva et al. (2009) this indicates that insulin secretion is affected but not insulin 
sensitivity. There were no differences in the responses after lunch and dinner (Spiegel et 
al. 1999). The LF/HF ratio was higher after PSD than after baseline sleep and recovery 
sleep which, according to the authors, could explain the impaired glucose breakdown 
after sleep deprivation. A downside of the study was the fact that the IVGTT and 
response to breakfast were not reported after baseline sleep, so these implications 
cannot be tested. A later study by the same group using the same protocol (and possibly 
the same subjects but this is not clear from the methods section) showed very similar 
results indicating that leptin, cortisol and homeostatic model assessment profiles after 
baseline sleep were intermediate between those after sleep deprivation and recovery 
sleep (Spiegel et al. 2004). Another study did not find significant effects of PSD (4 h 
sleep a night for 4 nights) on HRV as assessed by the root mean square of sequential 
differences of NN intervals (RMSSD) (Muenter et al. 2000). A similar recent study found 
comparable results to those of Spiegel and colleagues (1999) in 15 young men when 
they were subjected to 2 baseline nights (8 h), 5 PSD nights (4 h time in bed) and 3 
recovery nights (8 h) and compared to a control group who spent 10 h in bed across the 
10 days (van Leeuwen et al. 2010). In the experimental group but not in the control 
group, higher basal insulin levels and a higher basal insulin/glucose ratio were observed 
after sleep deprivation (insulin: 8.6 ± 7 mU/L ~ 51.5 pmol/L, ratio: 1.8 ± 1.3) compared to 
baseline sleep (insulin: 6 ± 2.9 mU/L ~ 36 pmol/L, ratio: 1.2 ± 0.57). Basal glucose levels 
were lower after recovery sleep (4.7 ±0.17 mmol/L) compared to baseline sleep (4.9 ± 
0.24 mmol /L) in the experimental group. However, physical activity was not restricted, 
food intake was 50 kcal higher in the experimental group and the paired t-tests done 
between either PSD or recovery sleep and baseline sleep are not appropriate. In 
agreement with these findings, IVGTT and hyperinsulinémie euglycemic clamp in an 
inpatient study in 20 men showed decreased insulin sensitivity (20%), disposition rate 
and glucose tolerance after 7 nights of 5 h in bed compared to 3 nights of 10 h in bed 
(Buxton et al. 2010). In addition, fasting glucose and insulin levels and insulin secretion 
were not changed. Another recent study, investigated 6 women and 5 men (39.5 ± 5
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years) when they were on a 14 day schedule of either 5.5 h or 8.5 h time in bed 
(randomised cross over), with a sedentary life style and ad libitum too6 intake (apart from 
the last days of each condition when energy intake was controlled) (Nedeltcheva et al. 
2009). During both conditions their weight increased by 2 kg. The 5.5 h time in bed 
condition resulted in increased glucose values 2 h after the oral glucose bolus and an 
increased area under the curve (AUC) after the OGTT. This was not the case for insulin. 
Indices for insulin sensitivity (SI) were reduced and glucose effectiveness (Sg) at basal 
insulin levels was increased. These results suggest, that despite a similar weight gain 
(and ad libitum food intake), sleep restriction results in a decreased glucose tolerance 
and insulin sensitivity.
In addition, Kerkhofs and colleagues observed significant increases in cholesterol and 
LDL after 3 days PSD (4 h sleep per night) but no difference in TAGs and HDL (Kerkhofs 
etal. 2007).
Other authors have aimed to investigate the effects of a single night of PSD (4 h time in 
bed (TIB)) compared to 8.5 h TIB on insulin sensitivity by hyperinsulinaemic euglycemic 
clamp study (Donga et al. 2010). PSD did not affect basal glucose (during labelled 
glucose infusion), NEFAs, insulin, glucagon, cortisol or endogenous glucose production. 
During the hyperinsulinaemic clamp study, steady state glucose and insulin did not differ 
between the sleep conditions but endogenous glucose production increased, the rate of 
glucose disposal decreased, the required glucose infusion rate decreased and plasma 
NEFA levels increased after PSD, all parameters with a magnitude around 20%, 
indicating decreased insulin sensitivity after PSD.
The only study that did not show any effects of sleep deprivation on glucose tolerance 
and insulin sensitivity was one by Schmid et al. (2009). A night of PSD affected neither 
basal glucose and insulin levels nor their response during hypoglacaemic clamp.
As there is also debate as to whether sleeping too long is as harmful as sleeping too 
little, one study investigated the effect of TIB restriction (Zielinski etal. 2008). Volunteers 
(n = 42) aged 50-70 years olds with an average sleep duration of > 8.5 h were asked to 
reduce their TIB by 90 minutes for 8 weeks. Fasting glucose was only 1% higher after 
reducing TIB and fasting insulin, glucose tolerance, postprandial insulin and insulin 
sensitivity did not change.
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Other recent studies have investigated the role of different sleep stages and nocturnal 
(micro)arousals rather than sleep as a whole on cardiovascular and metabolic function. 
One study, for instance, showed that suppression of SWS, without a reduction in total 
sleep time (TST), resulted in decreased insulin sensitivity which was not compensated by 
an increase in insulin release (Tasali et al. 2008). Glucose tolerance was also 
decreased. The authors suggested that this was due to a relative increase in 
sympathetic activity (assessed by HRV), rather than HPA axis activity (assessed by 
cortisol). In subjects working in IT, it was shown that those with a higher arousal 
frequency during the night, had higher morning cortisol, HR, DBP, total cholesterol, LDL 
and LDL/HDL ratio (Ekstedt et al. 2004). SBP and HDL were not so clearly affected.
1.6.2.2 Endothelial function
Endothelial function has been measured in groups of people with different types of 
cardiovascular problems but not in many populations with different kinds of sleep 
patterns. Evidence for the effect of sleep deprivation on endothelial function (either after 
TSD or PSD and either with ultrasound recordings or another method) is lacking. There 
are only 2, poorly controlled field studies. In 30 male college students FMD was 
significantly decreased from 7.4 ± 3 to 3.7 ± 2.3% after 4 weeks of chronic sleep 
deprivation (sleep < 80% of the normal amount) during exam preparations (Takase et al. 
2004). However, this period was also considered as chronic stress, which may confound 
the results. A study on patients with obstructive sleep apnoea showed that FMD was 
significantly lower in sleep apnoea patients than in controls both in the morning (6.04 ± 
3.18% vs 10.9 ± 2.6%) and in the afternoon (10.38 ± 4.23% vs 13.9 ± 2.32%) (Ofiaz et 
al. 2006). However, actual sleep was not mentioned in these patients. Within the group 
of OSAS patients, there was no difference between those with or without metabolic 
syndrome (Amra et al. 2009).
1.6.2.3 Alertness and mood
Alertness and mood are not only affected by TSD (section 1.6.1.2) but also by PSD. PSD 
(5 h a night, 7 nights) resulted in an increase in sleepiness on the SSS and in most of the 
subscales of the profile of mood states (POMS) but not depression (Dinges et al. 1997). 
Subjective mood and alertness worsened after the first night of PSD compared to
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baseline sleep and returned to near baseline levels after 1 night of recovery sleep (10 h 
in bed) and complete recovery after 2 nights of sleep. FRT decreased across PSD 
whereas the number of lapses increased. Both FRT and lapses only changed after 2 
nights of PSD whereas SRRT already changed after 1 night. As for the subjective 
measures, it took 2 days of recovery sleep for PVT performance to return to baseline 
levels. PSD only affected VAS ratings alert-sleepy and mental exhaustion and calmness 
but not others such as happy-unhappy. A similar protocol that also allowed 5 h TIB for 7 
nights (Buxton etal. 2010) showed an increase in PVT lapses and KSS sleepiness after 
the first PSD night. Sleepiness on the SSS also increased after 4 h sleep for 6 nights 
(Spiegel etal. 1999). Another study showed as well that PVT lapses and KSS sleepiness 
deteriorated significantly throughout 5 days of sleep restriction (4 h sleep per night) 
compared to a control group who slept 8 h each night) (Haavisto et al. 2010). Lapses 
and KSS were not significantly different between the groups after the first 8 h recovery 
night, but it took 2 nights of 8 h recovery sleep for lapses to fully return to baseline levels. 
In agreement with this, a semi-laboratory study (subjects were allowed to leave the 
laboratory for part of the protocol) showed an increase in KSS sleepiness and in RT and 
lapses after the first night of PSD (4 h sleep a night for 5 nights) which did not return to 
baseline levels after 1 night of recovery sleep and lapses did not even recover after 7 
days (Axelsson et al. 2008). Similarly, another semi-laboratory protocol which allowed 
subjects to go home between sleep and assessment periods also observed an increase 
in lapses, median RT, FRT and SRT after PSD (6 h sleep for 8 nights) (Vgontzas et al. 
2004)). PSD (4 h sleep per night for 12 nights) did not only increase fatigue but also 
decreased physical well-being and other aspects of emotional well-being such as 
optimism-sociability (Haack & Mullington 2005).
Another type of FD protocol than mentioned in sections 1.4.2 and 1.5.4.1 (with a cycle of 
42.85 hours with 32.85 h of extended scheduled wakefulness and 10 h of scheduled 
sleep), induced both acute (in contrast to previous FD protocols) and chronic sleep 
deprivation. This study showed that acute sleep loss was dissipated during the 10 h time 
in bed while the build up of chronic sleep loss resulted in a faster deterioration of median 
RT across the hours awake (Cohen et al. 2010). Moreover, in support of the previous 
findings, the circadian rhythm in performance (with a dip between 0- (melatonin peak) 
and 60- corresponding to 3:00 - 7:00 h) was stronger the longer subjects had been 
awake and in the chronic sleep deprivation condition. Similar time of day influences on 
the effects of sleep deprivation have also been shown by another recent study as the 
decrement in PVT lapses and subjective sleepiness was most affected around 8:00 h but 
less between 16:00 and 20:00 h (Mollicone etal. 2010).
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Another study showed decreased alertness (KSS) and multitask performance after one 
night with 2 h of sleep compared to a night with 8 h sleep (Sallinen et al. 2008). Both did 
not fully recovery after 1 night of recovery sleep. A 10 min rest improved multitasking and 
KSS but this was not more effective in the sleep debt condition. Subjective sleepiness 
(SSS) was significantly higher after a night of 2 h in bed and reversed to baseline levels 
after a nap plus 8 h recovery sleep or 10 h recovery sleep. However, 8 h recovery sleep 
was only sufficient at 13:00 but not 15:00 h on this day (Faraut et al. 2010).
These studies indicate that mood and alertness are negatively affected in partially sleep 
deprived conditions and that the length and distribution of recovery sleep influences the 
extent of reversal of mood and alertness levels to baseline. The findings suggest that 
subjective alertness may recover faster than objective alertness.
1.7 Smaller scale studies on shift work
There are several ways of assessing what shift work does to cardiovascular and 
metabolic function; either in the field in ‘real’ SW, via simulated shift work, or by a 
combination of the two methods.
1.7.1 Field studies of shift work
1.7.1.1 Metabolism
The effects of ‘real shift work’ were studied in SW on Antartica who were on a schedule 
of 7 day shifts (time in bed 00:00-8:00 h), 7 night shifts (time in bed 8:00-16:00 h) and 
again 7 day shifts. Acrophase determined by urinary 6-sulphatoxymelatonin showed that 
subjects delayed into the shift protocol (Lund et al. 2001). However, the delay in 
acrophase did not reach the 8 h by which sleep was delayed by the end of the night 
shifts and did not advance again into day shifts, causing the SW to be constantly out of 
phase from day 9 onwards. Blood samples were taken before and after a test meal at 
13:30 h on day 1 and day 16 and at 1:30 h on day 9. Fasting glucose, insulin, TAG and 
NEFA levels were similar on all study days. However, postprandial glucose, insulin and 
TAG levels (by AUG) were increased on the second night of night shifts while NEFA AUC 
was smaller on the second night shift. As the authors propose, this was possibly due to 
decreased glucose tolerance and insulin sensitivity at night (section 1.5.1.2). The
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increased insulin response may be responsible for the suppressed NEFA response 
(section 1.5.1.1). Whereas glucose and insulin levels decreased to normal levels upon 
returning to day work, TAG levels remained higher and NEFA levels remained lower. The 
authors suggest that these data show that altered postprandial responses take place in 
those who are maladapted. Furthermore, glucose and insulin responses had returned 
back to normal after returning to day work while the delay in melatonin acrophase was 
reaching significance then, reflecting an even larger desynchronisation. According to the 
authors this may be due to time awake overriding clock-related changes since for some 
parameters the clock component may be stronger than for others (see also section 1.4).
1.7.1.2 Heart rate variability
When data on cardiac function were compared at the same time of day (suggestive of 
similar circadian phase), LF norm and LF/HF were higher and RMSSD and the number 
of NN intervals longer than 50 ms (NN50) (means across 24 h or only the night) were 
lower when SW were on night duty compared to when they were off duty and asleep at 
night (Ewing et al. 1991; Furlan et al. 2000; Ito et al. 2001; Rauchenzauner et al. 2009; 
Su etal. 2008). LF/HF was also significantly higher and HF norm was lower during sleep 
from 3:00 -  5:00 h on 24 h duty than at the same time when off duty in ambulance men 
(Mitani et al. 2006). Even on days off LF and LF/HF were higher during night time sleep 
in permanent night nurses compared to day nurses when body posture and work were 
controlled (Chung et al. 2009). By contrast, other authors did not observe differences in 
variance, LF norm and LF/HF between 24 h recordings including either a night shift or a 
day shift (Freitas et al. 1997).
1.7.1.3 Endothelial function
Endothelial function in SW has been investigated only in a single study (Amir et al.
2004). In this study, 30 physicians with a shift work history of 5 ± 3 years (range 0.5 to 
15), had one FMD assessment between 8:00 and 10:00 h on a working day without 
previous night shift (baseline day) and a second assessment between 8:00 and 10:00 h 
after a continuous workday of 24 h, including a night shift. Baseline FMD was lower in 
those who had worked shifts for more than 3 years (8.6 ± 3.4%) than in those with a 
shorter shift work history (14.3 ± 4.1%). FMD was also significantly smaller after a night 
shift (6.7 ± 4.8%) compared to the baseline day (10.5 ± 4.5%). Multivariate regression 
showed that a larger decrease in FMD after shift work was associated with longer shift
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work duration, less sleep during the shift, higher baseline FMD and younger age (Amir et 
al. 2004). Although these results indicate that shift work may cause endothelial 
dysfunction, caution has to be taken when drawing this conclusion. The authors did not 
provide details about the shift schedules and whether the measurements after a night 
shift were always taken after 1 night shift or after more consecutive night shifts. This also 
makes it difficult to assess whether both the baseline FMD measurement and the 
measurement after the night shift have been taken at the same circadian phase.
Indirectly related to this, Hattori and Azami (2001) state that the von-Willebrand factor is 
an early marker of endothelial injury. Both this factor and blood glucose 3 h after the last 
meal were higher the morning after night work compared to the morning after a day shift, 
whereas systolic blood pressure was lower (Hattori & Azami 2001). Other differences 
depended on what time the shift ended. The authors claim that this demonstrates 
endothelial injury in taxi drivers. However, the study was poorly controlled, e.g food 
intake and movement were not comparable between day and night shifts.
1.7.1.4 Alertness and mood
Ample research over the last decades has consistently shown that shift work including 
night shifts affects sleep, sleepiness and performance (Akerstedt 1998, 2003; Akerstedt 
& Wright 2009; Harma et al. 1998). Although earlier studies indicated that shift length 
and rotation have little effect on sleep and mental and physical health (Smith et al. 1998; 
Tucker et al. 2000), more recent studies suggest that the sleep obtained in SW may be 
highly dependent on the combination and order of shifts and length of the working day 
and week (Harma et al. 1998; Sallinen et al. 2003; Sallinen & Kecklund). In irregular SW, 
for example, sleepiness is highest on morning shifts and night shifts. Important factors 
affecting sleepiness were shift length and duration of the main sleep period (Harma et al. 
2002). In accordance with this, subjective alertness and RT (by assessments other than 
KSS, VAS and PVT) was lower at 3:00 than at 15:00 and 19:00 h in rotating SW (Galy et 
al. 2008). Sleep and sleepiness are also affected in other conditions similar to shift work, 
such as jet lag. In airline pilots, for example, self-rated fatigue was predicted both by 
prior sleep and the type of intercontinental flight (Petrilli et al. 2006).
By contrast, there are not many comprehensive studies on the effects of shift work on 
mood. A recent study showed that rotating SW have a higher odds ratio for depression, 
even after adjustment for several factors such as age and educational level. However,
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the association was no longer present when corrected for work-related issues such as 
support and job demand (Driesen et al. 2010). These findings indicate that it may be 
mainly the flexibility aspect of shift work that influences job satisfaction, irritability and 
anxiety (Costa et al. 2006).
1.7.2 Simulated shift work studies
1.7.2.1 Metabolism
A simulated shift work semi-laboratory study was conducted by Ribeiro et al. (1998). 
Twelve volunteers were subjected to a protocol consisting of 4 days regular sleep/wake 
cycle, 5 days of gradual advance and 6 days back to the regular sleep/wake cycle.). 
Blood samples were taken before and after a test meal at 13:30 h (postprandial) during 
the baseline period, immediately after the gradual advance and after the return to a 
regular sleep/wake cycle, achieving sampling at different times of the body clock. No 
differences were observed in insulin and glucose. However, lower basal and postprandial 
NEFA levels were found immediately after the phase shift compared to before and 2 
days after. In addition, basal TAG levels were lower but postprandial TAG levels (with 
basal levels subtracted) were higher after the phase shift than before and 2 days after, 
depending on the time points of the postprandial response considered. Both NEFAs and 
TAGs also returned to basal levels slower after the phase shift. The authors suggest that 
the increased TAG levels may be due to a lower LPL activity. The results from this 
protocol were different from those emerging from a previous, very similar, study also 
from the Surrey laboratory (Hampton et al. 1996), which compared postprandial 
response to a test meal at 13:30 h after baseline sleep and after a simulated phase 
shifting period (after approximately 25.5 h of wakefulness). In this study an increased 
postprandial glucose and insulin response and a higher insulin/glucose ratio were 
observed after the simulated phase shift suggestive of insulin insensitivity. A delayed 
postprandial TAG response was demonstrated, again indicative of lower LPL activity; the 
delayed NEFA response implied an increased suppression of HSL by the 
hyperinsulinaemia. The authors mentioned that the different fat content of the pre-meal 
(before the test meal) or elapsed time awake could account for the discrepancy between 
the two studies. The study by Ribeiro et al. (1998) used a low-fat (4 %), high 
carbohydrate (92 %) pre-meal (as opposed to 27.5 % fat in the study by Lund (2001) and 
49 % fat in the study by Hampton (1996)), which may have prevented the shift-induced 
elevation in glucose and insulin responses. Nevertheless, both data sets show that the
51
Chapter 1 Introduction
response to a meal depends on the internal body clock time. Differences in postprandial 
responses were also observed when a snack was included at 16:00/4:00 h next to main 
meals at 13:30/1:30 h and 19:00/7:00 h, in subjects that were entrained to day shifts (Al- 
Naimi et al. 2004). The TAG response was significantly higher at night, with the largest 
difference after the snack. The insulin response was larger after the last meal but smaller 
after the first meal. Glucose and NEFA responses were not significantly different at night 
compared to during the day.
In another protocol, using FD to investigate various processes at different circadian 
phases, subjects were given breakfast, lunch, dinner and a snack and blood was 
sampled hourly (Scheer et al. 2009). This study showed that, when subjects were 12 
hours out of phase (on the 4^  ^day of the FD) they had higher glucose levels (especially 3 
h after breakfast) even though their insulin was also raised. They also had increased 
mean arterial pressure but there was no effect on heart rate or HRV.
1.7.2.2 Alertness and mood
In support of the findings from field studies, a simulated shift work study showed that 
reaction times (median RT, 25^ "^  and 75“  ^ percentile RT) were slower, lapses (> 90'  ^
percentile of the daytime baseline) were more frequent and the VAS score of sleepiness 
was higher on the first night shift compared to a day shift and subsequent night shifts 
(Santhi et al. 2007). These parameters also significantly deteriorated across a night shift 
but not during a day shift.
1.7.3 Simulated shift work combined with field studies of shift work
To my knowledge there is only one study, comparing SW and NSW in controlled 
laboratory conditions (Simon et al. 2000). In this study 24 h rhythms in glucose and ISR 
(under continuous enteral nutrition and recumbent position) in 8 night workers (6 nights a 
week for at least 2 years) were compared to 8 NSW with nocturnal sleep on one 
occasion and 8-h shifted sleep on the second occasion. The data showed that mean 24- 
h glucose and ISR were the same in the 3 conditions and that they were mainly 
regulated by sleep but also by a circadian component. The night shift workers were 
partly adapted as the glucose and ISR peaks shifted with 8 hours as did their sleep so 
that the peaks remained at mid-sleep and the glucose and ISR peak and nadir levels 
were not different from NSW. However, the adaptation was not complete as the sleep
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associated rise in glucose had only shifted by 6 hours and the ISR was prolonged. The 
night shift workers also showed some differences in ultradian oscillations.
In a study on shift work and sleepiness, SW followed simulated shift schedules (Eriksen 
et al. 2006). In the trained navigators in a 6 h on/6 h off sea watch simulator, sleep was 
reduced and sleepiness increased during the night and early morning shifts and on days 
off.
1.8 Interindividual differences in the tolerance to sleep deprivation and 
shift work
As for all biological processes, it is likely that there are interindividual differences in the 
tolerance to sleep deprivation and shift work. Previous sections have shown that the 
effects of sleep deprivation may depend on factors such as age, gender and ethnicity 
(section 1.2.2 and 1.3.2). Other studies have shown interindividual differences in 
neurobehavioural aspects such as variation in the effects of sleep deprivation on 
alertness and performance, not necessarily related to these factors (Van Dongen & 
Belenky 2009). Some studies (section 1.5.4.2) found significant differences between 
subjects in the number of lapses during 40 h sleep deprivation, with some subjects being 
very affected whereas others were not (Van Dongen et al. 2004). Similarly, when 
subjects were divided into resistant or vulnerable to sleep deprivation according to their 
increase in SRT during the selection sleep night, it appeared that during a subsequent 
sleep deprivation night, resistant subjects were able to maintain a fairly stable RT 
whereas vulnerable subjects showed an increase in RT, while both groups felt equally 
sleepy (KSS) (Galliaud et al. 2008). These interindividual differences in performance 
persisted even within a group of F-117 pilots self-selected to be sleep deprived as a 
result of their jobs (Van Dongen etal. 2006).
Furthermore, when subjects were divided into morning and evening types (Horne & 
Ostberg 1976) evening people were likely to be less sensitive to sleep debt (Volk et al. 
1994). In accordance with this, evening types accumulated more sleep debt during the 
working week but did not feel sleepier than morning types (Taillard et al. 1999). This 
might be due to a difference in the regulation of homeostatic sleep as morning types 
started their night with a higher level of slow wave activity in the EEG, indicating a higher 
sleep pressure at the end of the waking day (Mongrain et al. 2006b). In addition, an early 
study indicated that diurnal type affected the sleep length in rotating SW, with less sleep
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after afternoon and night shifts in morning types, although this could be related to the 
positive correlation between age and morningness (Akerstedt & Torsvall 1981). These 
inter individual differences in shift work tolerance have also been described in a recent 
systematic review (Saksvik et al. 2010). Mood in morning and evening types was 
differentially affected by TSD and PSD (Seivi et al. 2007). After PSD mood of morning 
types was not affected while depression in evening types decreased. After TSD 
depression increased in morning types but decreased in evening types.
Similar to morning types, individuals homozygous for the 5/5 genotype of the PERIOD 3 
[PER3) VNTR polymorphism had higher slow wave activity at the start of their baseline 
sleep than 4/4 genotypes {PER3^ '^^ ) and the deterioration of cognitive performance in 
response to TSD was greater (Viola et al., 2007). During PSD, slow wave energy was 
also higher in PER^'^ but, by contrast, the genotypes were not different at baseline and 
PER^'^ subjects even had a slightly better cognitive throughput during PSD (Goel et al.
2009). One of the first studies showing interindividual differences in physiology during 
sleep and sleep deprivation indicated changes in HRV (mainly an increased sympathetic 
activity) in PER^'^ genotypes, particularly during baseline sleep (Viola et al. 2008). In 
addition, others suggest that polymorphisms in the clock genes hCLOCK, PER2 and 
PER3 are associated with an individuals ability to adapt to shift work in terms of changes 
in body temperature, reproductive hormones and metabolites thought to be involved in 
the development of cancer (Davis & Mirick 2006).
Furthermore, variation in the adenosinergic system, which is important for the regulation 
of sleep (Porkka-Heiskanen et al. 2003), may affect sleep and vulnerability to the effects 
of sleep loss in humans (Landolt 2008). As for the PER3 genotypes, genetic substrates 
might show comparable phenotypes in homeostatic sleep regulation. An example is the 
G/A genotype of the adenosine deaminase enzyme (ADA) which is linked to fewer 
awakenings, more SWS and deeper sleep than the G/G genotype (Retey et al., 2005).
These studies have shown that there are interindividual differences in the regulation of 
sleep and the response to sleep deprivation and that there may be a genetic basis for 
this. It will be of interest to explore whether it is also possible to detect such 
interindividual differences between NSW and SW.
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1.9 Rationale and aims
Both epidemiological studies (sections 1.2.2 and 1.3.2) and laboratory studies (sections 
1.6 and 1.7) have shown that sleep deprivation and shift work affect cardiovascular and 
metabolic function and alertness and mood. However, these studies have often been 
confounded by factors such as circadian phase, physical activity, body posture, food 
intake and stress levels. Therefore, it is unclear whether the observations can be 
attributed purely to sleep deprivation and shift work or whether they are (partly) a result 
of these confounding factors.
Moreover, the effects of TSD on postprandial metabolic and insulin responses after a 
standard breakfast have not been investigated. Endothelial function following TSD has 
rarely been researched and it has not been assessed by the ultrasound method identical 
to the one used in our research group. In addition, the effects of sleep deprivation on 
HRV parameters in the time domain have not been reported widely.
Finally, it is still not known what aspects of shift work are causative. Interpretation of 
studies is often limited due to a poor description of the shift work population and lack of 
an appropriate control group. It is also unclear how many years of shift work are needed 
before changes in metabolic and cardiovascular function start to take place. Moreover, to 
date, few, if any, studies have compared SW directly to NSW in identical laboratory 
settings.
Therefore, the aim of the present study was to investigate the effect of a night of TSD, as 
a proxy for the first night of shift work, on metabolic and endothelial function and heart 
rate variability in controlled laboratory conditions. In addition, the effect of TSD on 
subjective and objective alertness as well as subjective mood was assessed. The effect 
of a recovery nap and recovery sleep following TSD was also investigated. Finally, 
experienced SW were compared to NSW in identical settings to assess the effects of 
chronic exposure to shift work, rather than the acute effects due to circadian 
misalignment, on the subject’s response to sleep deprivation and recovery sleep.
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1.9.1 Hypotheses 
It was hypothesised that:
• One night of TSD in a well controlled environment will adversely affect metabolic 
and endothelial function, heart rate variability and mood and alertness,
• Recovery sleep after one night of TSD will restore any disturbances in the 
measured parameters so that values after recovery sleep will return to or 
approach levels measured prior to TSD,
• There will be no difference in circadian phase or phase angle between SW and 
NSW,
• SW will have similar levels of CVD risk factors as matched controls on the 
baseline day of the study as they will be entrained and matched with NSW for 
age, cholesterol and BMI during screening,
• Following TSD, SW will have different responses in metabolic and endothelial 
function and heart rate variability compared to NSW due to previous chronic 
exposure to sleep deprivation and circadian misalignment,
• SW will show differential responses in the neurobehavioural effects of TSD 
compared to NSW.
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CHAPTER 2 METHODS
2.1 Procedures
The University of Surrey gave a favourable ethical opinion for all aspects of this study 
(EC/2007/43/SBMS; appendix A). All volunteer information was kept coded and held in 
the strictest confidence in compliance with the Data Protection Act (1998). All 
participants gave written informed consent stating that they agreed to all assessments, 
were aware of any potential risks and discomfort and understood that they were free to 
withdraw from the study at any given time.
2.2 Recruitment and screening
Male SW and NSW between 25 and 45 years of age were mainly recruited via 
advertisements in local newspapers and on local websites. In addition, volunteers were 
recruited via posters at the University and the University email list. A University press 
release was also distributed which resulted in a local newspaper editorial and 3 recorded 
radio interviews. Finally, some volunteers were informed about the study by advertising 
at their work place or by word of mouth.
Pre-study screening and the laboratory part of the study occurred in the Clinical 
Investigation Unit (CIU) of the Faculty of Health and Medical Sciences (FHMS), at the 
University of Surrey. An extensive screening procedure was applied. In the first stage 
applicants were provided with a brief overview of the study, either via email or on the 
telephone. If they were interested, they were asked some initial questions about their 
health, nicotine, alcohol and caffeine intake (categorical or in actual units/day) and shift 
work history (appendix B). If applicants appeared suitable, they were invited to visit the 
CIU to discuss the study in more detail, provide a blood sample for a standard 
haematological and biochemical screen (Royal Surrey County Hospitals NHS Trusts, 
Partnership Pathology Services) (appendix C), a urine sample for drugs of abuse 
(Epsom and St. Helier University Hospitals NHS Trust, Pathology Services) (appendix 
C), measure waist and hip circumference ((van der Kooy & Seidell 1993) appendix D) 
and answer a general health questionnaire and 4 validated questionnaires (appendix E): 
Horne-Ostberg (HO) questionnaire (Horne & Ostberg 1976), Pittsburgh Sleep Quality 
Index (PSQI) (Buysse at at. 1989), Beck Depression Inventory (BDI) (Beck &
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Beamesderfer 1974; Beck et al. 1974) and Epworth Sleepiness Scale (ESS) (Johns 
1991, 1992). As PSQI, BDI and ESS appeared to be dependent on the current shift 
pattern in SW, second assessments were carried out for some of the subjects during the 
week prior to the study or on the adaptation night. Subjects were then asked to keep only 
days off or day shifts in mind when completing the questionnaires. SW were also asked 
to fill out the Standard Shift Work Index (SSI) (Barton etal. 1995) which was mainly used 
to determine the total shift work duration and the shift pattern of their last job (appendix 
E). Finally written consent was obtained from the subject’s GP confirming that there was 
no known reason why the applicant would be unsuitable to participate in the study and 
stating dose, frequency and last administration of (recently) prescribed medication.
2.3 Subjects
If applicants were found suitable they were informed of their eligibility to participate in the 
study. For inclusion and exclusion criteria see Table 2.1. Moreover, SW had to have 
worked shifts continuously, with at least three night shifts per month to be eligible. 
Twelve SW and 14 NSW matched for age, BMI and cholesterol participated in the study. 
However, one shift worker withdrew from the study after the adaptation night and was 
not included in any further analyses. The results for the screening for all participants can 
be found in Table 3.1 and appendix F. Shift work schedules are summarised in appendix 
G. Although some subjects exceeded the official cut off values, they were included in the 
study. This will be discussed in section 6.1.4. The self-reported pre-study questionnaires 
confirmed that the subjects neither had a history of medical conditions or medication 
thought to affect cardiovascular, metabolic, gastrointestinal or immune function nor 
suffered from sleep or mental disorders at the time of recruitment and during the study.
2.4 Prior to the laboratory session
In order to maintain or establish entrained circadian rhythms (i.e. for the SW to be 
adapted to nocturnal sleep prior to the laboratory session) and to minimise sleep debt, 
volunteers were asked to keep a self-selected regular sleep-wake cycle (Revell et al.
2005) (or, strictly speaking, go to bed - get up cycle), with a sleep duration of 7.5 or 8 h 
the week prior to the study, (with bed times of 23.3 ± 0.5 h, 22 - 24 h (average ± SD, 
range, n = 25), wake up times of 7.2 ± 0.5, 5.5 - 8 h and a sleep duration 7.9 ± 0.2, 7.5 - 
8 h (for individual times, see appendix F). They were instructed to start this schedule 8 
evenings prior to the laboratory study and to try to sleep in a dark, quiet room without
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distraction (and not to deviate in their bed and get up times by more than 15 minutes). 
Volunteers were given a 4 hour window in the afternoon (centred 12 hours away from the 
midpoint of their night-time sleep) in which they were permitted to nap if they chose to do 
so. Naps scheduled this way are thought not to phase shift circadian rhythms (Buxton et 
al. 2000).
Table 2.1. Inclusion and exclusion criteria.
Participants must:
• be between 25 and 45 years of age,
• be male,
• in the case of SW: have done shift work for an accumulated duration of at least 5 years,
• be able and willing to give informed oral and informed written consent,
• have authorisation from their medical practitioner,
• complete and meet the defined criteria of pre-study questionnaires,
• agree to keep a constant sleep/wake cycle with a self-selected sleep duration of 7.5 or 8
hours (from which can not be deviated by more than 15 minutes) for one week prior to the 
lab study,
• obtain 15 minutes of sunlight within 1.5 hours of waking up and agree to nap only within a
4 h designated nap window for one week prior to the lab study,
• allow confirmation of compliance to these instructions by reporting wake up and sleep
times to the lab voicemail, wearing Actiwatches (AWL) continuously and complete daily
sleep and event diaries for one week before the study session,
• agree to refrain from alcohol, caffeine, heavy exercise and certain food components two 
days before the study session,
• agree to refrain from prescribed, ‘over the counter’ medication and food supplements for a 
wash-out period determined by the research team.
Participants wili be excluded if they:
• are taking regular medication (also non-prescribed) or food supplements (e.g vitamins, 
minerals, fish oil, antioxidant tablets) from which it is not possible to refrain, known to 
influence:
o  sleep/alertness/the circadian timing system (e.g. p-blockers, barbituates, 
antidepressants, benzodiazepines, melatonin, ritalin, modafinil, soporifics, St 
John’s Wort),
59
Chapter 2 Methods
o  any of the metabolic functions (e.g. affecting thyroid, kidney, liver or 
gastrointestinal function) 
o  any of the inflammatory markers (e.g. aspirin, ibuprofen, antibiotics, hay fever 
medication, medication for sore throats and colds) 
o  and/or any of the endothelial markers (e.g. AGE inhibitors and angiotensin 
(receptor) blockers, diuretics, p-blockers, anti-thrombosis medication), 
have a history of any circadian or sleep disorder or metabolic, cardiovascular or chronic 
infectious / inflammatory disease as confirmed by the GP or the pre-study questionnaires, 
have a history of psychiatric or neurological disease or drug and alcohol abuse, 
have a positive drug screen. A urine screen will be carried out to ensure that the 
participants are negative for drugs of abuse,
have donated over 400 ml of blood in the three months preceding the study, 
are anaemic, confirmed by a haematology screen,
have travelled across more than two time zones within two weeks of the study, 
in the case of NSW: have participated in shift work for more than 6 months, 
in the case of the SW, have been involved in shifts other than day shifts the week prior to 
the study,
do not keep a regular sleep-wake cycle
do not refrain from alcohol, caffeine containing drinks (e.g. coffee, coke, tea, redbull), 
heavy exercise and certain foods (e.g. those high antioxidants and nitrites/nitrates) two 
days before the laboratory session
To confirm this regular sleep-wake cycle participants were asked to call the laboratory’s 
voicemail within 10 min before going to bed and after getting up. They were also 
provided with two L-actiwatches (AWL) (Cambridge Neurotechnology, Cambridge, UK), 
one around the neck and one around the non-dominant wrist, both recording motor 
activity and light exposure via a light sensor on the upper side. The volunteers were also 
asked to complete a daily sleep diary, recording bed and get up times, estimates of sleep 
onset latency and awakings, a rating of the sleep quality on a 9-digit scale and whether 
they would have liked to sleep longer or nap (Lockley et al. 1999). For the 7 days prior to 
and on the morning of the laboratory study participants were asked to obtain 15 min 
exposure to outdoor natural light (without wearing sunglasses) within the 90 min after 
waking up to strengthen the regularity of the circadian rhythms (Revell et al. 2005). This 
was complemented by recording in a light diary when participants went outdoors during 
the light phase and whether they were wearing sunglasses and/or riding in a car/bus or 
train. In addition, volunteers were asked to complete an event diary, recording when.
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what and how much they ate and drank and when and how long they exercised and what 
type of exercise they did.
Participants were also asked to inform the research team of any changes in their medical 
condition and to take only paracetamol instead of non-steroidal anti-inflammatory drugs 
(NSAIDs) for minor aches. Moreover, it was emphasised that recreational drugs were 
prohibited. Finally, 24 out of 26 volunteers visited the CIU for an ‘actiwatch download 
appointment’ halfway through this week to confirm the actiwatches were working and to 
check whether subjects were adhering to the regular sleep/wake cycle.
The 2 days prior to the laboratory session, participants were asked to refrain from heavy 
exercise, smoking (although none of them were current smokers), alcohol, caffeine, 
foods high in anti-oxidants (Hampton et al. 2010) and nitrites/nitrates (Walters et al.
2006) (appendix H). On the day the subjects entered the laboratory they were asked to 
refrain from foods and drinks other than water for the 6 h before the dinner provided in 
the laboratory.
2.4.1 Genotyping
Buccal swabs (Epicentre® Biotechnologies, supplied by Cambio Ltd., Cambridge, UK) 
were collected from all participants prior to the study and they were genotyped for PER3 
according to an established protocol (Ebisawa et al. 2001), with some modifications 
(Vandewalle et al. 2009) (appendix I). The results can be found in Table 3.1 and 
appendix F.
2.5 The laboratory session
Volunteers spent 4 nights and 4 days in the CIU (Figure 2.1). They were not allowed to 
leave the CIU or to have visitors, but were allowed to know clock time and to make 
phone calls, watch television or DVDs, listen to music, read or use their laptop (with the 
brightness of the laptop screen reduced) when they were not doing the mood and 
alertness tests.
Light was kept constant at < 8 lux in the direction of gaze (immediately following the 
electrode attachment for the PSG recordings was finished until after the last alertness 
and mood assessment, apart from darkness during the sleep periods).
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Figure 2.1. Laboratory study protocol.
The diagram shows the 5 study days for a subject with a habitual sleep from 23:00 to 7:00 h. 
Interventions (see key) were all relative to the subject’s wake up time (see relevant sections). 
HRV, heart rate variability.
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This was regularly checked with a calibrated lux meter (Edmund Optics, York, UK). 
Temperature was set around 20°C and both light and temperature were continuously 
recorded with Hobos (Tempcon, Arundel, UK). There were at least 3 Hobos placed 
above the subjects head at the end of each bed and a random point in the room. For 
some sessions there were 2 additional Hobos at the end of each subject’s bed.
In order to control for inter-individual differences in circadian phase, all interventions and 
measurements were scheduled relative to each subject’s self-selected wake up time 
(appendix F) which can be used as a proxy for circadian phase (Burgess et al. 2003). 
During each session, only 2 volunteers were present because of the duration and 
frequency of the measurements. Their wake up times were scheduled 30 min apart to 
allow time to take all the measurements. The volunteers were in the same ward but could 
draw a curtain around their beds to allow for some privacy.
On the first afternoon subjects entered the laboratory around 11 h after wake up time. 
They were allowed some time to settle in and told again briefly what the study involved. 
On the adaptation, baseline and recovery night they were asked to try to sleep in the 
dark at the same times which were already agreed with them for the schedule the week 
prior to the study. They were provided with eye masks (and ear plugs if needed). From 
waking up after the baseline night, subjects were asked to stay awake for 30.5 h (as a 
proxy for the first night shift), followed by a 4 h recovery nap and recovery sleep, which 
was equal in length to adaptation and baseline sleep. During wake time subjects were 
monitored by staff in order to ensure they did not fall asleep, which was evaluated post 
hoc with polysomnography (section 2.5.4).
Timing of other interventions and measurements will be described in the relevant 
sections.
2.5.1 Body posture
As many of the measurements (e.g. cardiovascular parameters) are affected by body 
posture, this was strictly controlled throughout the study. During assigned periods, 
subjects were asked to remain in a semi-recumbent posture (with the bed at 
approximately 45°). During these periods they were not allowed to get out of bed. If they 
needed the toilet they were provided with a urinal. The semi-recumbent periods were the 
sleep periods, the sleep deprivation night (from habitual bed time to wake up time) and 4
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h periods each afternoon from 6.5 to 10.5 h after wake up time. Initially, this was done to 
establish controlled conditions mainly for the HRV assessments but the data during 
these periods were not analysed for this thesis due to the combined effect of sleep 
deprivation and the nap which makes the afternoons less comparable across days.
Physical activity was further restricted during blood and saliva sampling which was 
performed in a seated position. Subjects were allowed to use the toilet during these 
periods but were instructed to be seated 20 minutes before each sample as saliva 
melatonin concentrations may be influenced by changes in body posture (Deacon & 
Arendt 1994). Mood and alertness assessments were also conducted in a seated 
position. In addition, all subjects were allowed to have a shower after the last mood and 
alertness test before the sleep deprivation night. Finally, ultrasound recordings were 
taken in supine position.
Practically, this meant that subjects were in bed all the time and only got out of bed to 
use the bathroom. This ensured that body movement and energy expenditure were 
similar for all volunteers.
2.5.2 Food intake
All subjects were provided with the same standard breakfast, lunch, dinner and evening 
snack (Table 2.2) (appendix J) at 1.75, 4.75, 12 and 15 h after wake up time, 
respectively. These meals were provided from the dinner on the first evening until the 
dinner on the last evening included. Between these meals subjects were not allowed any 
other food or drinks, except for water ad libitum.
Table 2.2. Percentage protein, fat and carbohydrates and energy for each of the meals.
Protein (%) Fat (%) Carbohydrate (%) Energy (kcal)
Breakfast 7.8 39.7 53.3 967.5
Lunch 14.1 53.6 32.2 996.9
Dinner 13.3 43.9 42.5 950.0
Evening snack 14.9 25.4 59.1 300.0
Overall composition 12.0 43.9 44.1
Total 3214.4
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The breakfast had a relatively high fat and sugar content in order to elicit a well-defined 
postprandial response. The snack was included in the protocol to reduce feelings of 
hunger and irritation during sleep deprivation.
2.5.3 Blood sampling
On the first evening a blood sample was taken prior to the evening snack. On the 
adaptation day, 4 blood samples were taken prior to breakfast, lunch, dinner and the 
evening snack. Samples taken before breakfast are from here onwards referred to as 
‘basal’ samples. The 5 blood samples from the adaptation and baseline day were taken 
by venepuncturing by a qualified phlebotomist. On the baseline day, a cannula was 
inserted into the left arm by a qualified nurse, which allowed for frequent blood samples 
to be taken. After baseline sleep, sleep deprivation and recovery sleep, blood samples 
were taken 15 and 0 minutes prior to and 15, 30, 45, 60, 90, 120, 180 and 240 minutes 
after breakfast and again prior to the dinner and evening snack. The first sample on 
these 3 days was taken 1.5 h after wake up time (following a 10.5 h fast). This resulted 
in a total of 41 blood samples per subject over the course of the experiment. The 
samples taken after adaptation sleep and before the dinner and the snack each day 
were initially collected to be able to assess the daily pattern of metabolites, insulin and 
inflammatory markers across the days, but these data are not described in this thesis.
Each blood sample (with a total volume of 12 ml) was collected into 3 different collection 
tubes. One ml was collected into a 1 ml fluoride oxalate tube (Teklab Ltd., Sacriston, 
UK), 3 ml into a 5 ml tripotassium EDTA tube (Teklab Ltd.) and 8 ml into a 10 ml lithium 
heparin tube (Teklab Ltd.). The tubes were centrifuged at 1750 g, 4°C for 10 min and the 
resulting supernatant was aliquoted into 1.5 ml microcentrifuge tubes (Apex® plus. Alpha 
Laboratories Ltd., Eastleigh, UK) and stored at -20°C until analysis. Directly after each 
blood sample the cannula was flushed with 0.9% w/v sodium chloride (MacoPharma 
Ltd., Twickenham, UK) to keep the cannula patent.
2.5.4 Polysomnographic (PSG) recordings
Participants were prepared for PSG after their dinner on the first night of the laboratory 
session (see sections 4.2.3 and 5.2.2) (HRV and sleep) for further details). The PSG 
included EEG/EOG/EMG (section 5.2.2), EGG (section 4.2.3) and respiratory effort. To 
record respiratory effort a thoracic and abdominal band (NicoletA/iasys Healthcare,
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Warwick, UK) were put around the chest (at the height of the nipple line) and around the 
abdomen (at the belly button). PSG was then performed continuously throughout the 
laboratory session until the last alertness and mood test on the recovery day, with the 
exception of periods with data loss due to logistical and technical issues (e.g. to allow the 
subjects to take a shower, network connection problems, battery replacement, etc.). All 
electrodes were connected to an ambulatory system (Siesta EEG/PSG recorder, 
Compumedics Ltd, Abbotsford, Victoria, Australia) and signals were continuously 
recorded at 256 Hz with ProFusion PSG 2 (version 2.1 build 134, Compumedics Ltd). 
Impedance was checked regularly and if it was too high (> 5 kO or > 15 kO for ECG and 
EMG) electrodes were removed, the site was cleaned, new paste applied and the 
electrode reattached. The acquired data were converted into European Data Format 
(EDF) and imported into Somnologica Studio (version 5.0.1 build 1662, Embla, supplied 
by Stowood Scientific Instruments Ltd., Oxford, UK) for further analysis.
2.6 General statistics
Statistics were carried out in SPSS 14,16 and 17 (SPSS Inc., IBM company, Chicago, 
Illinois, USA), Graphpad Prism 4 and 5 (GraphPad Software Inc., La Jolla, San Diego, 
California, USA) and Statistica (release 5.1 -  ’97 edition, StatSoft Inc., Tulsa, Oklahoma, 
USA). The 3 programs yield similar results as long as exactly the same tests and 
adjustments were used. However, all programs had their limitations and therefore they 
were used alongside each other. For example, SPPS could not calculate post hoc tests 
for some main effects such as ‘day’ and ‘time’ whereas Statistica had this option. Tests 
for sphericity and Greenhouse-Geisser adjusted P-values (see next sections) for some 
effects and interactions were not calculated by Statistica but were available in SPSS. 
Finally, areas under the curve were calculated in Graphpad Prism (see next sections).
2.6.1 Normality
Almost all tests described in the next chapters are parametric tests. It is recommended 
that normality of the data is tested for before using parametric tests. Normality tests were 
carried out preferably per group, day and time point as each of these can be seen as an 
‘intervention’ and may cause the data not to be normally distributed. Although data were 
not normally distributed in some of the cases, parametric tests were proceeded with 
(according to advice from University statisticians) as the normality tests were thought not 
to be of major importance, due to the design of the study and the small sample size.
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2.6.2 Analyses of variance (ANOVAs) and Mauchly’s test of sphericity
The lay outs of the data sets in this thesis were suitable for testing with ANOVAs. The 
most complex design used was the three-factor ANOVA with repeated measures for 2 
within subjects factors (‘day’, having as many levels as the number of days compared 
and ‘time’, having as many levels as the time points within a day) and 1 between 
subjects factor (‘group’, which was defined by being a shift worker or non-shift worker).
When carrying out the ANOVAs, firstly, the data were tested for sphericity. According to 
SPSS results coach “Mauchly derived a test that verifies the variance-covariance matrix 
structure by performing a test of sphericity on the orthonormalised transformed 
dependent variables. Mauchly's test of sphericity tests the null hypothesis that the error 
covariance matrix of the orthonormalised transformed dependent variables is 
proportional to an identity matrix. The null hypothesis is rejected if the significance value 
is less than 0.05.” Therefore, when the null hypothesis was rejected, sphericity could not 
be assumed and one of the adjusted (usually higher,) significance values had to be 
chosen, which most commonly was the Greenhouse-Geisser adjusted value. As carrying 
out tests for sphericity and displaying adjusted values was not in the default settings of 
Statistica, these settings had to be customised. Furthermore, sphericity is assumed by 
Graph Pad Prism and it is not possible to obtain adjusted values. Therefore, the areas 
under the curve (AUCs) (S.2.5.4) calculated by Graphpad Prism had to also be analysed 
in Statistica.
2.6.3 ANOVA post hoc tests
If a significant main effect was found in an ANOVA with repeated measures, there are 
two ways to locate the differences between groups, days and time points; either by 
contrast analysis or by post hoc tests. While contrast analysis only allows testing 
significance of a priori specified comparisons (e.g. 2 comparisons for 3 days), post hoc 
tests allow multiple comparisons (e.g. between SW and NSW on different days). The 
latter is more likely to reveal more significant differences as Statistica help states that it is 
based on the assumption that for a comparison the most extreme (different) means (e.g. 
2 means) are chosen out of a number of total means (e.g. 20 means with a sample size 
of 5 each), whereas contrast analysis would test the difference between a number of 
samples from the original pool (e.g. 2 samples out of 100). It is an individual choice 
which of these methods to use.
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For this thesis it was decided to use Tukey honest significance difference (HSD) post hoc 
tests as this allowed all comparisons of a priori interest. As SPSS allows only contrast 
analyses but no post hoc tests for three-factor ANOVAs, the analyses were carried out in 
Statistica. If no significant interactions were found in the within subjects main effects, the 
post hoc tests were only used to locate differences within each main effect separately 
(e.g. between days). On the other hand, if significant interactions were found (e.g. for 
‘day’ by ‘group’) both factors were combined to locate differences with the post hoc tests 
(e.g. between days within SW).
2.6.4 Mixed-model analyses
As ANOVA cannot be carried out on data sets with missing values, these had to be 
replaced or subjects had to be excluded. After the data in CHAPTER 3 were analysed 
with ANOVA a University Statistician (Mr Peter Williams) designed a software code that 
could analyse the FMD data set (which also had missing values) and then this was 
modified to analyse the HRV and alertness and mood data. This mixed-model regression 
analysis was conducted in SAS 9.1 (TS level 1M3, SAS Institute Inc., Cary, NC, USA). 
Similarly to the ANOVA, the model determined main effects (group, day and time) and 
interactions between these main effects, with repeated measures within subjects, fixed 
effects SE method Prasad-Rao-Jeske-Kackar-Harville, covariance structure ‘variance 
components’ and Kenward-Roger method for calculating the degrees of freedom. To 
locate post hoc differences between days and time points, least squares means were 
calculated and t-type confidence limits were constructed for each of the least squares 
means.
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CHAPTER 3 METABOLISM
3.1 Introduction
Epidemiological research has shown that SW may be at higher risk of developing CVD 
(Boggild & Knutsson 1999; De Bacquer etal. 2009; Ellingsen et al. 2007; Esquirol etal. 
2009; Karlsson et al. 2001; Karlsson et al. 2003; Kawachi et al. 1995; Sookoian et al.
2007). This may, in part, relate to changes in hormone and metabolic responses (section
1.3.2). The mechanisms underlying these observations are still unclear, but it is thought 
that in SW the increased risk may, in part, be due to circadian misalignment (e.g. eating 
at night when metabolic activity is lower) (Knutsson & Boggild 2000) (section 1.4.3). 
Previous studies in SW (Knutsson et al. 2002; Lund et al. 2001 ; Simon et al. 2000) and 
studies on simulated shift work (Al-Naimi et al. 2004; Hampton et al. 1996; Ribeiro et al. 
1998) or circadian misalignment (Scheer et al. 2003) have shown increased TAG, 
glucose and insulin responses and decreased NEFA levels when the food intake of 
subjects was at an inappropriate circadian time (section 1.7). In addition, sleep 
deprivation, for example in SW, may contribute to an increased risk for CVD (e.g. 
Gangwisch et al. 2006; Sabanayagam & Shankar 2010; Taheri et al. 2004) (section
1.2.2). In agreement with this, some laboratory studies have demonstrated decreased 
glucose tolerance and insulin sensitivity after partial sleep deprivation (PSD) (Buxton et 
al. 2010; Donga et al. 2010; Nedeltcheva et al. 2009; Spiegel et al. 1999; van Leeuwen 
et al. 2010) (section 1.6.2) and after total s\eep deprivation (TSD) (Gonzalez-Ortiz et al. 
2000; VanHelder et al. 1993) (section 1.6.1). In addition, a decrease in NEFAs was 
observed under hypoglycaemic clamp conditions (Schmid et al. 2007) after 1 night of 
TSD and a reduction in the TAG rhythm and average TAG levels was found after 3 to 5 
days of total sleep deprivation (Vondra etal. 1986).
Furthermore, it is likely that there are inter-individual differences in the vulnerability to the 
effects of shift work and sleep deprivation (section 1 .8 ), due to e.g. genetics, 
morningness-eveningness or shift work history. This suggests that NSW and 
experienced SW may respond differently when subjected to the same sleep restriction 
conditions and dietary intake.
The effects of TSD on the postprandial response to a standard breakfast have not been 
investigated before, although TSD is occurring during at least the first night shift in many
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SW. In addition, differences between SW and NSW have not been assessed 
simultaneously in controlled laboratory conditions with food intake at a ‘normal’ circadian 
time.
3.1.1 Aims and hypotheses
This chapter investigates the effects of one night of TSD, a recovery nap and recovery 
sleep perse on basal and postprandial metabolic and insulin responses under controlled 
laboratory conditions. In addition, the responses of experienced SW (with a shift duration 
of 5 years or more) were compared with those of NSW.
It was hypothesised that:
• TSD will affect TAG, NEFA, glucose and insulin levels in both NSW and SW. 
Changes in these metabolite and insulin levels will indicate decreased insulin 
sensitivity after TSD.
• A nap and recovery sleep will have an impact on these postprandial changes by 
(partly) reversing the levels to those prior to TSD.
• There will be differences between SW and NSW.
Indications of insulin insensitivity will be higher after TSD in SW than in NSW; 
changes in metabolites and insulin will not recover as quickly in SW as in NSW.
• There will be no differences in cholesterol and HDL throughout the protocol and 
there will be no differences between NSW and SW due to the matching during 
screening.
3.2 Methods
Methods specific to this chapter are described below. For general methods see chapter 
2 .
3.2.1 Subjects
Demographics of all 25 subjects (14 NSW, 11 SW) are shown in Table 3.1 and appendix 
F. One NSW (C2) had problems with blood sampling and too few samples could be 
collected in order to assess a reliable postprandial response. Another NSW (Cl 3) had an 
extremely high insulin response and was excluded from all insulin analyses. The subject
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was considered an ‘outlier’ as the areas under the curve (AUCs) after baseline sleep, 
TSD and recovery sleep were > 2 SD from the mean.
3.2.2 Blood samples
The sampling procedure is described in detail in section 2.5.3 and Figure 2.1. Plasma 
glucose was measured from blood collected in fluoride oxalate tubes, while all other 
metabolites and insulin were measured in plasma derived from blood collected in K- 
EDTA tubes. The plasma samples were stored at -20'C until assayed. Repeated freeze- 
thaw cycles were avoided in almost all cases. Although measurements were carried out 
for all 41 samples collected throughout the study, the results for the glucose, TAGs, 
NEFAs and insulin are only described after baseline sleep, TSD and recovery sleep as 
the postprandial response was assessed just on these days. Cholesterol and HDL were 
measured in all morning (0 time point) and evening samples (i.e. 9 samples per subject) 
as concentrations were not expected to change postprandially.
A preliminary analysis for the first 11 subjects was carried out for glucose, TAGs, NEFAs, 
insulin, HDL and cholesterol. The samples from the remaining 13 subjects were analysed 
in a second batch approximately 1 year later.
3.2.3 Measurements of the metabolites and insulin
3.2.3.1 Metabolites
For the preliminary analysis, the plasma was thawed, centrifuged at 1500 g for 5 min at 
4'C and the tubes were placed in the l-lab 650 (Instrumentation Laboratory, Warrington, 
UK) for the measurement of the metabolites. For the remaining 13 subjects, the plasma 
was also thawed and centrifuged but the supernatant was then re-aliquoted into new 
plain tubes to optimise clarity of the sample and were placed in the l-lab for the 
measurements.
The plasma metabolite concentrations were determined with reagents for the detection 
of glucose (oxidase) (IL TestTM, catalogue number 0018250840, Instrumentation 
Laboratory), TAGs (IL TestTM, catalogue number 0018255640, Instrumentation 
Laboratory), NEFAs (catalogue number FA115, Randox Laboratories Ltd., Crumlin, UK), 
HDL-cholesterol (catalogue number CH2652, Randox Laboratories Ltd.) and cholesterol
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(IL TestTM, catalogue number 0018250540, Instrumentation Laboratory). All reactions 
were enzymatic, producing coloured end points, of which the absorbance was measured 
and directly proportional to the metabolite concentration (appendix K)
The l-lab was calibrated every day before the measurements were taken and quality 
control (QC) samples with a known concentration were measured and checked before 
measuring the samples of each subject to assess intra- and inter assay variability. 
Coefficients of variation (OVs) were 3 and 3.3, 3.8 and 4.2, 2.4 and 2.3, 7 and 8 . 8  and
4.3, 4.7 and 3.5 % for QC samples with 1.4 and 2.5 mmol/L TAG (n = 28), 2.4 and 5.1 
mmol/L cholesterol (n = 20), 5.3 and 14.4 mmol/L glucose (n =17), 1.1 and 1 mmol/L 
NEFA (n = 23) and 0.9, 1.4 and 2 mmol/L HDL (n = 21), respectively.
S.2.3.2 Insulin
Plasma insulin was measured with a human insulin specific radioimmunoassay (RIA) kit 
(catalogue number HI-14K, Millipore Ltd., Watford, UK). The plasma was thawed and 
centrifuged at 1500 g for 5 min at 4°C. Standards, QCs and samples were pipetted into 
LP3 tubes and the protocol supplied with the kit was followed (appendix L), with the 
exception of the following modifications. Four zero-binding tubes were used in order to 
improve precision. Two pairs of low and high QCs (before the first and after the last 
samples), or if samples of 2  subjects were assayed, 3 pairs of low and high QCs (before 
the first, in the middle of and after the last samples) were measured. Finally, the 
supernatant in step 1 0  was aspirated instead of decanted because the pellets were 
fragile. All samples from one subject were measured in one assay, usually those from 
one SW as well as one NSW and the day order was randomised to minimise any effects 
of possible assay drift.
After visual inspection, samples were measured again if the duplicates had a variation of 
approximately 10%, depending on the sample concentration. One value of the original 
duplicate closest to the repeated value was chosen as the final value. Samples were 
also diluted and repeated if insulin levels were higher than the linear part of the standard 
curve. The inter-assay CVs were 11.9 and 6 .6 % for 60.2 and 212.6 pmol/L insulin (n 
=16).
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3.2.4 Missing values and inter-Zextrapolation
Repeated measures analyses cannot be carried out in SPSS, Statistica or Graph Pad 
Prism on a data set with missing values. For TAGs, NEFAs, glucose and insulin, missing 
values had to be filled in using linear interpolation for missing values in the sampling 
period 15 to 180 min after breakfast and linear extrapolation for the samples taken 240 
min after breakfast. Missing values for the samples taken either 15 or 0 min prior to 
breakfast were not interpolated but it was assumed that these 2  samples should have 
equal values. Missing values for the dinner and evening samples were not added. The 
percentage of values which needed to be interVextrapolated was as follows: glucose 
3.6%, NEFAs 2.8%, TAGs 3.1% and insulin 3.8%. These added missing data are also 
shown in all graphs unless otherwise mentioned. Obviously, interpolation and 
extrapolation has limitations, especially when the missing value occurs exactly where the 
postprandial peak is expected and a linear assumption may not reflect the reality. 
However, this method has been chosen to avoid exclusion of too many subjects.
For cholesterol and HDL, interpolation is slightly different as samples were taken during 
a different time course (section 3.2.2). The values were added by taking the average of 
the remaining 3 time points 0 or 4 evening values (2.2% of the cholesterol and 1.8 % of 
the HDL data, 1 NSW and 3 SW still had missing data).
3.2.5 Statistics
General statistics were described in section 2.6. Methods detailed below hold for all 
metabolites and insulin unless otherwise stated.
3.2.5.1 Basal levels
Basal levels (the mean of the -15 and 0 time points) of all metabolites and insulin on the 
baseline day of the study and subject demographics were compared between SW and 
NSW with an independent two-tailed Student’s T-test. Basal levels of all metabolites 
were also compared after baseline sleep, TSD and recovery sleep. Analyses were 
carried out on the datasets of NSW and SW combined with a two-factor ANOVA (factors 
‘day’ (3 levels: ‘baseline sleep’, ‘TSD’ and ‘recovery sleep’) and ‘group’ (2 levels: ‘NSW’ 
and ‘SW’)). Since statistically significant differences between the groups may not be
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revealed in this combined analysis due to the small sample number, NSW and SW were 
also analysed separately using one-factor ANOVA (factor ‘day’).
3.2.5.2 Postprandial responses over 4 hours
Analyses were carried out on the datasets of NSW and SW combined with a three-factor 
ANOVA (factors ‘day’, ‘time’ (10 levels: time points 15 min prior to -  240 min after the 
standard breakfast) and ‘group’). NSW and SW were also analysed separately in two- 
factor ANOVA (factors ‘day’ and ‘time’).
As basal levels showed an effect of day (section 3.3.2), these basal levels were then 
corrected for. Thus, postprandial samples (time points 15-240 min) were calculated as a 
percentage of the basal levels prior to the breakfast. A three-factor ANOVA on the data 
sets of NSW and SW combined (factors ‘day’, ‘time’ and ‘group’) was then carried out on 
the normalised data. NSW and SW were also analysed separately in two-factor ANOVAs 
(factors ‘day’ and ‘time’).
3.2.5.3 Return to basal levels
An assessment was made as to whether TAG, NEFA, insulin and glucose return to basal 
levels 240 min after the standard breakfast. Firstly, a three-factor ANOVA on the data 
sets of NSW and SW combined (factors ‘day’, ‘time’ (2 levels: ‘basal state’ and ‘240 min’) 
and ‘group’) was carried out. NSW and SW were also analysed separately in two-factor 
ANOVA (factors ‘day’ and ‘time’).
Secondly, the basal levels were subtracted from the values for the 240 min time points 
and this difference was then calculated as a percentage of the fasting level. A two-factor 
ANOVA (factors ‘day’ and ‘group’) was carried out to assess whether there were any 
differences between the days and/or the groups.
3.2.5.4 Incremental area under the curve (lAUC)
The Incremental area under the curve (lAUC) was calculated for each individual on the 3 
days (GraphPad Prism) by subtracting the area under the basal level from the total AUC 
(TAUC). The 3 days and the groups were compared with a two-factor ANOVA (factors
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‘day’ and ‘group’). NSW and SW were also analysed separately in one-factor ANOVA 
(factor ‘day’). The same analyses were carried out for the TAUC.
3.2.5.5 Cholesterol and HDL-cholesterol
Cholesterol and HDL levels in the 9 samples were compared in a data set of NSW and 
SW combined by a two-factor ANOVA (factors ‘time points’ and ‘group’) of both the raw 
data and interpolated data. NSW and SW were also compared on the mornings and 
evenings of the adaptation and baseline days by an independent Student’s T-test.
3.3 Results
3.3.1 Comparison o f shift workers and non-shift workers
The characteristics of all participants are given in Table 3.1. Individual data can be found 
in appendix F. Basal plasma glucose, TAG, NEFA and insulin levels measured on the 
baseline day of the laboratory study and other parameters determined on the screening 
day were not significantly different between SW and NSW, apart from the number of 
years the subjects had worked shifts for (P < 0.001) and the PSQI (P < 0.05). However, 
the significant difference between SW and NSW for the PSQI disappeared when using 
the values of the second assessment in SW, obtained during the week prior to or on the 
adaptation night of the laboratory study (see section 2 .2 ). The PSQI in this group was 
now 5.1 ± 2.2 (mean ± SD), ranging from 2 - 1 0 .  In parallel with this, the BDI and ESS 
scores also came down in SW after the second assessment (4.7 ± 4.9, 0-17 and 6.2 ±
3.3, 2 -1 1 , respectively). The data did not show differences between NSW and SW in the 
PER3 polymorphism, but statistical analyses were not possible due the sample size. 
There was one SW and one NSW with the PER3^^  ^genotype but there were more SW 
than NSW with the genotype (5/11 vs 3/14) and, inversely related to this fewer
subjects with the PER3Z^ "^  genotype amongst SW than NSW (5/11 vs 10/14). 
Furthermore, no significant differences between SW and NSW were found in other 
screening parameters such as serum sodium, potassium, alanine transferase (ALT) and 
white blood cell counts (appendix F).
In addition, the ANOVAs showed that the ‘group’ effect (SW versus NSW) was not 
significant in any of the analyses described hereafter. However, separate analyses of the 
groups revealed some differences between NSW and SW.
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Table 3.1. Characteristics of non-shift workers and shift workers on the first 
assessment.
non-shift workers (n = 14) shift workers (n = 11)
mean ±SD range mean ±SD range
shift work (yrs) 0.03 ±0 .11 0 - 0.42 8.7 ± 5.2*** 5 - 18.5
time since last shift (months) 60 1.6 ± 5.4 0 - 18
age (yrs) 32.5 ± 6.2 25 - 42 35.7 ± 7.2 25 - 45
weight (kg) 83.7 ± 13.5 67.8 - 109 91.6 ± 10.3 82 - 117
height (m) 1.77 ± 0.06 1.66 - 1.85 1.79 ± 0.07 1.71 - 1.91
BMI (kg/m2) 26.6 ± 3.4 21.5 - 34.0 28.7 ± 3.8 23 - 35.7
waist circumference (cm) 91.2 ± 9.4 76 - 107 98.0 ± 6.7 90 - 110
hip circumference (cm) 100 ± 7.4 88 - 114 106 ± 6.2 95 - 114
WHR 0.91 ± 0.04 0.84 - 0.96 0.93 ± 0.03 0.86 - 0.98
cholesterol (mmol/L) 4.7 ± 0.5 3.9  - 5.5 4.9 ± 1.1 3 - 6.5
HDL (mmol/L) 1.3 ± 0.2 0.8 - 1.6 1.4 ± 0.4 0.9  - 2 .4
PER3^'^(#) 10 5
PERS^ /^^  (#) 3 5
PER3^/G 1 1
HÔ 60.2 ± 6.0 51 - 72 55.5 ± 13.0 34 - 75
PSQI 3.9 ± 1.9 1 - 7 6.5 ± 3* 2 - 10
BDI 3.3 ± 3.0 0 - 9 5.2 ± 4.7 0 - 17
ESS 4.9 ± 3.2 1 - 11 7.2 ± 3.6 2 - 11
currently smoke (units/day) 0 ± 0 0 - 0 0 ±  0 0 - 0
past smoked (units/day) 3.6 ± 5.8 0 - 15.5 4.5 ± 5.7 0 - 15
smoking duration (yrs) 2.6 ± 4.4 0 - 14 4.4 ± 6.3 0 - 20
time since last smoked (months) 17.9 ± 24.1 0.5 - 60 38.4 ± 54.1 0 - 132
scheduled bed time (decimal h) 23.3 ± 0.4 22.5 - 24 23.4 ± 0.6 22 - 24
scheduled wake up time (decimal h) 7.2 ± 0.5 6 - 8 7.2 ± 0.6 5.5 - 8
scheduled time in bed (decimal h) 7.9 ±  0.2 7.5 - 8 7.9 ± 0.2 7.5  - 8
Values are means ± SD and ranges, measured on the screening day, the week prior to the study 
(scheduled bed and wake up time and bed time) or the baseline day of the laboratory protocol (for 
glucose, TAGs, NEFAs and insulin).
* P < 0.05 and *** P < 0.001 compared to NSW  by independent two-tailed T-test.
3.3.2 Basal levels
Basal levels of plasma TAGs, NEFAs, glucose and insulin after baseline sleep, sleep 
deprivation and recovery sleep are shown in Figure 3.1 and Table 3.2. A significant 
effect of day was observed for the basal levels of all 4 parameters in the data sets with 
NSW and SW combined. There was a significant effect of day on basal TAG levels (F2.44 
= 13.7, P < 0.001) with significantly lower TAG levels after TSD (1.2 ± 0.1 mmol/L (mean 
± SEM)) than after baseline (1.3 ± 0.1 mmol/L) and recovery (1.5 ± 0.1 mmol/L) sleep (P 
< 0.05 and P < 0.001, respectively).
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Figure 3.1. Basal plasma metabolite and Insulin levels.
Basal plasma (A) TAGs, (B) NEFAs, (0 ) insulin and (D) glucose (mean ± SEM) following baseline 
sleep {•) , sleep deprivation (□) and recovery sleep (A )  in NSW , SW  and all subjects.
Graphs display means (horizontal lines) and raw data points. * P < 0.05, ** P < 0.01 and *** P < 
0.001. n = 13 for NSW (n = 12 for insulin) and n = 11 for SW. Basal = mean of -15 and 0 time 
points.
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When analysing the subject groups separately, both NSW and SW showed significant 
effects of day (p2,24 = 11.1, P < 0.001; p2,2o = 4.4, P < 0.05, respectively) with a larger 
increase in basal TAGs after recovery sleep compared to TSD in NSW (P < 0.001) than 
in SW (P < 0.05). There was a similar effect of day for basal glucose levels (P2.44 = 3.3, P
< 0.05), with lower basal glucose levels after TSD (5.1 ± 0.0 mmol/L) than after baseline 
sleep (5.2 ± 0.1 mmol/L) and recovery sleep (5.2 ± 0.1 mmol/L). Tukey post hoc test, 
however, was non-significant.
In the combined data set there was a significant effect of day on basal NEPA levels (p2,44 
= 4.2, P < 0.05), with significantly lower NEPA levels after recovery (0.25 ± 0.01 mmol/L) 
than after baseline sleep (0.31 ± 0.02 mmol/L) (P<0.05). When the groups were 
analysed separately, this appeared to be mainly due to an effect of day in NSW (p2,24 = 
6.4, P < 0.01) with lower NEPA levels after recovery (0.25 ± 0.02 mmol/L) than after 
baseline sleep (0.34 ± 0.04 mmol/L) (P < 0.01). A significant day*group interaction was 
observed for basal insulin levels (p2,42 = 4.2, P < 0.05), revealing higher basal insulin 
levels after recovery (86.0 ± 8.1 pmol/L) than after baseline sleep (67.4 ± 3.6 pmol/L) (P
< 0.01, P < 0.05 when the groups were analysed separately) and TSD (70.0 ± 5.4 
pmol/L) (P < 0.05) in NSW.
3.3.3 Postprandial responses
3.3.3.1 Raw data
The time course for TAGs, NEPAs, insulin and glucose was assessed after baseline 
sleep, TSD and recovery sleep. The graphs of the mean data for NSW, SW and all 
subjects combined are shown in Pigure 3.2. There was a significant effect of day on TAG 
levels in the combined subject group (p2,44 = 10.9, P < 0.001). TAGs were significantly 
increased after recovery sleep compared to TSD (P < 0.001) and baseline sleep (P < 
0.05). When NSW and SW were analysed separately, both groups showed a significant 
effect of day, but the effect was stronger in NSW (p2,24 = 8 .2 , P < 0.01) than in SW (p2,2o 
= 3.7, P < 0.05).
Insulin showed a day*group interaction (p2,42 = 4.2, P < 0.05) with higher levels after 
recovery sleep compared to both TSD and baseline sleep in NSW (P < 0.001).
79
Chapter 3 Metabolism
A TAGS NSW SW All subjects
3 .0-
■5 2.5-
E
ê 2 . e
0
<1- 1.5-
E« 1 .0-
a.
0 .5
B NEFAs
0 .5n
0
E
&
1
z
0 .4-
0 .3-
0.2-
I
Q.
0.1
0.0-
C Insulin
12501_1
O
E
Q.
1000
750c
5 0 0
re
I
Q.
250
D Glucose
0 6 0 1 2 0  1 8 0  2 4 0 0 6 0 1 2 0  1 8 0  2 4 0 0  6 0  1 2 0  1 8 0  2 4 0
Time after breakfast (min) Time after breakfast (min) Time after breakfast (min)
Figure 3.2. Plasma metabolite and insulin levels.
Plasma (A) TAGs, (B) NEFAs, (0 ) insulin and (D) glucose (mean ± SEM) prior to (-15 and 0 min) 
and after (15 to 240 min) a standard breakfast, following baseline sleep ( • )  sleep deprivation (□) 
and recovery sleep (A ) in NSW, SW and all subjects combined (mean ± SEM). n = 13 for NSW  
(12 for insulin) and n = 11 for SW.
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When NSW and SW were analysed separately, both groups showed a significant effect 
of day, but the effect was stronger in NSW (p2,22 = 10.9, P < 0.001) than in SW (p2,2o =
4.3, P < 0.05). Post hoc tests showed that insulin levels were significantly higher after 
recovery sleep than after TSD and baseline sleep in NSW (P < 0.01) and that they were 
higher than after TSD in SW (P < 0.05). A significant effect of day was also observed for 
NEFAs in the combined subject group (F2,4 4 = 5.2, P < 0.01), with lower NEFA levels after 
recovery sleep compared to baseline sleep (P < 0.01). When the groups were analysed 
separately, the NEFA levels after recovery sleep were significantly lower compared to 
baseline sleep in NSW only (P < 0.01). For glucose, no significant effect of day was 
observed, but there was a significant interaction between day and time (F8.3,183.2 = 2.2, P 
< 0.05), indicating that the time course varied over the 3 days. However, the post hoc 
tests revealed that the only difference between the same time points on different days 
was an elevated glucose level 30 min after the standard breakfast following recovery 
sleep compared to after TSD (P < 0.05). Separate analyses of the groups did not show 
any significant effects of day or day*time interactions.
3.3.S.2 Normalised data
Since there was a statistically significant effect of day on basal TAG, NEFA, insulin and 
glucose levels (section 3.3.2), the postprandial response was analysed as a percentage 
of the basal level (i.e. mean of -15 and 0 time points). Using normalised data, no 
significant effects were found, apart from a day*time interaction for glucose (Fi6,352 = 2 .0 , 
P<0.05). In addition, in contrast to the raw data, there were no significant differences
between the same time points on different days.
3.3.4 Return to basal levels
TAG, NEFA, insulin and glucose levels in the basal state and 240 min after the standard 
meal are shown in Figure 3.3. To assess the postprandial return to basal levels, the 
levels prior to the breakfast were compared to the levels 4 h after the breakfast (240 min 
time point). Statistical analyses showed a significant day*time interaction (F2,44 = 3.9, P < 
0.05) for glucose in the combined subject group, revealing that glucose levels after the 
standard breakfast did not return to basal levels by 240 min after TSD (P < 0.01) (Figure 
3.3 D a). Insulin in the combined subject group also showed a day*time interaction (p2,42
= 4.2, P < 0.05) with higher insulin levels 240 min after breakfast following TSD
compared to baseline sleep (P < 0.01) (Figure 3.3 0 b). TAG and NEFAs showed
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significant effects of time in each of the groups, indicating that levels 240 min after the 
meal did not return to basal levels on any of the 3 days (Figure 3.3 A-C c), apart from 
those of NEFAs in NSW.
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Figure 3.3. Plasma metabolite and insulin levels in the basal state and 240 min after the 
standard breakfast.
Plasma (A) TAG, (B) NEFA, (0 ) insulin and (D) glucose levels in the basal state and 240 min after 
the standard meal, following baseline sleep (• ) , sleep deprivation (□) and recovery sleep ( A)  in 
NSW (NSW), SW and all subjects combined. The letters represent the following comparisons: a, 
240 min after the standard meal following TSD vs basal state following TSD; b, 240 min after the 
standard meal vs basal state on all 3 days; c, 240 min after the standard meal following TSD  vs 
240 min after the standard meal following baseline sleep; sleep. * P < 0.05 ** P < 0.01 and *** P < 
0.001. n = 13 for NSW  (12 for insulin) and n = 11 for SW.
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Another way of assessing whether postprandial levels return to basal levels is by 
calculating the difference between basal levels and the plasma levels 240 min after 
breakfast as a percentage of the basal concentration. The glucose data showed a 
significant effect of day {?2m = 3 9, P < 0.05) and the relative difference between basal 
levels and the levels 240 min after breakfast was significantly higher after TSD compared 
to after recovery sleep (P < 0.05) and non-significantly higher after baseline sleep (P = 
0.0641). There was no significant effect of day on this relative difference between basal 
TAG, NEFA and insulin levels and the levels 240 min after the standard breakfast.
3.3.5 Incremental area under the curve (lAUC)
Since there was a significant effect of day on basal levels (section 3.3.2), lAUCs were 
assessed. Results are shown in Figure 3.4 and Table 3.3. Analysis of the lAUCs showed 
a significant effect of day on the insulin response in the combined subject group (Fi.4,30.4 
= 9.7, P < 0.01). The insulin lAUC was increased after recovery sleep (83148 ± 8524 
pmol/L.min) compared to both TSD (62644 ± 5422 pmol/L.min) and baseline sleep 
(59680 ± 5205 pmol/L.min) (P < 0.01). No significant effects were observed for the TAG 
and glucose responses. When NSW and SW were analysed separately, the effect of day 
on the insulin lAUC remained significant in NSW (Fi.4,15 = 7.8, P < 0.01), with a larger 
insulin lAUC after recovery sleep (96299 ±14174 pmol/L.min) compared to both baseline 
sleep (60923 ± 8622 pmol/L.min) (P < 0.01) and TSD (64089 ± 8323 pmol/L.min) (P < 
0.05).
Although calculation of the TAUCs (Table 3.4) does not take differences in basal levels 
into account, the analyses gave similar results but, in addition, revealed a significantly 
larger TAG TAUG after recovery sleep compared to baseline sleep (P < 0.05) and TSD 
(P < 0.001) and a smaller NEFA TAUG after recovery sleep compared to baseline sleep 
(P < 0.05). The insulin TAUG showed a significant day*group interaction (Fi.4,30.2 = 4.0, P
< 0.05) with a higher TAUG after recovery sleep compared to baseline sleep and TSD (P
< 0.001) in NSW. In addition, the effect of day on TAG, NEFA and insulin TAUGs 
appeared to be significant in NSW but not in SW, when the groups were analysed 
separately.
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Analyses were also carried out for specified time periods within the TAUCs and lAUGs; 
from time points -15 to 90 min and 90 to 240 min. These analyses did not reveal any 
large discrepancies in differences between groups or days when compared to the 
observations resulting from the -15 min to 240 min TAUGs and lAUGs.
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Figure 3.4. Incremental areas under the curve for metabolites and insulin.
Incremental areas under the curve (lAUCs) for (A) TAGs, (B) insulin and (0 ) glucose (mean ± 
SEM) after baseline sleep (■), sleep deprivation (□) and recovery sleep (■) in NSW, SW and all 
subjects combined.
** P < 0.01. n = 13 for NSW (n = 12 for insulin) and n = 11 for SW.
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3.3.6 Correlations with shift durations
The SW (n = 1 1 ) had worked shifts for various lengths. Especially because there were 3 
SW who had worked shifts for more than 15 years (aged 42 ± 3.6 years (mean ± SD)), it 
was of interest to assess whether these SW were different from the other 8  SW (aged
33.4 ± 6.9 years). Plots of TAGs, NEFAs, insulin and glucose in relation to shift duration 
are shown in Figure 3.5. Statistical analyses could not be carried out because of the 
small subject number and unequal distribution of shift duration across the subjects but 
there was no clear visual relation between either the lAUCs or basal TAG, NEFA or 
insulin levels and the duration of shift work.
3.3.7 Cholesterol and HDL-cholesterol
In agreement with the screening results described in Table 3.1, two-factor ANOVA did 
not show any overall differences between NSW and SW (Figure 3.6). In addition, the 
independent Student’s T-tests did not reveal any differences between the groups in the 
mornings and evenings of the adaptation and baseline days. Furthermore, two-factor 
ANOVA did not show any significant effect of time point, indicating there was no time of 
day variation and no effect of sleep deprivation or recovery sleep on cholesterol and HDL 
levels.
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Figure 3.5. Relationship between shift duration and individual incremental areas under the 
curve (lAUCs) as well as basal metabolite and insulin levels.
lAUCs (left) or basal levels (right) and shift work duration for TAGs, NEFAs (no lAUC), insulin and
glucose following baseline sleep (•), total sleep deprivation (TSD) (□) and recovery sleep (A) ,  n =
13 (12 for insulin) for NSW and n = 11 for SW; N/A, not applicable.
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Figure 3.6. Plasma cholesterol and HDL.
Plasma (A) cholesterol and (B) HDL on the first evening before adaptation sleep (0) and in the 
mornings (black) and evenings (grey) following adaptation sleep (o), baseline sleep ( • ) ,  sleep 
deprivation (□) and recovery sleep (A ) in NSW, SW and all subjects combined. Graphs display 
means (horizontal lines) and raw data points, n = 14 for NSW and 11 for SW  apart from some 
time points where values were missing. Interpolated values are not included.
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3.4 Discussion
This is the first study to report the effect of total sleep deprivation and recovery sleep per 
SB on postprandial metabolic and insulin responses to a standard breakfast. The 
responses of experienced SW with long term exposure to shift work for 5 years or more 
were compared to NSW in well controlled laboratory conditions.
Morning basal TAG levels were significantly lower after TSD compared to after baseline 
and recovery sleep. This finding is in agreement with observations using a protocol 
consisting of isocaloric meals every 3 hours, which showed that 3 to 5 days of TSD 
deprivation resulted in a significant decrease in the amplitude of the TAG rhythm and 
significantly lower TAG levels in the morning (Vondra at al. 1986). Han at al. (1992) also 
reported that 76-80 h TSD resulted in a decrease of TAG levels, although food intake 
was ad libitum and body posture was not controlled. The lower TAG levels in the morning 
after total sleep deprivation may, in part, be due to higher energy expenditure whilst 
staying awake during the night, even though in the current study the subjects were 
instructed to remain semi-recumbent throughout. In agreement with this hypothesis, 
animal studies have reported lower/unaltered TAG levels after sleep deprivation, 
accompanied by weight loss despite higher food/calorie intake, indicating a higher 
turnover of nutrients during sleep deprivation (Andersen at al. 2004; Everson & Wehr 
1993; Martins at al. 2010). Alternatively, these observations could be due to impaired 
nutrient absorption. In agreement with the current finding, previous studies did not 
observe any differences in fasting glucose and insulin levels between baseline sleep and 
total s\eep deprivation (Schmid at al. 2007) or pa/t/aZ sleep restriction (Buxton atal. 2010; 
Donga at al. 2010; Nedeltcheva at al. 2009). Other studies on parf/aZ sleep deprivation 
did not report the fasting glucose and insulin levels (Spiegel at al. 1999; Tasali at al.
2008).
Although energy utilisation may increase during sleep deprivation, the way the body 
deals with subsequent energy intake following a meal might be different. In the data of all 
subjects combined, glucose levels 4 h following the standard breakfast did not return to 
basal levels after TSD. In addition, insulin levels 4 h after the breakfast were significantly 
higher after TSD than after baseline sleep. The slower glucose clearance despite similar 
or increased insulin levels indicates insulin insensitivity (DeFronzo 1988; Reaven 2 0 0 2 ). 
This finding is in accordance with the hypothesis and previous sleep deprivation studies 
(Buxton at al. 2010; Donga at al. 2010; Nedeltcheva at al. 2009; Spiegel at al. 1999;
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Tasali et al. 2008; VanHelder at al. 1993). As glucose and insulin production and 
metabolism are tightly controlled by the autonomous nervous system (Iversen at al. 
2000), it has been suggested (section 1.4.3) also by other authors (Spiegel at al. 1999), 
that the insulin insensitivity after sleep deprivation may be due to an altered balance 
between the parasympathetic and sympathetic nervous system. More specifically, it 
could be that the hypothalamus and in particular, the wake promoting factor orexin 
(Saper at al. 2005), plays a role in this process. Neurons from the hypothalamus 
innervate fat tissue, the liver and the pancreas (Kreier at al. 2006) and orexin has been 
shown to simulate sympathetic neurons projecting to these tissues (van den Top at al. 
2003), which would lead to, for example, increased glucose mobilisation and altered 
insulin sensitivity (Shiuchi at al. 2009; Yi at al. 2009). Postponing sleep and thus 
increasing orexin levels (section 1.4.3) could subsequently result in an overstimulation of 
the sympathetic nervous system and higher glucose mobilisation.
Significant effects of TSD were observed on basal TAG levels and 4 h postprandial 
glucose and insulin levels. After a 4 h recovery nap followed by an 8  h overnight 
recovery sleep the basal TAG levels were significantly increased compared to after the 
sleep deprivation night in both groups. In NSW the average basal TAG level after 
recovery sleep was elevated above the levels reported to be associated with smaller and 
denser low-density lipoprotein production (TAG levels > 1.5 mmol/L) which may increase 
the risk for CVD (Griffin at al. 1994). However, it has to be kept in mind that the basal 
samples in the current study were taken after a fasting period of 1 0 . 5  h and are thus not 
strictly considered fasting samples.
Basal NEFA levels were significantly lower after recovery sleep compared to baseline 
sleep in NSW and in all subjects combined. Basal insulin levels were significantly higher 
after recovery sleep than after baseline sleep and TSD in NSW, suggestive of insulin 
insensitivity.
The overall TAG and insulin responses were higher and NEFA levels were lower after 
recovery sleep. Such a decrease in NEFA levels has only been reported in one sleep 
deprivation study, but then after TSD (Schmid at al. 2007). The increased lAUC for 
insulin suggests that this increase after recovery sleep is likely to be independent of the 
change in basal levels. Similar glucose levels despite a significantly larger insulin 
response indicate insulin insensitivity (Figure 1.1). Moreover, this hyperinsulaemic state 
would result in larger hepatic conversion of NEFAs to TAGs and suppresses lipid 
mobilisation by HSL (section 1.5.1.1.2), leading to hypertriglyceridemia (DeFronzo 1988;
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Reaven 2002), which may explain the lower postprandial NEFA levels after recovery 
sleep compared to baseline sleep. These results after recovery sleep are unexpected 
and not in agreement with the hypotheses as most of the parameters in other studies 
show the largest alterations following sleep deprivation and parameters either remain 
changed after recovery sleep or start to return to basal levels (e.g. Mullington etal. 2003; 
Spiegel etal. 1999; van Leeuwen etal. 2009) (section 1.6). However, in parallel with our 
findings another study showed that the TAG AUC was increased on the second day of 
night shift work compared to day shifts but was even larger after 2  days following the 
return to daytime work (Lund et al. 2001), indicating that responses can be largest after 
the recovery process. There is no satisfactory explanation, however, as to why some 
parameters would change after recovery sleep. This may either be a direct effect of 
recovery sleep or a delayed effect of sleep deprivation.
Future studies including a longer recovery period or longer periods of (partial) sleep 
deprivation may help to clarify this issue. In addition, most of the previous studies have 
used OGTTs and IVGTTs to assess insulin sensitivity (although the euglycaemic clamp 
is regarded as the gold standard (Wallace & Matthews 2 0 0 2 ). These tests, however, are 
technically harder to conduct than postprandial sampling, but they may be more accurate 
and sensitive than assessing postprandial responses after breakfast and therefore yield 
different results. Alternatively, another method to get an index of postprandial insulin 
sensitivity (although not validated) would be to use a model proposed by Caumo and 
colleagues (Caumo et al. 2000). Only AUCs for glucose and insulin need to be entered 
into the model and it is therefore a very practical method. However, due to time 
constraints and the fact that we only recorded oral carbohydrate rather than glucose 
intake (which is required by the model), these calculations were not carried out for the 
current study.
As expected cholesterol and HDL did not change throughout the experiment suggesting 
that these metabolites are indeed not affected by sleep deprivation or recovery sleep. In 
addition, there were no significant differences between NSW and SW, but there was one 
shift worker with higher HDL levels, which agreed with the screening results provided by 
the Royal Surrey Hospital (appendix F).
Although there were no significant differences between NSW and SW in TAGs, NEFAs, 
insulin and glucose when they were assessed in the same ANOVA, separate analyses of 
NSW and SW revealed some differences. In almost all analyses, the effects of sleep 
deprivation and recovery sleep were more pronounced in NSW than in SW. It could be
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speculated that SW in this study appeared to be habituated to sleep deprivation, in 
contrast to the hypothesis. Although their postprandial responses appeared to be less 
sensitive to variation, this does not necessarily provide an indication to their 
cardiovascular risk. A 10-year follow-up study showed that initial improved glycaemic 
control is related to decreased cardiovascular risk and that despite early loss in 
differences in glycated haemoglobin (an important risk factor for microvascular disease) 
the reduced microvascular risk persists during follow-up (Holman et al. 2008). These 
observations could imply that cardiovascular damage may have an early onset and may 
persist despite reversal of risk factors such as glycaemic control. The observed 
differences between SW and NSW might also be explained by other factors linked to the 
ability to cope with shift work and sleep deprivation and not to shift work directly. Some 
examples of these factors are morning and eveningness as assessed by the HO 
questionnaire, the PER3 polymorphism and genetic variation in the adenosinergic 
system (section 1.8). Eveningness has been proposed to be associated with a better 
tolerance for sleep deprivation and more flexibility in sleep timing, hence a better ability 
to cope with shift work (Akerstedt & Torsvall 1981 ; Mongrain etal. 2006a; Mongrain etal. 
2004; Taillard et al. 1999; Volk et al. 1994). Although SW and NSW in this study did not 
have significantly different HO scores, SW had a slightly wider range of scores and a 
lower mean HO score (Table 3.1). Since a lower HO score is associated with a stronger 
preference for eveningness, this would support the previous statements, as the SW 
seemed less responsive within the protocol. However the association with 
morningness/eveningness is more a neurobehavioural one and it is not known whether 
eveningness is also associated with a better physiological tolerance to sleep deprivation. 
The lack of major differences in the postprandial responses between SW and NSW may 
also be explained by the fact that the meal was given at the normal clock time. Previous 
studies reporting postprandial differences have given meals at an abnormal clock time 
(Hampton etal. 1996; Knutsson etal. 2 0 0 2 ; Lund etal. 2001; Ribeiro etal. 1998; Scheer 
et al. 2009) suggesting food intake at an inappropriate clock time may be a major 
contributor to the adverse effects of shift work.
One of the limitations of this study was the fact that the postprandial response was only 
measured for up to 4 h after the standard breakfast. Unfortunately, this time period could 
not be lengthened because lunch had to be included in the protocol before the scheduled 
nap. The peak of the TAG response was not observed, as this usually occurs up to 4 h 
postprandially (section 1.5.1.1 .2 ) and it can take approximately 9 h for TAGs to return to 
basal levels after a meal (Lund et al. 2001; Ribeiro et al. 1998; Sopowski et al. 2001). 
The decrease in TAGs observed after TSD may thus not be a decrease but a delay in
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the TAG response. Unfortunately the protocol is unable to distinguish between these two 
phenomena. Future research should include longer sampling periods to assess how long 
it takes for TAGs, NEFAs, insulin and glucose to return to basal levels. Alternatively, 
subjects could be monitored after both breakfast and lunch as the postprandial hormone 
and metabolic responses may be additive if the time between the two meals is short.
In conclusion, this is the first study to assess basal and postprandial insulin and 
metabolic responses after TSD and recovery sleep and to compare NSW and SW in 
controlled laboratory conditions. Significantly lower basal TAG levels after TSD indicate 
higher energy expenditure during sleep deprivation, despite any increased physical 
activity. Postprandial TAG and insulin responses were larger after recovery sleep, 
suggestive of insulin insensitivity. These results might be explained by an altered 
balance between the parasympathetic and sympathetic nervous system. The more 
pronounced effects of sleep deprivation and recovery sleep observed in the NSW require 
further study.
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CHAPTER 4 FLOW-MEDIATED DILATATION AND HEART RATE 
VARIABILITY
4.1 Introduction
Endothelial dysfunction, decreased flow-mediated dilatation (FMD) and changes in heart 
rate variability (HRV) have been shown to be risk factors for CVD (Bots et al. 2005; 
Buccelletti et al. 2009; Koskinen et al. 2009; Manfrini et al. 2008; Moens et al. 2005; 
Perciaccante et al. 2006; Rabbone et al. 2009; Shechter et al. 2009; Task Force of the 
European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology 1996; Thayer et al. 2010) (section 1 .1 ). Although it is thought that the 
risk for CVD in SW depends on shift work duration, the extent of circadian misalignment 
and sleep deprivation (Knutsson & Boggild 2000) (sections 1.2.2 and 1 .3 .2 ), hardly any 
epidemiological studies have been conducted indicating an association between shift 
work or sleep deprivation on one hand and lower FMD or changes in HRV on the other 
hand. One field study has shown lower FMD in experienced SW (Amir et al. 2004). By 
contrast, HRV has been assessed more frequently in field studies of SW (Togo & 
Takahashi 2009) (section 1.7). These studies predominantly showed a shift in the 
balance between sympathetic and parasympathetic innervation. Only a few studies have 
reported changes in HRV (mainly higher sympathetic activity) and decreased 
vasodilatation during and after (partial) sleep deprivation (Ewing etal. 1991; Sauvet etal. 
2009; Spiegel etal. 1999; Zhong etal. 2005) (section 1.6).
These studies have indicated that sleep deprivation and shift work may contribute to a 
lower endothelial function and altered HRV. However, especially the shift work studies 
were not well-controlled for various confounding factors such as circadian phase, 
assessment of actual obtained sleep (or time in bed), physical activity and food intake. In 
addition, they often had a poor description of the shift work population and lacked an 
appropriate control group. Therefore, it is unclear whether the observed effects of shift 
work are due to these confounding factors or sleep deprivation perse. Moreover, to date 
SW have not been compared directly to NSW in the same study, endothelial function has 
not been assessed by the ultrasound method identical to the one used in our research 
group and HRV parameters in the time domain have not been reported widely.
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4.1.1 Aims and hypotheses
The aim of the current study was thus to investigate the effect of one night of total sleep 
deprivation (TSD), a recovery nap and recovery sleep on FMD and HRV in controlled 
laboratory conditions and to assess the responses of experienced SW compared to 
NSW in the same study.
It was hypothesised that:
• TSD will induce changes in FMD and HRV.
FMD and variance in HRV will be lower but sympathetic activity will be higher 
after TSD.
• A nap and recovery sleep will (partly) reverse these changes.
• SW and NSW will respond differently to TSD and recovery sleep.
FMD and variance will be lower, whereas sympathetic activity will be higher after 
TSD in SW than in NSW and changes in FMD and HRV will not recover as 
quickly in SW as in NSW.
4.2 Methods
Methods specific to this chapter are described below. For general methods see chapter 
2.
4.2.1 Subjects
All 25 subjects underwent ultrasound recordings and HRV assessments. Their individual 
screening results can be found in appendix F; the averages for the NSW and SW groups 
are given in Table 3.1.
4.2.2 Flow-mediated dilatation
4.2.2 .1  Ultrasound recordings
High-resolution recordings with an ultrasound machine (Acuson Aspen, Siemens, 
Bracknell, Berkshire, UK) were used to assess endothelial function by flow-mediated 
dilation (FMD) (Celermajer at al. 1992) at 0.75 and 10.75 h after habitual wake up time
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(Figure 2 .1 ). The technique and conditions used for the ultrasound recordings were 
established by Donald and colleagues at Great Ormond Street Hospital, London, UK 
(e.g. Charakida et al. 2005; Donald et ai. 2006) and used and reported by our research 
group (Hampton et ai. 2010; Walters et ai. 2006) in accordance with guidelines from the 
International Brachial Reactivity Task Force (Corretti et ai. 2 0 0 2 ). Heart rate was 
recorded by the ultrasound machine with EGG electrodes (3 M (red dot) EGG monitoring 
electrodes, Medisave, Weymouth, UK) on 3 different locations; the upper and lower side 
of the sternum and near the lowest left rib. The subject was put in a supine position with 
the right arm in a 90° angle with respect to the body. The arm rested on a stool levelled 
with the bed. A pressure cuff was placed around the forearm immediately below the 
medial epicondyle, but left deflated until needed. The right brachial artery was imaged, 5 
to 1 0  cm above the antecubital fossa, with a high resolution ultrasound probe held in a 
stereotactic clamp attached to the stool (Table 4.1).
Figure 4.1. Ultrasound set up.
Ultrasound images from the brachial artery in the right arm are recorded during 220 frames for 11 
min, with an ultrasound probe held in a stereotactic clamp.
Location of the artery rather than a vein was confirmed by Doppler images. Optimal 
contact was achieved by applying EGG electrode gel (Scanmed medical instruments, 
Gloucestershire, UK). Depth and gain settings were chosen such that the lumen-intima 
contrast was optimal and kept the same within each recording. When a clear image of 
the artery had been obtained, the image was magnified. Hereafter, an 1 1  min recording 
was started (Brachial Imager™, Iowa Gity, Iowa, USA), capturing EGG-triggered images
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approximately every 3 sec. First of all, the brachial artery was imaged at rest for 1 min. 
Then the pressure cuff on the forearm was inflated to 200 mmHg, thereby occluding the 
brachial artery. After 5 min of occlusion the cuff was deflated and recording was 
continued for another 5 min when returning to rest. The images were recorded both onto 
a computer (Brachial Imager™) connected to the ultrasound machine and a video-tape 
inserted in the ultrasound machine (as a back up). Recording in Brachial Imager™ also 
allowed a second operator to make changes in contrast and brightness during the 
recording if necessary. Position of the probe (with respect to the antecubital fossa) and 
the arm were noted down and the position of the probe was marked after the first 
recording with a permanent marker to ensure that each recording was taken from the 
same part of the brachial artery.
4.2.2.2 Analysis
A region of interest (ROI) was chosen in which the brachial artery wall was tracked with 
edge detection software (Brachial Analyzer™, Iowa City, Iowa, USA) as clearly as 
possible, especially during rest and deflation. Within this ROI, the average arterial 
diameter was calculated for each of the 220 frames (Brachial Analyzer™) (Figure 4.2). A 
fit of the tracked edges with the arterial wall of over 80% was aimed for for each frame. In 
some cases Brachial Analyzer™ did not achieve this fit or did not fit the layer lining the 
vessel lumen (consistently) although the fit would be over 80 % (Figure 4.3 A). This can 
be due to either individual anatomy or the quality of the recording and any falsely tracked 
edges were rejected.
FMD was calculated as the maximum percentage change in diameter after cuff deflation 
compared to the baseline diameter. This percentage was calculated by the average of 
the 3 highest consecutive values for the diameter during and after cuff deflation as a 
percentage change of the average of 20 frames of resting diameters. The analyses were 
performed by myself with Dr Shelagh Hampton as a second operator. If the diameters at 
rest and at the end of deflation were not the same (Figure 4.3 B), the diameter after 
deflation was used for calculation of the FMD (34.8% of the re-assessed recordings), as 
this can be more reliable for example when occlusion causes movement resulting in 
under- or overestimation of the difference between the peak and resting diameter. The 
CVs averaged for all subjects, for the morning and afternoon resting diameters were 2.9 
and 3.3% respectively, which was similar to an earlier reproducibility assessment by
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W alters  et al. (2 0 0 6 ). S om e data  (7 .5 % ) w ere  not present because of missing d a ta  or 
poor quality recordings.
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Figure 4.2. An example of the screen In Brachial Analyzer™.
The left window shows the ultrasound recording with the brachial artery, the region of interest 
(R O I) , the tracked ( ) wall of the brachial artery, the ECO and part of the Doppler. The right
window shows the diameter for every frame, composing a graph which displays the diameter at 
rest, during occlusion and deflation. The table contains the diameter (dia.), standard deviation 
(STD.) and percentage of the fit (Gonf. (%)) for every frame and other information e.g. how many 
frames were valid.
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Figure 4.3. Two examples of ultrasound recordings that needed editing.
In the left diagram (A) Brachial Analyzer™ does not track the layer lining the vessel lumen and 
therefore probably not the tunica intima. In the right diagram (B) the resting diameter before 
occlusion and at the end of deflation are not the same. Both situations can result in under- or 
overestimation of the FMD.
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4.2.3 Heart rate variability
The EGG was derived from 2 positions, right mid-clavicular and around 6 cm under the 
left arm pit using EGG pads (electrode EGG wet gel adult short term 38 mm diameter 
foam backed offset stud Ambu Blue Sensor P-OO-S Pads, NHS Logistics Authority, 
Alfreton, UK) and EGG electrodes (Gompumedics, Abbotsford, Australia). Data were 
acquired, stored, converted and imported into Somnologica Studio (version 5.0.1 build 
1662, Embla, supplied by Stowood Scientific Instruments Ltd., Oxford, UK) for further 
analysis as described in section 2.5.4. HRV was assessed at set periods. On each of the 
four study days 5 x 5-min analysis intervals were chosen 0.25, 4.25, 11.5, 12.5 and 13.5 
h (Figure 2.1) after habitual wake up time when the subjects were required to be semi- 
recumbent for the Karolinska Drowsiness Test (KDT) (section 5.2.3). During the sleep 
deprivation night, data were combined into 13 x 30-min analysis periods starting 17 h 
after habitual wake up time. The detection of QRS complexes was automatically done 
using Somnologica algorithm settings (5 min analysis bins, data ± 5 SD from the mean of 
the preceding 5 s of data were considered as potential R-tops, a minimum 5 consecutive 
R-tops were needed for a valid sequence, an output sampling rate of 1 Hz was used, 
minimum and maximum heart rate was set at 25 and 350 beats per minute (bpm), 
respectively in compliance with the Task Force recommendations (Task Force of the 
European Society of Gardiology and the North American Society of Pacing and 
Electrophysiology 1996). Gorrect detection was manually confirmed and falsely detected 
or undetected QRS complexes (artefacts, mainly caused by noise or a lost signal) were 
removed (< 1% of the analysis period for the day time assessments and < 3% for the 
sleep deprivation night). Examples of recordings with and without artefacts are shown in 
Figure 4.4.
An HRV report based on the artefact-free data was automatically generated containing 
the following parameters: NN interval (interval between adjacent QRS complexes), 
RMSSD, standard deviation of differences between NN intervals (SDSD), SDNN/mean of 
the standard deviations of all NN intervals for all 5 min segments in the recording (SDNN 
index), percentage of NN intervals longer than 50 ms (pNN50), very low frequency power 
(VLF: 0.003 -  0.04 Hz), low frequency power (LF: 0.04 -  0.15 Hz), high frequency power 
(HF: 0.15 -  0.4 Hz), total power (TP), LF norm (LF/(LF+HF)), HF norm (HF/(LF+HF)) and 
LF/HF. All 13 analysis bins for the sleep deprivation night were complete apart from one 
NSW whose NN-interval data were excluded as an outlier (> 2.3 SD from the mean).
99
Chapter 4 Flow-mediated dilatation and heart rate variability
A
ii> 4-^  ^  ^
B
Figure 4.4. Examples of EGGs and heart rate, NN Interval and heart rate variability traces In 
Somnologica.
The figures represent parts of 30 s epochs of the EGG (upper panel), heart rate (bpm) (2"^  panel), 
NN interval (RR interval (s), 3"^  ^ panel) and heart rate variability (evenly sampled NN interval 
differences (bpm/s)) (bottom panel). Figure A is an example of a recording without artefacts and 
Figure B shows how Somnologica automatically removed the EGG artefact, caused by a lost 
signal, in the other 3 traces (1).
100
Chapter 4 Flow-mediated dilatation and heart rate variability
C
TD
Figure 4.4. Examples of EGGs and heart rate, NN Interval and heart rate variability traces In 
Somnologica.
The figures represent parts of 30 s epochs of the EGG (upper panel), heart rate (bpm) (2"'^  panel), 
NN interval (s) (RR interval, 3"^  ^ panel) and heart rate variability (evenly sampled NN interval 
difference (bpm/s)) (bottom panel). Failure to detect a heart beat (0) or detection of a heart beat 
while there was no heart beat present (D) results in false negatives and false positives in 
Somnologica’s heart rate, NN intervai and heart rate variability traces (g).
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Figure 4.4. Examples of EGGs and heart rate, NN interval and heart rate variability traces In 
Somnologica.
The figures represent parts of 30 s epochs of the ECO (upper panel), heart rate (beats per minute 
(bpm)) (2"^  panel), NN interval (s) (RR interval, 3""^  panel) and heart rate variability (evenly 
sampled NN interval difference (bpm/s)) (bottom panel). The detection of heart beats (QRS 
complexes) is checked. False negatives (C) or positives (D) are manually marked as artefacts in 
the ECO (E) and Somnologica removes these parts from the heart rate, NN interval and heart rate 
variability trace (1).
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For the 5 min analysis bins some data were missing and some bins were considered 
outliers according to the same criteria (total missing values comprised < 7.5% of the data 
set).
4.2.4 Statistics
The HRV assessments during the sleep deprivation night were analysed using a two- 
factor ANOVA (factors ‘time’ (13 levels) and ‘group’ (SW and NSW)). A mixed-model 
regression analysis was conducted in SAS 9.1 (section 2.6.4) to determine main effects 
of ‘group’, ‘day’ and ‘time’ and interactions between those effects on resting brachial 
diameter, FMD and HRV. Subsequently, body weight was entered into the analysis of 
resting brachial diameter as a random effect in order to assess whether there was an 
association between body weight and brachial diameter.
4.3 Results
4.3.1 FMD
There was no significant effect of day or time on the resting brachial diameter and no 
day*time interaction. However, there was a significant effect of group (Fi,i69 = 12.8, P < 
0.001) with a significantly higher resting diameter in SW compared to NSW. Body weight 
as a random effect was significantly associated with resting diameter (P < 0.001) and the 
observed effect of group on resting diameter became non-significant when body weight 
was used as a random effect.
The %FMD in both SW and NSW in the morning and afternoon is shown in Figure 4.5. 
There were no significant effects of day, time, group or interactions on %FMD. However, 
a trend for a group effect was observed (Fi,i69 = 3.3, P = 0.07) with a lower %FMD in SW 
compared to NSW.
4.3.2 HRV
4.3.2.1 HRV during TSD
Examples of time and frequency domain parameters, SDNN index and LF/HF, during 
sleep deprivation are shown in Figure 4.6.
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Figure 4.5. Flow-mediated dilatation.
% FMD (mean ± SEM) in (A) the morning (0.75 h after habitual wake time) and (B) the afternoon 
(10.75 h after habitual wake time), following adaptation sleep, baseline sleep, sleep deprivation 
and recovery sleep in NSW  (• )  (n = 14) and SW (o )  (n = 11).
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Figure 4.6. SDNN and LF/HF during sleep deprivation.
HRV during (A) SDNN and (B) LF/HF (mean ± SEM) in NSW  (• )  (n = 14) and SW  ( o )  (n = 11) 
during sleep deprivation (from 17 to 23 h after waking). * P < 0.05, ** P < 0.01 and *** P < 0.001 
compared to 17 h after waking.
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Average values for the other HRV parameters across the TSD night are shown in Table 
4.1. There was a significant effect of time on SDNN (p4.6,io6 = 8.9, P < 0.001), VLF 
(F7.1.164 = 11.1, P < 0.001), LF (F5.6.129 = 2.7, P < 0.05) and TP (Fas,151 = 11.5, P< 0.001) 
with the values increasing through the night. There were no significant effects of group, 
time or interaction on any of the other parameters.
Table 4.1. HRV parameters of non-shift workers and shift workers during sleep deprivation.
Non-shift workers Shift workers
Time domain 
NN interval (ms) 917 ± 26 937 ± 24
pNN50 (%) 22 ± 4 18 ± 3
SDNN index (ms) 88 ± 6 87 ± 7
SDSD (ms) 33 ± 4 31 ± 3
RMSSD (ms) 47 ± 5 42 ± 4
Frequency domain 
TP (ms2) 20664 ± 1455 21225 ± 1896
VLF (ms2) 13216 ± 1307 13563 ± 1501
LF (ms2) 6014 ± 477 6386 ± 644
HF (ms2) 1335 ± 112 1179 ± 132
LF/HF 5.3 ± 0.6 6.3 ± 0.6
LF norm (n.u.) 0.8 ± 0.0 0.9 ± 0.0
HF norm (n.u.) 0.19 ± 0.02 0.15 ± 0.02
Data are means ± SEM during the sleep deprivation night (17 -  23 h after waking), n = 11 for SW  
and n = 14 for NSW (apart from the NN interval for which n = 13). No significant effects of group 
or group*time interactions were shown by two-factor ANOVA.
Abbreviations used: HF, high frequency power (0.15 -  0.4 Hz); HF norm, normalized high 
frequency power (HF/(LF+HF)) in normalized units (n.u.); LF, low frequency power (0.04 -  0.15  
Hz); LF norm, normalized low frequency power (LF/(LF+HF)) in normalized units (n.u.); LF/HF, 
low frequency power divided by high frequency power; NN-interval, normal-to-normal interval 
(intervals between QRS complexes); pNN50, percentage of intervals longer than 50 ms; RMSSD, 
square root of the mean of the sum of the squares of differences between NN intervals; SDNN  
index, mean of the standard deviations (SD) of all NN intervals for all 5 min segments in the 
recording; SDSD, SD of differences between NN intervals; TP, total power; VLF, very low 
frequency power (0.003 -  0.04 Hz).
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4.S.2.2 HRV across the study days
The SDNN and LF/HF after adaptation and baseline sleep, during and after sleep 
deprivation and after recovery sleep are shown in Figure 4.7. Although for completeness 
the data during TSD are shown again in Figure 4.7, the statistical analysis mentioned 
hereafter only includes the 5 min day time points on each of the 4 study days. There was 
a significant effect of group (Fi,43o = 15.1, P < 0.001) and a significant day*time 
interaction (Fi2,43o = 2, P < 0.05) on SDNN. SDNN was significantly lower in SW than in 
NSW (P < 0.001). The most consistent observation emerging from the day*time 
interaction was that SDNN following a night of TSD (0.25 h after habitual wake up time) 
was significantly higher than at all other time points (P < 0.001 for all points apart from 
0.25 h after waking up following baseline sleep for which P < 0.01) (Figure 4.7 A).
There was also a significant effect of group (Fi,4 i 7 = 4.2, P < 0.05), day (p3,4 i 7 = 5.4, P < 
0.01) and time (p4,4 i 7 = 12.7, P < 0.001) on LF/HF. LF/HF was significantly higher in SW 
than in NSW (P < 0.05). LF/HF was significantly lower after adaptation sleep than after 
baseline sleep and TSD (P < 0.01) and recovery sleep (P < 0.001). In addition, LF/HF 
was significantly higher 13.5 h after waking than at 4.25 h after waking and significantly 
higher at 13.5, 12.5 and 4.25 h than at 11.5 and 0.25 h after waking (Figure 4.7 B).
Most of the other HRV parameters also showed significant effects of group, day and time 
(Table 4.2). NN was higher and pNN50 was significantly lower in SW than in NSW (P < 
0.05). Both NN and pNN50 changed significantly across study days with higher NN and 
pNN50 after adaptation sleep than after baseline sleep, TSD and recovery sleep and 
higher NN and pNN50 after baseline sleep and TSD than after recovery sleep (Figure 
4.8 A and B). RMSSD and SDSD were significantly lower in SW than in NSW (P < 0.001 
and P < 0.01, respectively). In addition, RMSSD and SDSD were significantly higher 
after adaptation sleep, baseline sleep and TSD than after recovery sleep (Figure 4.8 C 
and D). LFnorm had the same significant effects as LF/HF and estimates for the effects 
were in the same direction, whereas the estimates for HF norm had the opposite sign. 
Both TP and VLF showed no group effect but a day*time interaction (P < 0.01). A 
significant effect of time was observed for LF (P < 0.01) with higher LF 0.25 h after 
waking than at the other time points.
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Figure 4.7. Daytime SDNN and LF/HF.
(A) SDNN and (B) LF/HF (mean ± SEM) in NSW  (• )  (n = 14) and SW  (o )  (n = 11) 0.25, 4.25,
11 .5 ,12 .5  and 13.5 h after habitual wake time following adaptation sleep, baseline sleep, sleep 
deprivation and recovery sleep.
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Table 4.2. P-values for main effects and interactions for all HRV parameters at 5 time points 
across the 4 study days.
Time domain NN pNN50 SDNN SDSD RMSSD
Day <.0001 <.0001 0.0002 0.0021 0.0003
Time <.0001 <.0001 <.0001 <.0001 <.0001
Group 0.0465 0.0333 0.0001 0.0013 <.0001
Day*time 0.5997 0.0666 0.0267 0.1328 0.2869
Frequency domain TP VLF LF HF LF/HF LF norm HF norm
Day 0.0012 0.0034 0.0747 <.0001 0.0012 0.0007 <.0001
Time <.0001 <.0001 0.0086 <.0001 <.0001 <.0001 <.0001
Group 0.0546 0.0896 0.3487 0.0008 0.0405 0.0268 0.0130
Day*time 0.0070 0.0037 0.3307 0.5211 0.9377 0.7508 0.4848
Values in bold indicate statistical significance, n = 11 for SW  and n = 14 for NSW . No significant 
day*group, time*group and day*time*group interactions were shown by two-factor ANOVA. 
Abbreviations used: HF, high frequency power (0.15 -  0.4 Hz); HF norm, normalized high 
frequency power (HF/(LF+HF)) in normalized units (n.u.); LF, low frequency power (0.04 -  0.15  
Hz); LF norm, normalized low frequency power (LFZ(LF-i-HF)) in normalized units (n.u.); LF/HF, 
low frequency power divided by high frequency power; NN-interval, normal-to-normal interval 
(intervals between QRS complexes); pNN50, percentage of intervals longer than 50 ms; RMSSD, 
square root of the mean of the sum of the squares of differences between NN intervals; SDNN, 
standard deviation (SD) of all NN intervals; SDSD, SD of differences between NN intervals; TP, 
total power; VLF, very low frequency power (0.003 -  0.04 Hz).
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Figure 4.8. Day time NN Interval, pNNSO, SDSD and RMSSD.
(A) NN interval, (B) pNN50, (0) SDSD and (D) RMSSD after adaptation sleep, baseline sleep, 
sleep deprivation and recovery sleep in NSW {■) (n = 14) and SW (=) (n = 11). Values are mean 
(of the day time averages of all subjects) ± SEM. See text for P-values.
4.3.3 Correlations with shift durations
As in section 3.3.6 the association between shift duration and the assessed parameters 
was explored. There was no relation between shift duration and FMD in either the 
morning or the afternoon after TSD or recovery sleep (Figure 4.9 A). Furthermore, there 
was no relation between shift duration and relative power in the frequency domain such 
as LF/HF (Figure 4.9 B) during TSD. By contrast the SW with the longest shift work 
duration (> 15 years) had the lowest variance, for example SDNN (r  ^= 0.7, P < 0.01) 
(Figure 4.9 C) and the lowest pNNSO during TSD.
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Figure 4.9. Relation between FMD, SDNN and LF/HF and shift duration.
(A) FMD in the afternoon after sleep deprivation, (B) LF/HF during sleep deprivation and (0) 
SDNN during sleep deprivation versus shift duration.
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4.4 Discussion
The present study investigated the effects of sleep deprivation and recovery sleep on 
cardiovascular function in controlled laboratory conditions. Non-invasive methods to 
assess cardiovascular function were used, namely FMD and HRV (Bots et al. 2005; 
Buccelletti et al. 2009; Koskinen et al. 2009; Manfrini et al. 2008; Moens et al. 2005; 
Perciaccante et al. 2006; Rabbone et al. 2009; Shechter et al. 2009; Task Force of the 
European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology 1996; Thayer et al. 2010). Experienced SW were compared directly to 
NSW matched for age, BMI and cholesterol levels in an identical laboratory setting with 
strict control of body posture, physical activity, meals, circadian phase and ambient 
lighting.
The results showed a trend towards a lower FMD in SW compared to NSW. This finding 
is in agreement with results from a study by Amir and colleagues (2004) who showed 
that baseline FMD was lower in physicians who had worked shifts for more than 3 years 
(8.6 ± 3.4% FMD) compared to those with a shorter shift work history (14.3 ± 4.1% 
FMD). This result may in part be due to sleep deprivation as daytime FMD in the 
physicians after a night shift was also significantly smaller (6.7 ± 4.8% FMD) compared 
to daytime FMD without a previous night shift (10.5 ± 4.5% FMD). In addition, 
vasodilatation has been shown to be lower after TSD when assessed by endothelium- 
dependent vasodilatation (after acetylcholine administration) at 12:00 and by 
endothelium-independent dilatation (after sodium nitroprusside solution administration) at 
both 12:00 and 18:00 (Sauvet et al. 2009). In contrast to the hypothesis, the current 
study, however, was not able to observe a significant effect of TSD on FMD. This 
discrepancy could be due to methodological differences between the studies (e.g. control 
of circadian phase and physical activity or a different method used to assess endothelial 
function).
In addition, the analysis of the resting brachial diameter revealed a larger diameter in SW 
than in NSW. This is in agreement with previous studies that showed a larger resting 
diameter in individuals with a lower FMD (Ofiaz etal. 2006; Shechter et al. 2009; Witte et 
al. 2005). As these patient groups also had a higher BMI and weight seemed to be most 
related to resting diameter in the current study, weight was entered into the model for 
resting diameter analysis as a random effect. Weight and resting diameter appeared to 
be positively associated and entering weight into the model rendered the effect of group
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non-significant, tying in with previous observations. These results indicate that resting 
diameter may be related to weight rather than shift work itself.
Significant differences were also observed between SW and NSW in HRV parameters. 
SDNN, RMSSD and SDSD were significantly lower and LF/HF was significantly higher in 
SW compared to NSW. This finding is in agreement with the idea that lower SDNN, 
RMSSD and SDSD reflect a lower variance and higher LF/HF indicates higher 
sympathetic activity, both factors being associated with a higher risk for CVD (Buccelletti 
et al. 2009; Perciaccante et al. 2006; Rabbone et al. 2009) in SW. Most previous studies 
(section 1.7) have shown that sympathetic activity (e.g. normalized LF or LF/HF) was 
higher on night duty than when off duty and asleep at night (Ewing et al. 1991 ; Furlan et 
al. 2000; Ito et al. 2001 ; Mitani et al. 2006; Rauchenzauner et al. 2009; Su et al. 2008) 
and was higher on days including a night shift compared to days including a morning 
shift (Van Amelsvoort et al. 2001a). Sympathetic activity has also been shown to be 
higher in SW compared to NSW when both groups work day shifts (Ishii et al. 2005; Ishii 
et al. 2004) or are asleep at home (Chung et al. 2009). One study in SW found lower 
SDNN and RMSDD during a night shift compared to sleep at night (Su et al. 2008). This 
is strengthened by the observation that the 3 SW with the longest shift work duration (> 
15 years) had the lowest variance, e.g. SDNN, during sleep deprivation. By contrast, 
some studies have not been able to show this association between higher LF/HF and 
lower variability and shift work (Freitas et al. 1997; Murata et al. 2005; van Amelsvoort et 
al. 2001b). The current study confirmed that these predominant observations of a higher 
sympathetic activity and lower variability in field studies of SW are also detectable in SW 
studied in controlled laboratory settings. The consistent but non-significant trend of a 
higher LF/HF ratio in SW during TSD suggests that SW have a higher sympathetic 
activity than NSW during this period similar to when they are on day shifts (Ishii et al. 
2005) or asleep (Chung et al. 2009). Thus, both the FMD and HRV data suggest that SW 
may exert higher levels of sympathetic activity on the cardiovascular system. A lack of a 
significant day*group interaction indicates that, in contrast to the hypothesis, this is an 
overall difference which is not only induced by acute sleep deprivation.
As in previous studies, it is not possible to extract a single cause for the observed 
differences between the SW and NSW. The long term effects of shift work may be a 
plausible explanation as all SW in the current study had worked shifts for 5 years or more 
and there are indications that alterations in endothelial function are already discernable 
after 3 years (Amir et al. 2004). The studies that have reported effects of shift work on 
HRV differ in the duration of shift work (range 0.5 -  37 years (Ishii et al. 2005; Mitani et
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al. 2006; Munakata et al. 2001), average 3 - 1 7  years (Amir et al. 2004; Chung et al. 
2009; Furlan et al. 2000; Murata et al. 2005; Su et al. 2008)) section 1.3.2. In addition, 
repeated sleep deprivation and/or circadian misalignment (Knutsson & Boggild 2000) of 
rhythms in HRV and endothelial function with the imposed lifestyle (e.g. sleep/wake cycle 
and physical activity) in unadapted SW could contribute to the effect of shift work 
duration on HRV.
In the present study, FMD and the daytime SDNN values in SW and NSW were lower 
than the values reported in healthy volunteers, namely a FMD above 7-10% (Moens et 
al. 2005; Shechter et al. 2009) and a SDNN above 70 ms (Buccelletti et al. 2009). This 
difference might be a result of the different study methodologies (e.g. controlled posture, 
diet and light in the current study may play a role) but is unlikely to be due to the 
techniques used as we have reported higher average FMD values using similar 
equipment and software (Hampton et al. 2010; Walters et al. 2006). In addition, time of 
day effects were observed for the HRV parameters. These findings suggest that for 
correct interpretation of FMD and HRV data, use of strict thresholds to indicate 
cardiovascular risk is not possible and that comparison with an appropriate control group 
in controlled conditions would be more valid.
The HRV parameters not only showed significant differences between SW and NSW but 
also across study days. The significantly higher SDNN observed following a night of TSD 
is in agreement with a study from Viola et al. (2002). The reason for this higher variance 
(also seen in RMSSD and SDSD) after sleep deprivation, is not known. A few studies 
have reported significantly higher sympathetic activity (Sauvet et al. 2009; Spiegel et al. 
1999; Zhong etal. 2005) and a lower NN50 (Ewing etal. 1991) during and after TSD and 
PSD however, other studies have found no difference in HRV parameters in these 
conditions (Gould et al. 2009; Muenter et al. 2000). The reason for lower LF/HF after 
adaptation sleep compared to the other 3 study days is also not clear. Other unexpected 
observations were the lower RMSSD and SDSD observed after recovery sleep indicating 
a lower variance and a decrease in NN-interval and pNN50 throughout the study.
In addition to changes across days, changes within a day and circadian rhythms have 
been reported in LF (peak at 6:15 h) and HF (peak at 5:16 h) (Vandewalle et al. 2007), 
but not in other HRV parameters such as LF/HF in CR studies (Vandewalle et al. 2007; 
Viola et al. 2002). Although not a CR study, the current study also observed an increase 
in LF and no effect of time on LF/HF throughout the sleep deprivation night as well as a 
significant effect of time on HF during the day. Compared to the previous findings
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(Vandewalle et al. 2007; Viola et al. 2002), however, HF did not show a significant 
increase during the sleep deprivation night and LF/HF showed a significant effect of time 
during the day.
SDNN also showed significant variation over the day and a significant increase during 
TSD. These observations are supported by previous studies which have shown a 
significant circadian rhythm in SDNN with a peak between 4:45 and 7:00 h (Bonnemeier 
et al. 2003; Vandewalle et al. 2007; Viola et al. 2002). It is unclear how an increase of 
SDNN throughout the night (with higher SDNN being associated with better 
cardiovascular health) is related to reports of a sudden increase in CVD events and 
stroke around habitual wake up time (e.g. Mulcahy et al. 1996; Muller 1999; Peckova et 
al. 1998; Turin et al. 2009; van der Palen et al. 1995). However, the contribution of 
endogenous circadian rhythms towards this phenomenon has rarely been separated 
from external factors (such as activity, food intake, report rate and presence of medical 
care) using appropriate study conditions such as a ‘CR’ protocol (Walters et al. 2003). 
On the other hand, the increased risk of experiencing life-threatening cardiovascular 
events in the early morning may be unrelated to the observed SDNN peak.
As mentioned in section 6.3.1 Somnologica software was not very flexible for HRV 
analysis and did not allow for data manipulation other than artefact removal. Therefore it 
would be useful to further explore HRV analysis with free software available online, 
which has extra options such as for detrending (of a low frequency baseline trend) and 
NN interval interpolation (Niskanen et al. 2004). The only requirement for the data to be 
imported is a series of NN intervals in a text file (without time stamps). This can be 
achieved by using Somnologica but is not straightforward. The software can either 
manually export the whole trace of 1 recording (e.g. 12 h) or event data if a period of 
interest is marked as an event. However, both methods create large, inaccessible files 
with 0 values where no QRS complex was detected and NN-intervals when there was a 
QRS complex. Alternatively, in the analysis settings the option ‘export NN intervals to 
patient folder’ can be chosen, which creates a text file with the NN interval per second for 
each recording. Also in this case, the time stamps are somewhat unclear and artefacts 
are omitted but not indicated in the file. This latter method is therefore applicable to 
generate a series of NN intervals but not ideal for very precise data and artefact 
manipulation. However, with appropriate expertise and training both programs could be 
used alongside each other to record the EGG, generate NN intervals and analyse HRV.
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In conclusion, significantly lower variance, higher sympathetic activity and a trend for a 
lower FMD was observed in the SW compared to the NSW. These findings suggest that 
HRV and FMD have potential as non-invasive assessments of cardiovascular function 
and may be useful to assess CVD risk in this vulnerable group.
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CHAPTER 5 CIRCADIAN PHASE, SLEEP, ALERTNESS AND MOOD
5.1 Introduction
Previous chapters have dealt with the main aims of this thesis; namely to assess the 
effects of sleep deprivation and shift work on metabolic and cardiovascular function. 
Whereas alterations in these parameters may be more evident after chronic exposure to 
sleep deprivation and shift work, mood and especially alertness are likely to show mainly 
acute responses to sleep deprivation.
There is ample research showing that sleep deprivation affects alertness (Lim & Dinges 
2008, 2010; Rogers et al. 2003) (section 1.6). Although it is clear that sleep deprivation 
results in decreased alertness, the impact on mood seems to be less consistent. In most 
healthy people, sleep deprivation has been shown to increase negative mood (Pilcher & 
Huffcutt 1996) (section 1.6), while sleep deprivation has been reported to be a very 
effective treatment for depressive patients (Giedke & Schwarzler 2002; Hemmeter et al. 
2010; Ringel & Szuba 2001).
Other studies have shown that shift work increases measures of sleepiness, due to the 
need to work at the wrong circadian phase and the concurrence of sleep deprivation 
(Akerstedt 1998, 2003; Akerstedt & Wright 2009; Harma et al. 1998) (section 1.7). 
Effects of shift work on wellbeing have been shown (Costa 2003) mainly when different 
shifts were compared (Cavallo et al. 2002; Folkard et al. 1993) or in simulated shift 
schedules (Smith et al. 2009), but there are not many reports that describe the 
differences in mood between SW and NSW. Some of these studies show that the 
frequency of unhappiness was higher in night SW (Kaliterna et al. 2004). A recent meta­
analysis indicated that SW have a higher odds ratio for depression than day workers 
(Driesen et al. 2010) but these authors and others (Costa et al. 2006) suggest that this 
association is likely to be related to high job demand and low control over shift 
schedules.
Few previous studies, however, have assessed the effects of sleep deprivation and 
recovery sleep on alertness and mood in SW when they were tested in a laboratory 
setting. In addition, SW and NSW have not been compared directly when both were 
subjected to the same sleep deprivation and recovery conditions in a laboratory protocol.
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5.1.1 Aims and hypotheses
The aim of the study was to assess the effects of one night of TSD, a recovery nap and 
recovery sleep on objective and subjective alertness and subjective mood and to 
compare responses from SW to those of NSW in an identical laboratory setting. 
Moreover, the correlation between subjective and objective alertness was determined to 
explore whether this correlation changed as a result of sleep deprivation and recovery 
sleep and whether it was the same in SW and NSW.
It was hypothesised that:
• Alertness and mood will be affected by TSD, a recovery nap and recovery sleep. 
Subjective sleepiness, reaction times and lapse frequency will increase, 
reciprocal reaction time will decrease and mood will be less positive after TSD. A 
nap and recovery sleep will (partly) reverse these changes.
• SW and NSW will respond differently to TSD and recovery periods.
Subjective sleepiness will be less severe and mood will be more positive during 
and after TSD in SW than in NSW. Reaction times and lapse frequency will not 
be different between the groups. Subjective sleepiness after recovery sleep will 
have returned to baseline levels to a larger extent in SW than in NSW.
• The correlation between subjective sleepiness and PVT performance will be
different between days and between groups. TSD will gradually lead to a loss of
correlation between these 2 parameters. In addition, the correlation will be
stronger in NSW than in SW.
• Circadian phase and phase angle of entrainment will not be different between 
NSW and SW.
5.2 Methods
5.2.1 Assessment o f circadian phase
Saliva was collected into scintillation vials (PerkinElmer, Beaconsfield, UK) every 30 min 
for 4 h before the participants’ self-selected bed time and 9 saliva samples were 
collected immediately following waking until 4.75 h after waking (approximately 1 sample 
every 30 min) (Figure 2.1). Salivary melatonin concentrations were measured on the 
evening before baseline sleep according to an established protocol (English at al. 1993)
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with rabbit anti-melatonin antiserum (code R/R/19540-16876, Stockgrand Ltd., University 
of Surrey, Guildford, UK), overnight incubation at 4°C with ^^^l-iodomelatonin 
(PerkinElmer, Beaconsfield, UK) and separation by cellulose-linked donkey anti-rabbit 
IgG (SacCell, IDS Ltd., Boldon, Tyne & Wear, UK). In addition, 1 mL Brij/saline wash 
solution (0.9% w/v NaCI, 0.06% Brij 35, Sigma Ltd., Poole, UK) was added to all samples 
prior to the centrifugation step. In every assay samples from SW and NSW were 
assayed together. The average limit of detection for the saliva melatonin assay was 1.5 ±
1.2 pg/ml (mean ± SD) (n = 5). The inter-assay CVs were 15.9, 13.0 and 7.7 % for 
quality control samples with 7.1 (n = 6), 19.5 (n = 6) and 44.1 pg/ml (n = 5) melatonin, 
respectively. Dim light melatonin onset (DLMO) as a marker of circadian phase was 
determined for each subject as the time that the melatonin level exceeded the calculated 
threshold of > 2 SD from the mean basal concentration (mean of the 3 or 2 (in 3 subjects 
due to missing data) consecutive lowest concentrations) and did not return below this 
basal level (Burgess et al. 2003). The DLMO could not be assessed in one shift worker 
(subject S8) as elevated melatonin concentrations were already present at the time the 
first saliva sample was collected. For this subject and 2 other subjects, melatonin 
concentrations were also determined in the morning after the baseline sleep in order to 
confirm a melatonin rhythm. In addition, individual phase angles were computed by 
calculating the difference between DLMO and bed time.
5.2.2 Assessment o f sleep
Polysomnographic recordings were taken continuously throughout the study (section 
2.5.4). Signals for the EEG were derived from gold plated electrodes (Astromed Inc., 
Slough, UK) (occipital 01 and 02, central 03 and 04 and frontal F3 and F4 electrodes 
referenced to mastoid Ml and M2 electrodes) using tape measure and wax pencil to 
indicate the correct positions, according to the American Academy of Sleep Medicine 
(AASM) guidelines (Iber etal. 2007) (Figure 5.1 A & B). Left and right EOG and EMG (2 
electrodes placed 2 cm below the inferior edge of the mandible) were also derived using 
the gold electrodes as well as subject ground and system reference for which the 
electrodes were placed on the forehead (Figure 5.1 C).
All electrodes were applied with EC2 paste (Astromed Inc., Slough, UK) with gauze or 
tape after cleaning of the skin with NuPrep gel (Astromed Inc., Slough, UK). Data were 
acquired, converted into European Data Format (EDF) and imported into Somnologica 
Studio (version 5.0.1 build 1662, Embla, supplied by Stowood Scientific Instruments Ltd., 
Oxford, UK) as described in section 2.5.4.
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Figure 5.1. EEG, EOG and EMG electrode positions.
The international 10-20 electrode placement system from (A) the left side (adapted from 
Malmivuo & Plonsey, (1995)) and (B) the top (adapted from Iber et al. (2007)) and (C) frontal 
electrodes.
The nasion, inion and preauricular points are used as landmarks from which the head is 
measured and sites for electrode placement, each 10 or 20%  apart from each other, are 
determined. M = mastoid (behind the ear (A)), F = frontal, C = central, O = occipital, ROG and 
LOG are right and left oculogram, EMG = electromyogram, GND = subject ground and Ref = 
system reference.
To determine the extent of sleep/wakefulness during TSD, recordings were scored for 
wake, non-rapid eye movement sleep (NREM) stage 1, NREM 2, NREM 3 and rapid eye 
movement sleep (REM) from habitual bed time on the baseline day until the nap after 
TSD (comprising a period of 14.4 ± 0.3 h, mean ± SD) according to the AASM criteria
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(apart from 3.5 ± 2.8 % data loss due to changing of batteries or technical issues). 
Difficult epochs due to noise or signal loss were scored as wake as the sleep statistics 
report could not be generated if epochs were left unscored. The sleep statistics report 
contained several parameters such as total sleep time (TST), sleep onset latency (SOL) 
(time until the first occurrence of 60 s of consecutive sleep events) and number of 
awakenings (at least 30 s of wakefulness). TST, time spent in NREM 1, NREM 2 and 
NREM 3 and REM was also calculated as a percentage of the total scoring time). In 
order to assess the duration of single sleep periods, TST was divided by the number of 
awakenings + 1 (for the final awakening as this awaking is not counted by Somnologica) 
for each subject. Although this is not a conventional method, it was chosen to give an 
impression about sleep continuity.
5.2.3 Alertness and mood
5.2.3.1 Subjective alertness and mood
Subjective alertness and mood were assessed at 0.25, 4.25, 5.25, 7, 8, 9, 11.5,12.5 and
13.5 h following adaptation sleep, baseline sleep, TSD and recovery sleep (with 
exception of time points 7, 8, and 9 during the nap after TSD) (Figure 2.1). During the 
TSD night alertness and mood assessments were carried out every hour starting 16.5 h 
after waking up. For the first 6 subjects this was done relative to their individual wake up 
time but for later subjects, assessments for the two subjects in the study session were 
synchronised for feasibility. As wake up time for the two subjects in a session was 
always 30 min apart, this implied a 30 min margin in the timing relative to wake up time, 
e.g. subjects with wake up times at 7:00 and 7:30 h would both have assessments 
during TSD at 23:30, 00:30, etc., resulting in one subject starting 16 h and the other 
subject starting 16.5 h after waking. Whether the assessment was started at 16 or 16.5 h 
was alternated between NSW and SW. In addition, for the first 6 subjects, the alertness 
and mood assessments started 17.5 h after waking up as the assessment at 16.5 h had 
not yet been added in.
Subjective mood and alertness were assessed by Karolinska Sleepiness Scale (KSS) 
(Akerstedt & Gillberg 1990), with descriptions for each odd number ranging from 1 Very 
alert’ to 9 Very sleepy’ (appendix M) and 9-digit rating scales with only the descriptions 
for the extreme values (1 Very alert’ - 9 Very sleepy’, 1 Very cheerful’ -  9 Very 
miserable’, 1 Very calm’ -  9 Very tense’ and 1 Very depressed’ -  9 Very elated’). In 
order to explore whether adjustments of the raw data would make a difference to the
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visual representation of the data, KSS scores of each subject were z-scored in two ways; 
(value - mean of the values for the subject after baseline sleep)/standard deviation of the 
values for the subject after baseline sleep (‘z-scored to baseline day’) and (value -  mean 
of all values for the subject)/standard deviation of all values for the subject (‘z-scored to 
overall mean’). KSS scores were also calculated as a fraction of the mean baseline day 
values (‘normalised to mean baseline day’).
5.2.S.2 Objective alertness
The subjective alertness and mood assessments were directly followed by a modified 
Karolinska Drowsiness Test (KDT) (Akerstedt & Gillberg 1990; Cajochen et al. 1999; 
Lafrance & Dumont 2000) for which the data will not be described in this thesis. In 
summary, the subjects were semi-recumbent and the distance between the volunteers’ 
head and the fixation point was approximately 120 cm with the black 4 cm fixation dot on 
a white A4 paper placed at the end of the bed. The volunteer was requested to “maintain 
a stable, relaxed position (try not to move your head and arms) and fixate on the black 
dot in front of you for 5 minutes with your eyes open.” (After 5 minutes) “Now close your 
eyes and remain in this position for 1 more minute”.
After the KDT, objective alertness was assessed at 0.35, 4.35, 5.35, 7.1, 8.1, 9.1, 11.6, 
12.6 and 13.6 h following adaptation sleep, baseline sleep, TSD and recovery sleep (with 
the exception of time points 7.1, 8.1, and 9.1 h during the nap after TSD) by visual PVT 
(Dinges & Powell 1985) (Ambulatory Monitoring Inc., Ardsley, NY, USA). The first 6 
subjects, 4 NSW and 2 SW, were excluded as by mistake they performed both an audio 
and visual PVT simultaneously. The PVT box was placed on the volunteer’s lap with their 
forearms/wrists/hands resting on their thighs and the device tilted slightly so that the 
stimulus window was visible. The distance between eyes and display was approximately 
35-55 cm and the volunteer was instructed to use the same hand and finger throughout 
all tests performed. Further instructions were given according to the PVT manual 
(Ambulatory Monitoring Inc.). All subjects performed a ‘practice trial’ to familiarise 
themselves with the equipment and test. The PVT is assumed to have only a small 
learning effect, i.e. during the first 1-3 trials (Kribbs & Dinges 1994). The total trial time 
(10 min) and interstimulus interval (minimum 2 and maximum 10 s) were set according to 
the default settings. Data were downloaded using PVTcommW (Version 2.10.1.1, 
Ambulatory Monitoring Inc.) and analysed using REACT (Version 1.1.05, Ambulatory 
Monitoring Inc.). For each 10-min epoch the following performance indices were
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calculated for comparison with previous studies (e.g. Cajochen et al. 1999; Dinges et al. 
1997; Vgontzas etal. 2004): mean reaction time per 10-min epoch (mean RT), reciprocal 
reaction time (1/RT or RRT), median RT, increases in the response duration in the lapse 
domain (i.e. slowest 10% RTs per 10-min epoch, SRT), the shift in optimum RT (i.e. 
fastest 10% RTs per 10-min epoch, FRT) and the number of lapses (i.e. reaction times 
(RTs) > 500 ms). According to the default settings, lapses were included in these 
parameters. The only previous study which mentions that lapses were excluded from the 
reaction time calculations is a recent study by Florne & Burley (2010).
5.2.4 Statistical analysis
5.2.4.1 Circadian phase
Melatonin DLMOs and phase angles in SW and NSW were compared by two-tailed 
independent Student’s T-test.
5.2.4.2 Sleep
Sleep parameters were compared between SW and NSW with unpaired Student’s t-tests 
(or Mann-Whitney tests if the data were not normally distributed). A Pearson correlation 
test was carried out to determine whether the number of awakening was related to the 
TST.
5.2.4.S Alertness and mood
The alertness and mood assessments during the sleep deprivation night were analysed 
using a two-factor ANOVA (factors ‘time’ (13 levels) and ‘group’ (SW and NSW)) (SPSS 
16, SPSS Inc.). If applicable, P-values were Greenhouse-Geisser adjusted when 
Mauchly’s test for sphericity was significant.
A mixed-model regression analysis was conducted in SAS 9.1 (TS level 1M3, SAS 
Institute Inc.) to cope with missing data in the daytime alertness and mood assessments 
(section 2.6.4).
The data were also analysed omitting all the afternoon measurements (i.e. those around 
7, 8 and 9 h after wake up time) as the imbalance between the presence of these
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measurements after adaptation sleep, baseline sleep and recovery sleep but not after 
TSD caused problems for the post hoc tests for the main effects and day*group 
interactions in some cases.
The correlation between objective alertness (median RT) and subjective alertness (KSS) 
was tested with a Pearson correlation at all different time points in NSW and SW 
separately, in a similar way to the association between subjective wellbeing and 
subjective sleepiness in two different protocols (Birchler-Pedross et al. 2009). As there 
was variance in TST, the association between TST and the assessed parameters was 
also investigated with a Pearson correlation.
5.3 Results
5.3.1 Circadian phase
Figure 5.2 shows the individual melatonin profiles for SW (n = 11) and NSW (n = 14) on 
the evening before baseline sleep and the morning after baseline sleep for 3 subjects. A 
brief case study for subject S8 can be found in appendix N, showing the melatonin profile 
measured before baseline sleep in the laboratory despite a regular sleep wake cycle the 
week prior to the study (confirmed by actigraphy, a subjective sleep diary and a time 
stamped voicemail). Average melatonin profiles and those for subjects with the longest 
and shortest phase angle are shown in Figure 5.3 A & B. The DLMO was not 
significantly different in SW compared to NSW (21.1 ± 0.5 h (mean ± SD) and 21.2 ± 0.7 
h, respectively) (Figure 5.3 C). In addition, the phase angle between DLMO and bed 
time was also similar in SW and NSW (2.2 ± 0.5 h and 2.1 ± 0.6 h, respectively) (Figure
5.3 D).
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Figure 5.2 A. Individual saliva melatonin profiles in non-shift workers.
Saliva melatonin profiles in NSW on the evening before baseline sleep (from 4 -  0.5 h before bed 
time).
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Figure 5.2 B. Individual saliva melatonin profiles in shift workers.
Saliva melatonin profiles in SW on the evening before baseline sleep (from 4 -  0.5 h before bed 
time) and in the morning following baseline sleep (from 0 -  4.75 h after waking) in 3 SW. Note, y- 
axis scales differ between graphs.
125
Chapter 5 Circadian phase, sleep, alertness and mood
B
l “ ]
§ 20-1 
«  15
E 10
-5 -4 -3 -2 -1
time before bed (h)
g  30^
§ 20-1
«  15-1 0)
E  10-1
-4 -3 -2 -1
time before bed (h)
24-,
23-
i 22-_io 21-
SWNSW
JC
<Q PU i
Oo
a.
NSW SW
Figure 5.3. Saiiva meiatonin profiies, DLMOs and phase angies on the evening before 
baseiine sieep.
Upper diagrams show saliva melatonin profiles in (A) NSW  showing the average (± SEM ) in all 
NSW (A) (n = 14 ), the subject with the longest phase angle ( • )  and the subject with the shortest 
phase angle (■), and in (B) SW showing the average (± SEM) in all SW  (A ) (n = 10), subject with
the longest phase angle (#) and subject with the shortest phase angle (■).
Bottom diagrams show (C) individual DLMOs and mean ± SEM and (D) individual phase angles
and mean ± SEM in NSW  (• )  (n = 14) and SW  (o )  (n = 10).
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5.3.2 Sleep
The assessment of the amount and architecture of sleep during the sleep deprivation 
period is shown in Figure 5.4 and Table 5.1. No significant differences were observed 
between SW and NSW in any of the parameters. However, there were large 
interindividual differences in the subjects’ ability to stay awake (TST was 35 ± 8  min, 7 -  
83 (mean ± SEM, range)) in SW and 29 ± 7 min, 0 - 74 in NSW) and how long it took 
before they fell asleep (SOL was 263 ± 51 min, 50 -  547 in SW and 370 ± 41 min, 113- 
547 in NSW) (Figure 5.4 A and B). The number of awakenings was significantly 
positively correlated with the TST (r^  = 0.79, P < 0.001) (Figure 5.4 D), showing that 
subjects who had a longer TST did not necessarily sleep longer compared to those with 
a shorter TST, but fell asleep more often. To further assess continuity of the sleep 
episodes, the TST was divided by the number of awakenings. It appeared that NSW had 
on average 1.6 min of sleep and SW 2.2 min before they awoke (Table 5.1). Finally, the 
data showed that there was no difference between the groups in the time spent in each 
of the sleep stages (Table 5.1). Only one SW had a REM episode.
5.3.3 Alertness and mood
5.3.3.1 Subjective alertness and mood
Raw, z-scored and normalised KSS data are shown in Figure 5.5. As the different data 
forms did not make a big difference in the visualisation, all subjective data are presented 
as raw data. Subjective alertness and mood parameters are shown in Figure 5.6 and for 
the sleep deprivation night in Figure 5.7. Both KSS and the 9-digit scale score for 
alertness showed significant effects of day (F3J51 = 49.4, P < 0.001 and Fsysi = 34.8, P < 
0.001, respectively), time (Fs.tsi = 3.9, P < 0.001 and Fgjsi = 5.1, P < 0.001, respectively) 
and day*time interactions (p2 i,75i = 4.1, P < 0.001 and p2 i,75i = 5.6, P < 0.001, 
respectively). Subjects were less alert according to the KSS and 9-digit scale score in 
the morning following TSD (0.25, 4.25 and 5.25 h after habitual wake up time) than at all 
other time points. When the same time points on different days were compared, 
additional significant findings were increased alertness on the KSS in the late afternoon 
and evening following recovery sleep compared to following baseline sleep (8 ,12.5, 13.5 
h after habitual wake up time) and increased alertness in the evening after recovery 
sleep compared to after TSD (at 12.5 and 13.5 h).
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Figure 5.4. Sleep parameters during the TSD night.
(A) Total sleep time, (B) sleep onset latency and (C) total number of awakenings during sleep 
deprivation in NSW  ( • )  and SW (o )  (individual and mean ± SEM) and (D) the correlation between 
the number of awakenings and total sleep time (□) (i^ = 0.79, P < 0.001) from habitual bed time 
on the sleep deprivation night until the nap. n = 14 for NSW  and n = 11 for SW.
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Table 5.1. Sleep parameters during the sleep deprivation night in non-shift workers and 
shift workers.
Non-shift workers Shift workers
Total sleep time (min) 29 ± 7 35 ± 8
SOL (min) 370 ± 41 263 ± 51
Number of awakenings 18 ± 4 19 ± 5
Average sleep duration before awakening (min) 1.6 ± 0.3 2.2 ± 0.5
Total sleep time (%) 3.7 ± 0.8 4.5 ± 0.9
NREM 1(%) 2.6 ± 0.4 2.9 ± 0.7
NREM 2 (%) 1.3 ± 0.4 1.1 ± 0.2
NREM 3 (%) 0.1 ± 0.0 0.5 ± 0.2
REM (%) 0.0 0.04 ± 0.04
Data are means ± SEM during the sleep deprivation night (from habitual bed time until the 
scheduled nap on average 14.4 h later). %  is relative to total scored time, 
n = 14 for NSW  and n = 11 for SW.
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Figure 5.5. Raw, z-scored and normalised day time KSS scores.
(A) raw KSS scores, (B) KSS z-scored to all days, (C) KSS z-scored to the baseline day and (D) 
KSS scores normalised to the baseline day (mean ± SEM) in NSW  (• )  and SW ( o )  0.25, 4.25, 
5.25, 7, 8, 9, 11.5, 12.5 and 13.5 h after habitual wake up time following adaptation sleep, 
baseline sleep, sleep deprivation and recovery sleep, n = 14 for NSW and n =11 for SW .
130
Chapter 5 Circadian phase, sleep, alertness and mood
E
g
£
5
(5
I
g-«
ë
g
I
ë
ejoos SS)I i
Figure 5.6. Subjective day time alertness and mood.
(A) KSS and 9-digit scale scores for (B) alertness, (C) cheerfulness (D) calmness and (E) 
depression (mean ± SEM) in NSW (•) and SW (o )  0.25, 4.25, 5.25, 7, 8, 9, 11.5, 12.5 and 13.5 h 
after habitual wake up time following adaptation sleep, baseline sleep, sleep deprivation and 
recovery sleep, n = 14 for NSW and n =11 for SW. Note, y-axis scales differ between graphs.
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Figure 5.7. Subjective alertness and mood during TSD.
(A) KSS and 9-digit scale scores for (B) alertness, (C) cheerfulness, (D) calmness and (E) 
depression (mean ± SEM) in NSW  ( • )  and SW (o )  during TSD (from 16.5 to 23.5 h after waking), 
n = 14 for NSW  and n =11 for SW . Note, y-axis scales differ between graphs.
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The 9-digit scale also showed increased alertness at the last time point (13.5 h) after 
recovery sleep compared to after adaptation sleep and after baseline sleep and TSD. 
Moreover, both the KSS and 9-digit scale showed a significant effect of group (F^si =
15.7, P < 0.001 and Fi,7si = 7, P < 0.01, respectively) revealing that SW felt more alert 
than NSW.
There was a significant effect of day { f 3,751 = 11.0, P < 0.001) and a day*time interaction 
(p2i,75i = 1.7, P < 0.05) for cheerfulness. When the same time points were compared 
between days, subjects felt significantly less cheerful in the morning after TSD compared 
to in the morning after adaptation sleep (at 0.25, 4.25 and 5.25 h), baseline sleep (at 
4.25 and 5.25 h) and recovery sleep (at 0.25, 4.25 and 5.25 h). Subjects also felt 
significantly more cheerful at the last time point (13.5 h) after recovery sleep compared 
to all the other days. There were also significant differences between the groups. The 
SW were significantly more cheerful than NSW (Fijsi = 22.9, P < 0.001). SW also felt 
significantly calmer (Fi,75i = 32.0, P < 0.001) and more elated (F^si = 46.8, P < 0.001) 
than the NSW. Finally, there was a significant effect of day (Fsysi = 2.9, P < 0.05) on 
depression ratings. When the afternoon measurements were left out the effect of day 
became non-significant (p3,544 = 2.3, P = 0.0735) but subjects were significantly more 
elated after recovery sleep than after TSD (P < 0.05). There was also a trend for more 
depression after TSD compared to after adaptation sleep (P = 0.0511 ).
During the sleep deprivation night there was a significant effect of time on the KSS score 
(F7.178 = 6.3, P < 0.001) and the 9-digit score for alertness (p7,i78 = 7.4, P < 0.001), 
caused by an increase in sleepiness throughout the night. All parameters were 
significantly different between SW and NSW, with SW feeling less sleepy according to 
the KSS (Fi,i78 = 5.5, P < 0.05) and 9-digit scale (Fi,i78 = 5.8, P < 0.05) and more 
cheerful (Fi,i78 = 12.5, P < 0.001), elated (Fi,i78 = 10.2, P < 0.01) and calmer (Fi,i78 = 
9.0, P< 0.01).
S.3.3.2 Objective alertness
PVT parameters were measured at regular intervals throughout the protocol (Figure 2.1). 
All assessed PVT parameters on all time points can be found in Figure 5.8 with a 
selection for the TSD night in Figure 5.9.
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Figure 5.8. Objective day time alertness.
(A) mean RT, (B) median RT, (C) mean RRT, (D) lapses, (E) mean SRT and (F) mean FRT 
(mean ± SEM) in NSW (•) and SW (o )  0.35, 4.35, 5.35, 7.1, 8.1, 9.1, 11.6, 12.6 and 13.6 h after 
habitual wake up time following adaptation sleep, baseline sleep, sleep deprivation and recovery 
sleep, n = 10 for NSW and n = 9 for SW.
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Figure 5.9. Objective alertness during TSD.
(A) mean RT, (B) median RT, (C) mean RRT, (D) lapses, (E) mean SRT and (F) mean FRT  
(mean ± SEM) in NSW  (• )  and SW (o )  during TSD (from 16.6 to 23.6 h after waking), n = 10 for 
NSW and n = 9 for SW.
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There appeared to be a significant effect of day (F3,556 = 32.3, P < 0.001), time (F8,556 =
2.7, P < 0.01) and day*time interaction (F21.556 = 3.9, P < 0.001) for mean RT as well as 
for mean SRT (p3,556 = 28.5, P < 0.001 ; p8,556 = 2.8, P < 0.01 and F21.556 = 4.3, P < 0.001, 
respectively) and for lapses (F3.556 = 24.9, P < 0.001; p8,556 = 3.3, P < 0.01 and F21.556 = 
2.2, P < 0.01, respectively). There was a significant effect of day (F3.556 = 40.7, P < 0.001) 
and a day*time interaction (F2i,556 = 2, P < 0.01) on mean RRT. Similar to subjective 
alertness, post hoc tests revealed a decrease in alertness shown by a significant 
increase in mean RT and SRT in the morning (0.35, 4.35 and 5.35 h) after TSD 
compared to all other time points, in addition, mean RT and SRT were significantly 
slower at 0.35 h than at 4.35 h and at 4.35 h than at 5.35 h after TSD. In parallel with 
these findings, mean RRT was significantly lower (i.e. reaction time was slower) and 
lapses were more frequent in the morning (0.35, 4.35 and 5.35 h) following TSD than 
almost all other time points. However, some additional differences were seen such as a 
significantly lower mean RRT at 11.6 h after TSD and recovery sleep compared to 
baseline sleep whereas other previously found differences in other PVT parameters were 
not present. The number of lapses at 5.35 h after TSD did not differ from that at 8.1 h 
after baseline sleep and 5.35, 8.1 and 9.1 h after recovery sleep. Furthermore, median 
RT and FRT did not only show a significant effect of day (F3,556 = 25.3, P < 0.001 and 
F3.556 = 9.4 and P < 0.001, respectively) but also a significant day*group interaction for 
median RT (p3,556 = 2.9, P < 0.05) and a group effect for mean FRT (Fi,556 = 6.2, P < 
0.05). When the afternoon assessments (at 7.1, 8.1 and 9.1 h) were left out, median RT 
showed significant effects of day (p3,403 = 23.2, P < 0.001) and day*time interaction 
(Fi5,403 = 1.7 , P < 0.05). As for mean RT and SRT, median RT was longer in the 
morning following sleep deprivation than all other time points, apart from the reaction 
times at 4.35 h and 5.35 h after TSD which were not different from those at 5.35 h after 
recovery sleep. Moreover, median RT showed an effect of group (Fi,403 = 6.6, P < 0.05) 
and a day*group interaction (p3,403 = 3.1, P < 0.05). It appeared that both NSW and SW 
had a higher median RT after TSD than after adaptation and baseline sleep. However, 
NSW had a significantly longer median RT than SW after TSD and recovery sleep. In 
parallel with this, NSW had significantly longer RTs after TSD compared to after recovery 
sleep and longer RTs after recovery sleep than after adaptation and baseline sleep. For 
FRT a trend for an effect of group remained after omitting the afternoon measurements 
(Fi,403 = 3.8, P = 0.0517) with a tendency for slower FRT in SW. The significant effect of 
day (F3,403 = 9.8, P < 0.001) was still present with longer FRT after TSD compared to all 
other days.
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During TSD none of the PVT parameters showed significant group effects nor 
time*group interactions. Significant increases throughout the TSD night were observed 
for mean RT (p7,i3 4 = 3.5, P < 0.01), median RT (p7,i3 4 = 2.6, P < 0.05), mean SRT (p7,i34 
= 3.2, P < 0.01) and number of lapses (p7,i3 4 = 3.4, P < 0.01), but a decrease in mean 
RRT (p7,i34 = , P < 0.001) (Figure 5.9). Posf/?oc tests showed that in the NSW mean RT 
and SRT were significantly slower around 1.5 h before habitual wake up time than 2.5 
and 0.5 h before, while the complete data set indicates that in SW this performance ‘dip’ 
appears to occur an hour later and was much smaller.
5.3.4 Correlation between subjective alertness and PVT performance
Figure 5.10 illustrates that there was no clear change in the association between 
subjective alertness (KSS) and objective alertness (median RT) across time points or 
between SW and NSW.
5.3.5 Association between sleep during TSD and assessed parameters
As the protocol aimed to induce TSD, it was of importance to assess whether the extent 
of incomplete sleep deprivation was related to the measured parameters. There was no 
significant association between TST during TSD and KSS or median RT just before the 
nap (Figure 5.11). Similarly, there was no significant correlation between TST during 
TSD and either the lAUCs of TAGs, insulin and glucose or the AUCs of TAGs, NEFAs, 
insulin and glucose after TSD and after recovery sleep. There was also no correlation 
between TST and FMD in the morning and afternoon after TSD and after recovery sleep. 
Nor was there a correlation between TST and SDNN or LF/HF at any time point following 
TSD, or average RMSSD, SDSD, NN interval or pNN50 after recovery sleep (data not 
shown).
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Figure 5.10. Correlation between subjective and objective alertness.
Correlation between KSS and median RT (A) throughout the laboratory study and (B) during 
sleep deprivation (with the time points for median RT) in NSW  (• )  and SW (o ) .  n = 10 for NSW  
and n = 9 for SW. During sleep deprivation the statistically significant correlations are indicated by 
an asterisk (P < 0.05).
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Figure 5.11. Correlation between sleep during TSD and subjective and objective alertness.
Correlation between total sleep time during sleep deprivation and (A) KSS at 5.25 h and (B) 
median RT at 5.35 h after habitual wake up time following sleep deprivation in NSW and SW. n = 
25 for KSS and n = 19 for median RT.
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5.4 Discussion
Sleep deprivation has been shown to decrease alertness and affect mood (section 1.6). 
These findings may also be observed in SW, either due to the acute effects of insufficient 
sleep or the circadian phase at which alertness and mood are measured during a shift. A 
major aim of the current study was to investigate the chronic rather than acute effects of 
shift work on alertness and mood responses to sleep deprivation and recovery sleep by 
subjecting experienced SW to identical laboratory settings as NSW. In addition, a 
preliminary analysis was conducted to explore whether the correlation between objective 
and subjective mood and alertness differed across the sleep deprivation protocol as well 
as between SW and NSW. Additional aims were to determine circadian phase and 
phase angle of entrainment and to assess wakefulness during the sleep deprivation night 
in all subjects.
Circadian phase was assessed by measuring the DLMO, considered a reliable marker 
for circadian phase (Arendt 2003; Burgess et al. 2003; Klerman et al. 2002). The results 
show that using the week at home study period (prior to the laboratory session), control 
of the participants’ circadian phase was achieved in this study since there was no 
significant difference in the DLMO of SW compared to NSW. In addition, the data 
confirmed that the SW were normally entrained to the light/dark cycle since the time 
interval (phase angle) between DLMO and bed time was not only very similar in SW and 
NSW (2.2 ± 0.5 h and 2.1 ± 0.6 h, respectively) but also comparable to previous reports 
in healthy young volunteers (phase angle of 2 ± 1.4 h and similar DLMO at 21.7 ± 1.5 h) 
(Burgess et al. 2003).
Despite intensive monitoring by staff, subjects still fell asleep during the TSD night. This 
also occurred in other studies that aimed to achieve TSD (many other studies did not 
report polysomnographic sleep or did not analyse sleep outside the planned sleep 
episodes). In previous studies, ranges of sleep lengths have been shown 0 - 1 6 . 5  min 
(Urrila etal. 2007), 0 - 49 min NREM 1 (Cajochen et al. 1999), with an average length of 
sleep episodes and sleep architecture (Urrila et al. 2007) similar to those found in the 
current study. Faraut et al. (2010) only observed 2 sleep episodes of 7 and 8 min of 
NREM 2 outside the permitted hours and other studies demonstrated an average sleep 
duration less than the restricted hours that were allowed (Donga et al. 2010; 
Nedeltcheva et al. 2009; Spiegel et al. 1999). However, TST in some of the current 
subjects was long. This discrepancy may be due to differences in the study designs. 
Most importantly, in the current study subjects were required to lie very still for at least 20
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min during the ultrasound recordings for FMD, which is especially sleep-inducing. In 
addition, in some previous studies, subjects were allowed to eat and move around in 
light brighter than the dim light used in the current study (Faraut et al. 2010; Nedeltcheva 
et al. 2009; Spiegel et al. 1999; Urrila et al. 2007) which would have helped the subjects 
to stay awake.
Not surprisingly, both the KSS and the 9-digit scale score showed a significant increase 
in subjective sleepiness across the TSD night. In accordance with this, an increase in 
mean RT, median RT, mean SRT and lapse frequency but a decrease in mean RRT 
indicates increasing objective sleepiness during prolonged wakefulness. This increase in 
reaction time, lapse frequency and sleepiness may be part of the rising phase of the 
circadian rhythm observed in subjective and objective alertness which has been shown 
to display a maximum deterioration around the body temperature minimum (around 2 h 
before habitual wake up time) (Cajochen et al. 1999; Cajochen et al. 2001; Dijk et al. 
1992; G raw et al. 2004; Kline et al. 2010; Lee et al. 2009; Wyatt et al. 1999) (section 
1.5.4.1). As other authors have mentioned (Cajochen et al. 1999), the current data also 
indicated some improvement of performance around the last hour before habitual wake 
up time in NSW and after wake up time in SW, although it has to be kept in mind that the 
resolution may not be high enough to distinguish in the timing between NSW and SW as 
tests during TSD were taken within a 30 min margin with respect to wake up time 
(section 5.2.3). In contrast to the other PVT parameters, FRT did not change significantly 
during TSD. However, a circadian rhythm in FRT with an increase, albeit possibly less 
steep, throughout the night is likely to exist (Cajochen et al. 1999; G raw et al. 2004; Kline 
et al. 2010; Wright et al. 2002). In addition, there were no significant changes in the 
mood parameters during the TSD night although previous studies indicated a circadian 
rhythm in mood with a trough around the temperature minimum (Boivin et al. 1997; Kline 
et a/. 2010).
When the day time measurements (0.25/0.35 h -  13.5/13.6 h after habitual wake up 
time) were analysed, both the KSS and 9-digit scale demonstrated that subjects felt less 
alert in the morning after sleep deprivation (before the nap) than at any other time point. 
Similarly, mean RT and mean SRT were higher in the morning after TSD than at any 
other time point. In addition, mean RRT was lower and median RRT and the number of 
lapses were higher the morning after TSD than most but not all other time points. Mean 
RRT was also lower at 11.6 h after TSD than after baseline sleep. These observations 
are not surprising and are in agreement with previous studies showing that alertness is 
decreased after TSD (Gould et al. 2009; Jay et al. 2007; Kahn-Greene et al. 2007;
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Zhong et al. 2005), PSD (Axelsson et al. 2008; Buxton et al. 2010; Cohen et al. 2010; 
Dinges et al. 1997; Faraut et al. 2010; Haavisto et al. 2010; Mollicone et al. 2010; 
Sallinen et al. 2008; Spiegel et al. 1999; Vgontzas et al. 2004) and in sleep deprived 
subjects compared to subjects with normal sleep (Franzen etal. 2008) (section 1.6). FRT 
was slower after TSD compared to all other days but the effect was not as strong as for 
the other parameters, suggesting that FRT is less sensitive to sleep deprivation. This 
result is supported by findings from a study that did not find differences in FRT between 
a high sleep pressure protocol (CR) and a low sleep pressure protocol (nap protocol) 
(Graw et al. 2004). The time course of changes in PVT parameters across the baseline 
day and the sleep deprivation night was similar to that observed in other studies with a 
fairly stable performance up to 16 h after habitual wake up time and deterioration beyond 
this point (Cajochen etal. 1999; Dijk etal. 1992; Urrila etal. 2007).
The current study showed a trend but no significant effect for an increase in depression 
ratings after TSD compared to after adaptation sleep. By contrast, subjects were less 
cheerful in the morning after TSD than on the other mornings. Most studies have also 
shown deteriorations in some aspects of mood but not in others and inconsistent results 
within a sub-type of mood (e.g. depression) after TSD (Kahn-Greene et al. 2007), PSD 
(Dinges et al. 1997; Haack & Mullington 2005) and in sleep deprived compared to non­
sleep deprived subjects (Franzen etal. 2008).
The first recovery period after the TSD night was the 4-h nap. The data indicate that the 
nap has been able to partly reverse the increased sleepiness in the morning after TSD 
as there were no significant differences in the evening subjective and objective 
measures after the nap compared to the evenings of the adaptation and baseline day. 
This is in agreement with findings that a nap is helpful (Dinges et al. 1987; Gillberg et al. 
1996) but the current data do not provide evidence that a nap mostly improves 
performance above subjective sleepiness (Dinges et al. 1987; Gillberg et al. 1996). 
Moreover, a lower mean RRT at 11.6 h following TSD, compared to following baseline 
sleep and the absence of a day*time interaction for FRT (but an overall increase after 
TSD) are the only indications that objective vigilance was not fully recuperated after the 
nap. Alternatively, a significant increase in sleepiness in the morning after TSD but not 
after the nap could also be due to circadian modulation of the effects of sleep 
deprivation. Previous studies have shown that the worst effects of sleep deprivation were 
displayed between the body temp minimum and shortly after habitual wake up time 
(Cohen etal. 2010; Lee etal. 2009; Mollicone etal. 2010).
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The recuperative effect of the nap, however, may be temporary and therefore it is of 
interest to assess the effect of recovery sleep. The effectiveness of recovery sleep 
appeared to depend on the parameter measured. For example, subjective sleepiness, 
mean RT and SRT showed full recuperation after recovery sleep. In agreement with this, 
other studies have also shown that 9 h recovery sleep following 40 h TSD was sufficient 
for subjective sleepiness and RT to return to baseline levels (Jay et al. 2007) and that 
subjective sleepiness recovered after 1 PSD night (2 h sleep) plus a 30-min nap and 8 h 
recovery sleep (Faraut et al. 2010). However, reversal to baseline levels was possibly 
less complete in lapse frequency and median RT (the 5.35 h time point following 
recovery sleep did not differ from the same time point after TSD) and mean RRT (still 
lower at 11.6 h after recovery sleep compared to after baseline sleep). In addition, one of 
the next paragraphs will discuss that NSW not only had a longer median RT after TSD 
but also after recovery sleep than after baseline and adaptation sleep. In agreement with 
this, other studies have shown that subjective sleepiness may recover faster than 
objective sleepiness, especially lapses (Axelsson et al. 2008; Haavisto et al. 2010; 
Lamond et al. 2007). Despite this observation, overall recovery seems faster in the 
current study than in previous studies on repeated PSD where it took at least 2 recovery 
nights for PVT parameters (and in some cases subjective sleepiness) to return to 
baseline levels (Axelsson et al. 2008; Dinges et al. 1997; Sallinen et al. 2008). However, 
recovery from repeated PSD may take longer than a single night of TSD and, in addition, 
there was no nap opportunity in those studies.
Furthermore, the results from the KSS revealed increased alertness in the evening 
following recovery sleep compared to following baseline sleep and TSD and the 9-digit 
scale showed higher alertness levels at the last time point (13.5 h) after recovery sleep 
compared to after adaptation and baseline sleep and TSD. In addition, subjects felt more 
elated after recovery sleep compared to after TSD. Furthermore, subjects were more 
cheerful during the very last assessment compared to the same time point on other days. 
The alertness and mood data are suggestive of the so-called ‘end-of-study-effect’. This 
phenomenon is characterised by an increase in positive mood towards the end of an 
experiment due to the prospect of completing the study (despite the fact that in the 
current study the subjects were not told exactly when the last measurement will take 
place). This may reflect feelings of relief as staying in a laboratory has been indicated to 
have a negative influence on mood (Paterson etal. 2010).
The current protocol did not only show effects of sleep deprivation and recovery sleep on 
alertness and mood, but also of shift work. In accordance with the hypotheses.
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throughout the sleep deprivation night SW felt less sleepy according to the KSS and 9- 
digit scale. By contrast, PVT parameters showed no significant differences between the 
groups. During the day time measurements SW felt more alert than NSW according to 
the KSS and 9 digit scale. Also objectively, NSW may have been less alert as they had a 
significantly longer median RT than SW after TSD and recovery sleep and higher median 
RT after recovery sleep than after adaptation sleep and baseline sleep. The latter also 
indicates that NSW do not recover as well from sleep deprivation as SW, although the 
hypothesis was that this would be observed in subjective rather than in objective 
alertness. Remarkably, the only indication of the SW performing worse than NSW was 
the observation that FRT tended to be slower in SW than in NSW. During TSD, SW did 
not only feel more alert but also more cheerful, elated and calmer than NSW. This 
consistent pattern was seen during the day time measurements as well when SW felt 
significantly more cheerful, elated and calmer than NSW, which confirmed the 
expectations but this has not been reported before.
There were no significant differences between groups in circadian phase and sleep 
parameters during TSD so differences in alertness and mood between the groups are 
probably not due to this. There are no previous reports studying SW and NSW under 
identical settings for comparison with the current findings. A plausible explanation for the 
difference between SW and NSW may be selection into and out of shift work rather than 
the long term consequences of shift work itself. Primary selection into shift work of those 
who rate themselves as more tolerant to shift work and sleep deprivation can influence 
the outcome of studies of differences between SW and NSW (Boggild 2009). Along the 
same lines, it may be those who are least affected by shift work and sleep deprivation, 
that continue their jobs in shift work (Knutsson 2004). Therefore, the SW in the current 
study may be those who feel that they can tolerate sleep deprivation fairly well (also 
confirmed by personal communications with the SW). These phenomena and the fact 
that the current study did not investigate the acute effects of being in a shift schedule but 
compared SW and NSW when subjected to sleep deprivation may explain why the 
increased sleepiness and negative mood as observed in SW (Akerstedt & Wright 2009; 
Driesen et al. 2010; Kaliterna et al. 2004) (section 1.7) is not seen in the current study. 
Moreover, as suggested in section 1.7.1.4, it may be the flexibility aspect of shift work 
that affects irritability, anxiety and depression (Ahlberg et al. 2004; Costa et al. 2006) 
rather than sleep deprivation itself. However, van Dongen (2006) noted there was still a 
fair amount of variation in a self-selected group of F-117 pilots in flight simulator 
performance. These differences between groups and individuals could also be related to
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genotype (Retey et al. 2005; Van Dongen & Belenky 2009; Viola et al. 2007) 1.8 but this 
is not likely to play a role in the current study (section 6.4.1).
The differences between NSW and SW also indicated that during TSD a more alert 
feeling in SW was not accompanied by a better PVT performance. In agreement with 
this, the KSS scores and median RT were not correlated in SW during TSD around 22.6 
h after waking up while there was a significant correlation in NSW. By contrast, the only 
indication that subjective alertness correlates with objective alertness in SW could be 
found in the day time data that showed that SW felt more alert and also performed 
better, at least according to the median RT, after TSD and recovery sleep. The 
preliminary analysis on the correlation between subjective (KSS) and objective alertness 
(median RT) showed no clear difference across days and between groups. In contrast to 
expectations, the data do not suggest that sleep deprivation results in the loss of the 
capability to judge one’s own alertness as the correlation was not better before sleep 
deprivation. Neither do the correlation data confirm the hypothesis that NSW would 
generally be able to accurately judge how sleepy they are whereas SW would 
overestimate their performance (feel more alert but are objectively not more alert) (only 
at 22.6 h after waking) as the TSD analyses indicated.
The data rather indicate there is no pattern in the correlation of an indvidual’s subjective 
and objective alertness. This may suggest that subjective and objective alertness are 
correlated within a group of subjects (e.g. SW) but not within a subject. This is in 
agreement with previous studies which have shown no good correlation between 
subjective and objective sleepiness (section 1.5.4.2), apart from a situation where the 
KSS was administered during the PVT and the within PVT correlation was determined 
(Horne & Burley 2010). For example. Van Dongen et al. (2004) found significant 
differences between subjects in the number of lapses whereas their subjective 
sleepiness (on the SSS) was similar. Similarly, when subjects were divided into resistant 
or vulnerable to sleep deprivation according to their increase in SRT during the selection 
night, it appeared that during a subsequent sleep deprivation night, resistant subjects 
were able to maintain a fairly stable reaction time whereas vulnerable subjects showed 
an increase in reaction times, while both groups felt equally sleepy (KSS) (Galliaud et al. 
2008). Additional results also demonstrated independence between neurobehavioural 
performance on one hand and subjective sleepiness on the other hand (Franzen et al. 
2008; Frey et al. 2004). Another study showed that during consecutive simulated night 
shifts subjects had a moderate ability to rate their actual performance before or after PVT 
and that these pre-test self-ratings were correlated to subjective alertness but the study
145
Chapter 5 Circadian phase, sleep, alertness and mood
does not reveal whether subjective alertness also directly correlates with PVT 
performance (Dorrian et al. 2003). Finally, when a dose-response relationship between 
hours of sleep in the previous night and either sleepiness (SSS) or PVT performance 
was investigated, it also appeared that though both improved in a saturating exponential 
manner with more sleep, subjective sleepiness improved more slowly (Jewett et al. 
1999). It is not clear as to why there would be a poor correlation between subjective 
sleepiness and PVT performance. One possible reason would be that different brain 
areas or downstream pathways are involved in each of the behaviours. A second 
explanation could be that the correlation is dependent on the specific parameters 
compared and the study conditions present. The correlation between subjective and 
objective alertness could be improved, for example in PSD by sitting still with eyes 
closed for 1 min prior to the assessment in order to minimise transient activation (Yang et 
al. 2004).
In agreement with previous studies, the current study demonstrated that during and after 
sleep deprivation subjective alertness and PVT performance deteriorated. Mood did not 
change during the sleep deprivation night but cheerfulness was lower in the morning 
following the TSD night. Both subjective sleepiness and PVT performance returned to 
baseline levels after a nap plus recovery sleep. When SW were compared to NSW in 
identical settings (e.g. circadian phase, physical activity, food intake and light exposure), 
it appeared that SW felt better and more alert than NSW, possibly due to selection in and 
out of shift work, leaving mostly those individuals amongst the experienced SW who felt 
that they could tolerate shift work and sleep deprivation.
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CHAPTER 6 GENERAL DISCUSSION
This study investigated the effect of sleep deprivation, recovery sleep and shift work on 
metabolic and cardiovascular function. In addition, the consequences for mood and 
alertness were assessed. Epidemiological studies have indicated that short sleep and 
shift work are associated with alterations in metabolic and cardiovascular function. 
Smaller scale field and laboratory studies have supported this relationship. However, 
there is a paucity of information about the effects of TSD on the postprandial metabolic 
and insulin responses to a standard breakfast as well as endothelial function and heart 
rate variability (HRV) (especially the time domain parameters). Furthermore, previous 
studies were often not well-controlled for environmental conditions. Moreover, in many 
cases the shift work population was poorly characterised and not compared to the 
appropriate control group.
Thus, these metabolic and cardiovascular parameters were assessed following TSD in a 
laboratory setting with strict control of body posture, physical activity, meals, circadian 
phase and ambient lighting. In addition, experienced SW were compared directly to NSW 
matched for age, BMI and cholesterol levels in these identical settings.
6.1 Discussion of the results
Previous chapters have shown changes in the assessed parameters on different days 
throughout the protocol. Here the changes in these parameters will be discussed per day 
and SW will be compared to NSW.
6.1.1 Adaptation sleep
First of all, a lower LF/HF, longer NN intervals and higher pNN50 were observed after 
adaptation sleep than on the other days. A plausible explanation would be that this is a 
consequence of adapting to the laboratory environment. This explanation would imply 
that stress levels and therefore sympathetic activity (Black & Garbutt 2002) would be 
slightly higher than on all other days. However, a lower LF/HF indicates that sympathetic 
activity is lower after adaption sleep than on all other days. Opposite reasoning would be 
that the first day is the least stressful day as other studies have shown that negative 
feelings increase by staying in a laboratory (Paterson etal. 2010).
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6.1.2 One night o f TSD
After one night of TSD basal TAG levels were significantly decreased. This suggests that 
wakefulness during TSD (without an increase in physical activity) may induce an 
increase in the use of nutrients (section 3.4) possibly by an increased metabolic rate 
(Koban & Swinson 2005; Young at al. 1998). Insulin levels 4 h after the standard 
breakfast following TSD were higher than the levels after baseline sleep. However, 
glucose levels 4 h postprandially did not return to basal levels after TSD. This reduced 
suppression of glucose levels by raised insulin concentrations indicates insulin 
insensitivity (Figure 1.1), which has also been observed after sleep deprivation by others 
(Buxton et al. 2010; Donga et al. 2010; Nedeltcheva et al. 2009; Spiegel et al. 1999; 
Tasali et al. 2008; VanHelder et al. 1993) (section 1.6). In agreement with results from 
Viola et al. (2002) the current study also demonstrated a peak in variance (most clearly 
in SDNN but also visible in RMSSD and SDSD) around habitual wake up time. However, 
there is no explanation for the increased variance after sleep deprivation. FMD was not 
significantly affected by TSD. Nevertheless, the metabolism and HRV data reflect effects 
of sleep deprivation on the autonomic nervous system, most likely a shift in the balance 
between sympathetic and parasympathetic modulation. Other authors found a shift 
towards sympathetic activity after TSD (Sauvet et al. 2009; Zhong et al. 2005) and PSD 
(Spiegel etal. 1999).
An interesting candidate to link the effects of sleep deprivation on the brain with those 
occurring in the rest of the body could be the wake promoting factor orexin (section 
1.4.3). Orexin neurons have been shown to project to the ventral medulla thereby 
affecting heart rate (Berthoud et al. 2005) and to stimulate sympathetic neurons 
innervating tissues involved in metabolism (van den Top et al. 2003). Sleep deprivation 
has also been shown to increase orexin levels in the cerebrospinal fluid of both squirrel 
monkeys and rats and hypothalamic prepro-orexin mRNA levels in rats were higher 
(Deboer et al. 2004; Martins et al. 2010; Zeitzer et al. 2007). Increased exposure to 
orexin during sustained wakefulness may therefore result in a shift between sympathetic 
and parasympathetic modulation, affecting metabolism, HRV and possibly FMD. In 
addition, there are other sleep-promoting factors (Borbely & Tobler 1989) that could play 
a role in ‘peripheral effects’ of sleep deprivation. If these factors are able to promote 
sleep, they are likely to show differences after sleep deprivation when sleep needs to be 
induced. It would be very interesting to explore the possibilities to find a ‘biomarker of 
sleep deprivation’ that could be related to metabolic and cardiovascular function and that 
can be sampled from humans for example in blood, saliva or urine. Examples that could
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be proposed as such ‘biomarkers’ are prostaglandin D2 (PGD2) (Borbely & Tobler 1989) 
and lipocalin-type prostaglandin D synthase (L-PGDS) (that produces PGD2), which are 
thought to be involved in the regulation of sleep in addition to their function in 
inflammation and regulation of vascular tone (Sasaguri & Miwa 2004). L-PGDS has been 
shown to be decreased in plasma at night during TSD (Jordan et al. 2004) and in CSF of 
subjects with excessive daytime sleepiness (Bassetti et al. 2006). Insulin and 
acetylcholine have also been suggested as sleep promoting factors (Borbely & Tobler 
1989).
In the present study, not only metabolic and cardiovascular function were affected by 
sleep deprivation. Subjective and objective sleepiness significantly increased throughout 
TSD, probably reflecting the rising phase of the circadian rhythm in sleepiness (Cajochen 
et al. 1999; Cajochen et al. 2001; Dijk et al. 1992; Graw et al. 2004; Kline et al. 2010; 
Lee et al. 2009; Wyatt et al. 1999) (section 1.5.4.1). In agreement with previous studies 
on sleep deprivation, both subjective and objective sleepiness were higher in the 
morning after TSD compared to after baseline sleep (Axelsson et al. 2008; Buxton et al. 
2010; Cohen et al. 2010; Dinges et al. 1997; Faraut et al. 2010; Gould et al. 2009; 
Haavisto et al. 2010; Jay et al. 2007; Kahn-Greene et al. 2007; Mollicone et al. 2010; 
Sallinen et al. 2008; Spiegel et al. 1999; Vgontzas et al. 2004; Zhong et al. 2005) 
(section 1.6). Cheerfulness was lower in the morning after TSD as has been shown by 
some of the results in previous studies (Dinges etal. 1997; Franzen et al. 2008; Haack & 
Mullington 2005; Kahn-Greene et al. 2007). Decreased PVT performance and alertness 
have been related to changes in brain activity (Drummond et al. 2005) and the basal 
forebrain was one of the areas affected by sleep deprivation (Thomas et al. 2000). 
Another wake promoting factor, adenosine, accumulates in the basal forebrain after 
sleep deprivation (Porkka-Heiskanen et al. 2003) (section 1.4.3) and increased 
adenosine levels have been shown to impair PVT performance in the rat (Christie et al. 
2008). These data suggest that the basal forebrain and elevated adenosine levels may 
be important in mediating the impairing effects of sleep deprivation on PVT performance 
and alertness.
6.1.3 Recovery sleep
In the present study, metabolic function, HRV, alertness and mood were affected by 
sleep deprivation but some important changes were also observed after recovery sleep. 
Basal and postprandial NEFA levels were lower and basal and postprandial insulin and
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TAG levels were higher after recovery sleep. Higher TAG levels in the presence of 
elevated insulin levels indicate insulin insensitivity as insulin insensitivity can cause an 
enhanced release of TAGs by the liver and impaired plasma clearance of TAGs by LPL 
(section 1.5.1.1). This process has been reported to result in increased TAG levels in the 
circulation (DeFronzo 1988; Griffin 2009; Heaven 2002). Mobilisation of lipids due to 
hormone sensitive lipase activity, however, may still be suppressed by the higher insulin 
levels as the NEFA response was smaller after recovery sleep (section 1.5.1.1). Similar 
patterns in TAG, NEFA and insulin responses have been observed after phase shifting 
(Hampton et al. 1996; Lund et al. 2001; Ribeiro etal. 1998) (section 1.7). In parallel with 
our findings another study showed that the TAG AUC was increased on the second day 
of night shift work compared to day shifts but was even greater after 2 days after the 
return to daytime work (Lund et al. 2001), indicating that responses can be largest after 
the recovery process.
After recovery sleep, a lower variance (SDSD, RMSSD) as well as a decreased pNN50 
and duration of NN intervals were also observed. Sauvet et al. (2009) found significant 
increases in intercellular adhesion molecule-1 (ICAM-1), IL-6 and norepinephrine, after 
recovery sleep but not after TSD. The observation that both HRV parameters and 
metabolites and insulin change after recovery sleep indicates that both pathways may be 
related. As suggested earlier for the effects of sleep deprivation, the effects of recovery 
sleep could also be mediated by a common substrate for both metabolism and HRV, 
such as the autonomic nervous system. Alternatively, the changes in the parameters 
could be ‘serial’ rather than ‘parallel’ with alterations in one parameter inducing changes 
in a second parameter. Some authors for instance have suggested that insulin 
insensitivity and the compensatory hyperinsulinémie response may induce sympathetic 
activity and increase heart rate (Facchini et al. 1996). However, most studies show return 
to baseline levels after recovery sleep (section 1.6) and the reasons why these changes 
in metabolism and HRV occur after recovery sleep but not after TSD remain to be 
elucidated.
In contrast to the metabolic parameters and HRV, subjective alertness and PVT 
performance did not show their largest responses after recovery sleep but returned to 
pre-sleep deprivation levels. Only in the evening after recovery sleep, did subjects feel 
more alert and cheerful better than on the other evenings, probably due to the prospect 
of going home (the so-called ‘end-of-study-effect’).
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6.1.4 Comparison of shift workers and non-shift workers
The metabolic data did not show any overall statistically significant differences between 
SW and NSW. However, when the groups were analysed separately, the responses of 
NSW were more pronounced than those of SW, with higher basal insulin levels, lower 
basal NEFA levels and an increased postprandial insulin but decreased NEFA response 
after recovery sleep in NSW but not in SW. By contrast, HRV showed significant overall 
group differences with a lower SDNN, SDSD, RMSSD and pNNSO, increased NN-interval 
and higher LF/HF in SW compared to NSW. SW also showed a trend for a lower FMD. 
The observations in HRV and FMD agree well with previous findings (section 1.7). 
Furthermore, SW felt significantly more alert, happier, more cheerful and calmer 
throughout the protocol.
The differences between the groups in subjective alertness and mood could be 
explained by selection into shift work (Boggild 2009) and coping with shift work 
(Knutsson 2004) of those individuals who feel that they are least affected by sleep 
deprivation. However, this statement may not hold for the physiological data in the 
current study as a trend for decreased FMD and lower variance and higher sympathetic 
activity might be related to increased cardiovascular risk in the SW. This suggests a 
mismatch between parameters assessed and/or acute and chronic effects of sleep 
deprivation. Although SW appear to cope with acute sleep deprivation, chronic shift work 
may adversily affect their cardiovascular health.
It is difficult to reconcile an explanation for these cardiovascular changes with one for the 
stronger insulin and NEFA response to recovery sleep in NSW compared to SW. A 
possible explanation may be based on the 10-year follow-up study mentioned in section
3.4 by Holman et al. (2008) which indicated that microvascular damage is likely to have 
an early onset and may persist despite reversal of risk factors such as glycaemic control. 
The authors suggest the mechanism underlying this could be that ‘long-term 
hyperglycaemia is associated with a slow onset of microvascular disease, which may be 
mediated by the gradual accumulation of advanced glycation end products that are 
subsequently slowly degraded with intensive glycaemic control. This mechanism may 
also be implicated in the development of CVD.’ In agreement with this, other researchers 
state that endothelial dysfunction and increased sympathetic activity are thought to be 
caused by repeated exposure to postprandial hyperglycaemia, hyperinsulinaemia and 
hyperlipedaemia (Konukoglu et al. 2003; Nesto 2004; O'Keefe & Bell 2007; Wascher et 
al. 2005). Alternatively, others suggest that there is a mutual interaction between insulin
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resistance and endothelial dysfunction (Hadi & Suwaidi 2007) or even that changes in 
endothelial function may show before changes in glucose control and insulin sensitivity. 
An animal study, for example, showed that changes in endothelial function occurred 
earlier in a high fat diet model than changes in fasting insulin, TAG and glucose levels 
and peripheral insulin resistance (Kim et al. 2008), suggesting that the endothelium is 
more sensitive to this high fat load and that these early changes in endothelial function 
make the tissue more sensitive to be damaged by later metabolic stress. These 
observations indicate that damage to cardiovascular system (e.g. HRV and FMD) may 
have already occurred earlier in the SW and that this damage persists even though 
glucose and TAG responses do not show major differences compared to NSW. 
However, it is not clear how this could explain why SW show less divergent insulin and 
NEFA responses to recovery sleep compared to NSW.
The observed differences between SW and NSW were found despite both groups being 
matched in their screening data. In order to be able to match SW and NSW, some 
parameters such as cholesterol and BMI were allowed to exceed the official cut off 
values as for example cholesterol and BMI have been shown to be higher than ‘normal’ 
in SW (section 1.3.2). Some other parameters were also allowed larger margins, such as 
the HO, BDI, PSQI and ESS. It appeared that many of the questions in these 
questionnaires are influenced by shift work and do not necessarily indicate extreme 
diurnal preference or sleep disorders. Answers to questions such as ‘During the past 
month, when have you usually got up in the morning?’ in the PSQI or question 16 on 
sleep in the BDI (appendix E) may be influenced by the time of day and the particular 
shift during which the questionnaire is given and the instructions provided. This was 
observed with the BDI, PSQI and ESS scores that dropped significantly when the 
questionnaires were completed in the week of regular sleep before the study with the 
instruction to keep only day shift or days off in mind. In addition, many SW find it difficult 
to answer questions like: ‘Considering only your own “feeling best” rhythm, at what time 
would you get up if you were entirely free to plan your day?’ or ‘If there is a specific time 
you have to get up in the morning, to what extent are you dependent on being woken up 
by an alarm clock?’ and their answers may be different depending on whether they keep 
morning or evening shifts in mind when replying to the question. To address these issues 
an adapted version of the Munich ChronoType Questionnaire (Roenneberg et al. 2007; 
Roenneberg et al. 2003) for SW has been developed (Juda 2010), but for many other 
questionnaires a differential outcome for SW has not been considered.
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In parallel with this, SW and NSW were also not different in other screening parameters 
such as serum sodium and potassium (affecting de- and repolarisation of myocardial 
cells (Fox 1996), and therefore the shape of the EGG), ALT (a marker of hepatoxicity and 
altered gluconeogenisis (Ozer 2008)) and white blood cell counts, although previous 
studies have suggested that SW at risk for the metabolic syndrome have elevated ALT 
levels (Lin et al. 2009) and that an increased leukocyte count is independently 
associated with shift work duration (Sookoian et al. 2007). Another subject demographic 
was the PER3 VNTR polymorphism which has been associated with vulnerability to 
sleep deprivation (Viola et al. 2007). Those having the PER3P^  ^genotype were shown to 
live under higher sleep pressure compared to matched individuals with the PER3^ "^^  
genotype (section 1.8). This has also been related to a physiological measure, namely 
lower HRV (and possibly worse cardiovascular function) in PER3^^  ^ individuals (Viola et 
al. 2008). In most populations around 10% of individuals are homozygous for PER3P^ ,^ 
whereas approximately 50% are homozygous for PER3*^ "^  (Ciarleglio et at. 2008; 
Nadkarni et al. 2005). Due to the small sample size of the current study and no prior 
matching of the participants for genotype, statistical analyses could not be carried out on 
the current data set. Therefore, the data were thus only visually explored and the 2 
subjects with the PER^^^ genotype (1 SW and 1 NSW) did not show any overt 
differences compared to the other subjects, except for the observation that 013 had the 
highest TAG I AUCs of all subjects, was excluded from all the insulin analysis and had 
the highest glucose lAUCs of the NSW. However, this could also be related to ethnicity 
as this subject was Asian. Asians have been shown to have a more insulin resistant-like 
profile, probably despite a similar BMI (Wulan et at. 2010). The 5/5 genotype did not 
have clear effects on FMD, SDNN and LF/HF, but especially during TSD these two 
subjects (013 and 35) were at the lower end of the NN spectrum. In addition, their 
median RT during TSD was in the upper range of the spectrum. Amongst the NSW 
subject 013 had the longest total sleep time during TSD.
The assessment of circadian phase using DLMO showed that there were no differences 
in the DLMOs between SW and NSW. Moreover, both groups had a similar phase angle 
between DLMO and habitual bed time. This finding implies that all the parameters 
described in previous chapters were assessed at a similar circadian phase for all 
subjects and thus any differences observed between the groups are unlikely to be due to 
differences in circadian timing. PSG-derived sleep was assessed during the TSD night. 
There were no differences between SW and NSW in TST, SOL, number of awakenings 
and time spent in each of the sleep stages as a percentage of total scored time. This
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also supports the statement that any differences seen between the groups cannot be 
explained by differences in sleep during the TSD night.
6.2 Impact
As screening parameters (e.g. cholesterol and BMI) were not significantly different 
between the groups, the current findings suggest that non-invasive FMD and HRV 
assessments may be more sensitive to detect alterations in cardiovascular function than 
other parameters. This agrees with research showing that attenuated FMD predicts 
cardiovascular events in groups of subjects with comparable other risk factors for GAD 
(Shechter et al. 2009). Therefore, FMD and HRV might be predictive of altered 
cardiovascular function, for example in SW in our study, which were otherwise similar to 
NSW in many other parameters (e.g. screening parameters, glucose and TAGs). 
However, care should be taken with the conditions in which FMD and HRV are assessed 
and the control groups against which they are compared.
It is likely that the differences between SW and NSW in metabolic and hormonal 
responses and cardiovascular function assessed in epidemiological studies and smaller 
scale studies with more flexible conditions (such as circadian phase, physical activity and 
food intake) were not solely due to acute differences in these conditions at the time of 
assessment as differences between SW and NSW persisted in the current study when 
environmental conditions were strictly controlled.
Despite indications that cardiovascular physiology may be negatively affected by shift 
work, subjective alertness and mood data suggest that SW felt better under the sleep 
deprivation conditions. There thus appears to be a mismatch between the SW response 
to the acute effects of SD and the long term consequences of shift work for 
cardiovascular health. This emphasises that shift schedules should be designed to allow 
for optimal physiological recovery as subjectively SW may underestimate how much 
recovery time they need. The alertness and mood data suggest a nap is an effective 
countermeasure for the neurobehavioural effects of sleep deprivation and should be 
considered more often to be incorporated in shift schedules and other environments 
where sleep deprivation occurs.
It is not clear from the current data, however, how many recovery nights are needed for 
metabolic and cardiovascular parameters to return to baseline levels following one night
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of TSD. For SW working a number of night shifts, recovery is impossible to predict at this 
stage. Although a nap proved very effective for recuperation of mood and alertness, one 
night of recovery sleep following the nap may not be sufficient for recovery of metabolic 
and cardiovascular function. Although the changes are probably reversible initially, 
repeated shortened recovery periods in environments where sleep deprivation occurs 
frequently, such as in (rotating) shift work, may result in the build up of disturbances in 
metabolism, HRV and FMD, which become chronic and may contribute to increased 
cardiovascular risk.
6.3 Limitations
The main limitation of this study was the sample size. The initial power calculations were 
based on the FMD measurements as these were thought to have the highest variation of 
all the parameters. The calculations (based on the study by Amir et al. (2004)) indicated 
that a sample size of n = 14 would be needed to reveal significant differences within the 
same subject (e.g. between days) and (n = 8 to observe differences between NSW and 
SW) with a power of 0.8 (see application for ethical approval, appendix A). As this 
number was achieved for NSW but not for SW, this may imply that differences within the 
groups, e.g. before and after sleep deprivation, do not reach statistical significance. 
However, it was very difficult to recruit SW who fitted the inclusion criteria (Table 2.1), 
especially the requirement of having worked shifts for 5 years or more and not suffering 
from any medical conditions (allergies especially were common amongst all applicants) 
and the request to be working day shifts or have days off for the week prior to the 
laboratory study.
6.3.1 Assessed parameters
As mentioned earlier, the assessment of FMD is a technique with more variability than 
many other methods. However, FMD is thought to be more robust than other techniques 
such as pulse wave analysis or pulse contour analysis to asses endothelial function 
(Donald et al. 2006). Although the coefficient of variation for within subject %FMD 
between study visits is not much higher at 7.1 -15% (Donald et al. 2006; Walters et al. 
2006) than for example for a plasma insulin or saliva melatonin radioimmunoassay, 
reviews suggest that higher numbers of subjects are needed than those in the current 
study to be able to detect effects between interventions and groups (Corretti et al. 2002; 
Moens et al. 2005). Variability in FMD can arise from different sources, such as anatomy
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of the subject, methods and study conditions and operators (as also described by others 
(Corretti et al. 2002; Stout 2009)). The current study used several standards to decrease 
variability and increase reproducibility such as brachial diameter calculation using 220 
frames, EGG-triggered images, marking of the ultrasound probe location of the arm, 
same operator to set up and conduct the recording (as also suggested in a 
methodological review by the Brachial Reactivity Task Force (Corretti et al. 2002) and 
Stout (2009)), whereas previous studies did not always have all of these conditions thus 
making comparison of data on reproducibility or interventions more difficult. Most 
noticeably, in some previous studies the brachial diameter was measured in only 3 
frames; at rest, ~1 min after deflation and again after 10-15 minutes of rest (or in 4 
frames for comparison with endothelium-independent dilatation following administration 
of a NO donor such as nitroglycerin) (Amir et al. 2004; Fathi et al. 2004; Ofiaz et al. 
2006; Sorensen et al. 1995). An interesting analysis to reduce variability further is to 
calculate FMD normalised to the amount of shear stress for the duration of time-to-peak 
as reactive hyperaemia shows interindividual differences (Padilla et al. 2008). Another 
suggestion to deal with interindividual differences would be to report absolute change in 
diameter as larger arteries have been shown to dilate relatively less than smaller arteries 
(Corretti et al. 2002), a trend which was also seen when SW and NSW were compared in 
the current study.
Another technical limitation was the fact that Somnologica software was not so flexible 
for HRV analysis. There were some bugs in the software’s artefact removal. Sometimes 
the artefact was not adequately removed in the NN trace and the length and place of the 
artefact identification had to be altered slightly to achieve satisfactory results. 
Furthermore, there were no options for other manipulations of the data which have been 
used in some other studies, e.g. interpolation of removed NN intervals (Task Force of the 
European Society of Cardiology and the North American Society of Pacing and 
Electrophysiology 1996). Also inherent to the calculation of HRV parameters, it must be 
kept in mind that the interpretation of absolute VLF, LF and HF power and TP has to be 
cautious as these indices may be sensitive to (removal of) artefacts. Therefore, 
normalised indices (LF norm, HF norm and LF/HF) were given more weight when 
drawing conclusions about the data. Also related to the calculation of HRV parameters, it 
is not surprising that LF norm, HF norm and LF/HF yield very similar P-values and 
estimates (except for the sign of HF norm estimates) as Burr (2007) noted ‘these 3 
indices are algebraically pairwise redundant at the level of definition’. However, he still 
regarded the use of these parameters as appropriate and informative but emphasised
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that these interdependencies should not be forgotten. Likewise, the parameters in the 
time domain may show similar results as they are derived from an identical EGG.
Finally, saliva sampling for melatonin measurements was only conducted in the evening 
before bed time and in the morning after waking up. However, circadian phase 
calculations using the basal levels and the melatonin peak (Revell et al. 2005; Sletten et 
al. 2009) may be more reliable as the resolution is better. However, this would require 
subjects to be woken up for saliva sampling or too frequent blood sampling (exceeding 
limits of blood volume allowed to be taken within 3 months) and was therefore not 
feasible in the current study.
6.3.2 Study design
One of the comments often made on sleep deprivation protocols, is that sleep 
deprivation is likely to cause stress. Stress increases the release of hormones such as 
cortisol and epinephrine (Black & Garbutt 2002). Both cortisol and (nor)epinephrine 
influence metabolism; cortisol has catabolic effects by increasing lipid mobilisation but 
these effects are long term as they involve gene expression and occur over a period of 
days (Frayn & Akanji 2003). The direct action of hormones is faster, for instance the 
mobilisation of fuels through stimulation of (3-receptors by epinephrine. Stress also 
affects other aspects of the autonomic nervous system and could therefore also 
influence HRV and FMD. In accordance with this hypothesis, (evening) cortisol and 
(nor)epinephrine have been shown to be increased after sleep deprivation (Buxton et al. 
2010; Irwin et al. 1999; Leproult et al. 1997; Nedeltcheva et al. 2009; Schussier et al. 
2006; Spiegel et al. 1999). However, other studies have shown that 1 night of ISO 
resulted in a decrease in morning cortisol and had no overall effects on (nor)epinephrine 
(Schmid et al. 2007; Schmid et al. 2009). Since the amount of stress caused by sleep 
deprivation is probably also subject to interindividual differences, as is the response to 
other stressors (Kudielka & Wust 2010) this may add an additional layer of variance onto 
the differences that are already present. The amount of stress during TSD may be 
reduced by allowing moderate food intake or physical activity. Although this could be 
done in controlled manner, such a protocol would be most informative if the differences 
between groups were the main focus. However, this would compromise comparisons 
between baseline sleep, sleep deprivation and recovery sleep.
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Related to this is the fact that the current study did not include a control group who did 
not undergo sleep deprivation. Although a within subject design is statistically more 
robust in order to reveal intervention effects, it can not rule out that some parameters 
may have decreased or increased due to the stay in the laboratory. This has been shown 
in the case of depression, where both sleep deprivation and staying in a laboratory 
increased depressive feelings (Paterson et al. 2010). However, it is unlikely that the 
laboratory stay is a main explanation for the findings as many changes were also 
observed after sleep deprivation but not after recovery sleep at the end of the protocol. 
Moreover, some studies including a control group have shown that merely staying in a 
laboratory did not affect parameters such as glucose and insulin (van Leeuwen et al. 
2010).
Including a 4 h nap in the protocol created some difficulties when analysing the results. 
As mentioned in section 5.2.4.S SAS post hoc differences for main effects of day and 
day*group interactions for the alertness and mood data could not be determined as there 
were 9 time points after adaptation, baseline and recovery sleep but only 6 time points 
after TSD due to the presence of a nap period. In order to assess these post hoc effects 
the 3 afternoon measurements after adaptation, baseline and recovery sleep had to be 
left out of some of the analyses, leading to the loss of possibly informative data from 
these 9 time points. In addition, the data observed after recovery sleep have to be 
considered a combined effect of the nap plus recovery sleep. For the same reason we 
decided not to analyse the HRV data during the 4-h afternoon periods as initially 
intended, since the days would be incomparable; on 3 days the observations would be 
the result of adaptation, baseline and recovery sleep, whereas after TSD the obtained 
data would show the effect of both sleep deprivation and sleep during the nap.
6.4 Future research
6.4.1 Parameters to assess
Much of the future research could focus on extending the analyses. This also holds for 
the alertness and mood data, for which for example interindividual differences could be 
teased apart further. The first suggestion would be to further analyse the subjective and 
objective alertness data by a multilevel regression type analysis which could take into 
account multiple correlations, for example within a day, across days and within a group 
and identify whether these correlations are significantly different between time points.
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days and groups. It would also be interesting to conduct an analysis similar to Santhi and 
colleagues (2007) who computed a cumulative RT percentile distribution. This method 
may give a more complete view of the whole RT spectrum (rather than taking the FRT or 
SRT) and is possibly able to reveal more subtle differences. In addition, the PVT 
generates other, not so commonly reported, parameters such as the number of false 
starts, standard deviation of the reaction times and the change in the RRT regression 
line from beginning to the end of the trial. These could be informative, especially in 
combination with other parameters. For example, faster reaction times may sometimes 
coincide with more false starts and the ratio between this could give an idea about the 
speed/accuracy trade off. In addition, variation across a trial or a condition could test the 
‘state instability’ hypothesis and the relation between false starts and lapses may enable 
one to distinguish between compensatory effort and lack of motivation (Doran et al. 
2001). Also within the PSG, other parameters could be assessed, such as the 
distribution of sleep episodes across the night. This is done in a hypnogram but 
Somnologica has no simple method of quantifying or extracting these data. In addition, 
the nap and recovery night could be scored for sleep stages to assess whether NSW 
and SW recover to a similar extent and in the same way. Ideally, the adaptation and 
baseline night should also be scored to ensure both groups had similar sleep quantities 
and architecture. Finally, the additional chapters of the SSI could be used to explore 
sleep, fatigue, health, wellbeing and the social and domestic situation and to detect 
whether and which coping strategies are present in the current group of SW.
Although the PER3 genotypes were determined in the current study, the study was not 
specifically designed to assess the effect of genotype on metabolic and cardiovascular 
function or to detect whether the PEP3 genotype frequencies were different between SW 
and NSW. Directions for future research would be either to conduct a large 
epidemiological study or, in order to have more control over the environmental and 
experimental conditions, match subjects for genotype and then investigate the responses 
of interest as has been done in some studies (Viola et al. 2008). The same conditions 
hold for investigating the characteristics of different genotypes in the adenosinergic 
system that may be important in the regulation of sleep (section 1.8). The G/A genotype 
of ADA has been linked to various observations such as fewer awakenings, more SWS 
and deeper sleep than the G/G genotype (Retey et al. 2005). However the G/A genotype 
is only present in 8-12% of the population while 88-92% of people have the G/G 
genotype, so matching of subjects for ADA genotype would be necessary to assess 
whether they respond differently to sleep deprivation. Another interesting candidate 
would be the adenosine A2A-receptor, although its C/C genotype only showed enhanced
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power in the high theta/low alpha range compared with the T/T genotype (Retey et al. 
2005). Polymorphisms in this receptor may also affect vulnerability to sleep deprivation 
as sensitivity for its antagonist, caffeine, influence the neurobehavioural response to 
sleep deprivation (Retey et al. 2006).
SW working shifts for 5 years or more participated in the present study. Three of the 11 
SW had a shift work duration of longer than 15 years. Although there were no obvious 
differences between them and the 8 SW that had worked shift for 5-7 years (apart from a 
lower SDNN during the TSD night in the 3 SW with the shift work duration longer than 15 
years (section 4.3.3)), future research should compare SW with long shift durations to 
those with a shorter shift work duration e.g. more than 15 years vs 3-5 years and match 
them for other screening parameters.
Another suggestion would be to match subjects for socioeconomic status as both this 
factor and health problems have been shown to be independently associated with the 
amount of self-reported sleep problems in the British population (Arber et al. 2009). 
Therefore, differences in socioeconomic status between subject groups may affect their 
attitude towards sleep and how they respond to sleep deprivation. Although mental and 
physical health aspects of the screening data were not significantly different between SW 
and NSW, they may have been dissimilar in their socioeconomic status (data not 
captured).
Some parameters that were initially planned to be measured in the current study but 
could not be assessed due to time and financial constraints are inflammatory markers 
and factors influencing endothelial function. This aim was based on research showing 
that even though the metabolic component is still linked to the development of GVD, 
inflammation is receiving more attention (Grundy et al. 2004; Libby 2006; Shaw et al. 
2005). Proinflammatory cytokines (such as IL-6 and TNF-a) as well as changes in insulin 
concentrations are thought to stimulate the expression of vascular cell adhesion 
molecules (V-GAMs), which in turn, attract leukocytes. Upon migration of leukocytes into 
the vascular intima, macrophage proliferation is stimulated which results in matrix 
remodelling. This may eventually lead to collagen degradation and plaque rupture and 
thrombosis, characteristic for GVD (Libby 2006). The role of inflammation is thought to be 
partially reflected in moderately, but constantly elevated high sensitivity G-reactive 
protein (hsGRP) levels (Grundy et al. 2004; Libby & Ridker 2004).
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These inflammatory markers and cell adhesion molecules have indeed been shown to 
be affected by sleep deprivation (Mullington et al. 2009). TSD for 40 - 88 h or PSD for 5 
days increased hsGRP and the level was still elevated after recovery sleep (Frey et al. 
2007; Meier-Ewert et al. 2004; van Leeuwen et al. 2009). Furthermore, 1 night to 4 
nights of TSD or PSD affected l-GAM, L/E-selectin and various factors in the 
inflammatory and immune system such as interleukins and TNF-a pathways (Frey et al. 
2007; Irwin et al. 2006; Irwin et al. 2008; Redwine et al. 2004; Red wine et al. 2000; 
Shearer et al. 2001; van Leeuwen et al. 2009; Vgontzas et al. 2007; Vgontzas et al. 
2004). By contrast, there are hardly any studies reporting the effects of shift work on cell 
adhesion molecules or factors involved in inflammation. However, some studies have 
demonstrated alterations in SW in other related pathways contributing to changes in 
vascular function, for example alterations in fibrinolytic activity in rotating SW (Andreotti & 
Kluft 1991) or increased plasma homocysteine in shift working bus drivers compared to 
day workers. Another study investigated several parameters (normetanephrine / 
creatinine, von Willebrand factor, anti-thrombin III, T-plasminogen activator -  
plasminogen activator inhibitor 1 - complex, hematocrit) before, during and after a night 
shift in taxi drivers (Hattori & Azami 2001). Most of these factors showed differences 
between morning, midnight and next morning, depending on what time the shift was 
finished. According to the authors, these results indicated endothelial dysfunction. 
However, as in many shift work studies, the differences may be due to differences in 
physical activity and/or circadian phase, not necessarily the night shift or sleep 
deprivation itself.
Finally, it would be informative to study other factors involved in metabolism, such as the 
hormones leptin and ghrelin, signalling satiety and hunger, respectively. A decrease in 
leptin amplitude was observed after sleep deprivation, indicating reduced satiety 
(Mullington et al. 2003; Spiegel et al. 2004). In support of these findings, other studies 
have observed increased hunger ratings and ghrelin levels after both PSD and TSD 
(Schmid et al. 2008) and increased ghrelin levels in the early evening after sleep 
deprivation (before recovery sleep) compared to before sleep deprivation (Schussier et 
al. 2006). These findings support the increased energy expenditure during/after sleep 
deprivation that was suggested based on the observed decrease in basal TAG levels. By 
contrast, others have shown that leptin increased and satiety and hunger did not change 
after PSD (Schmid et al. 2009; Schussier et al. 2006; van Leeuwen et al. 2010). 
Differences between studies, however, may be related to the extent of ad libitum food 
intake.
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6.4.2 Study design
The most important next step to take with respect to the study design would be to extend 
the recovery period. As discussed in previous sections, a longer period of recovery sleep 
would be needed to investigate further the time course of these observed changes in 
metabolism and HRV following recovery sleep. To elucidate why these changes take 
place after recovery sleep but not after sleep deprivation also requires further study. 
Other studies have also suggested that one night of recovery sleep may not be sufficient 
because some changes only became overt after recovery sleep (Sauvet et al. 2009). 
Alternatively some studies on alertness have indicated that one recovery night of 8 h 
may not be enough to reverse the effects of sleep deprivation and either longer hours (a 
longer recovery night or the inclusion of a nap) (Faraut et al. 2010) or more days (section 
1.6.1.2) are needed.
Another modification to the study design could be to study an even more defined group 
of SW. The current study included SW with a range of shift durations, schedules and job 
types. In addition to restricting the range of shift work durations (see previous section), 
only one type of shift schedule could be specified, for example the selection of SW 
rotating in a clockwise direction. However, the current study criteria were left a little wider 
in order to be able to recruit a sufficient number of subjects. In addition, the job type was 
left unspecified as this may result in comparing the effect of certain job against day work, 
whereas the aim of the study was to assess the effects of shift work in general.
6.5 Conclusion
The data from the current study have demonstrated that sleep deprivation resulted in 
significantly decreased basal TAG levels and postprandial glucose clearance as well as 
a peak in HRV variance around habitual wake up time. Lower variance in HRV and 
indications of a hyperinsulinaemic response and insulin insensitivity were observed after 
recovery sleep. Alertness and mood significantly deteriorated after TSD but showed 
effective recuperation after recovery sleep. These statistically significant changes were 
observed despite the small sample number. Future studies should increase the sample 
number and include longer periods of sleep deprivation and recovery sleep to assess the 
time course of these changes and to investigate why some changes only take place after 
recovery sleep but not after TSD. Furthermore, shift workers showed decreased HRV 
variance and increased sympathetic acitivity, a trend for lower FMD and a smaller
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decrease in NEFA and increase in insulin levels after recovery sleep compared to non­
shift workers. It would be of interest to elucidate which factors are responsible for the 
observed differences in metabolic and cardiovascular function between shift workers and 
non-shift workers by either studying a different shift work population or additional 
parameters that can reveal information about the underlying mechanisms. Interindividual 
differences, for example in the response to sleep deprivation and the mechanisms 
underlying these, are also important areas of future research.
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Appendix B Email questionnaire
UNIVERSITY OF
SURREY
E-mail questionnaire for the study:
'  I . / /
The effects of total sleep deprivation on metabolic and 
cardiovascular function”
Name: 
Phone #: 
Email: 
Address: 
Post code:
Thank you for your interest in our study. Our selection process is pretty extensive. After receiving 
your completed questionnaire, we will review it and may give you a follow-up call to collect some 
additional information. W e then mav determine that vou are not elioible for this studv. If you are 
eligible, we will ask you to fill out some more questionnaires, to come to our unit so that we can 
show you around, explain the study in more detail, and ask you to provide a blood and urine 
sample for a standard screen. Onlv after the completion of this visit and once we have support 
from vour GP we will be able to determine whether or not we can fit vou into our studv.
Attached is a brief overview of the study. If you are still interested, please complete and return via 
email the following questionnaire. If you would rather not complete these forms via email, we can 
ask you these questions over the phone. To do so, or if you have any further questions, please 
call us at 01483 689705. If you return the filled out questionnaire, you should hear from us within 
the next few days. Thanks again for you interest.
Please fill out the entire questionnaire as completely and precisely as 
possible; this wili speed up the selection process.
The information you provide will be kept confidential and will not be shared 
with anyone other than the research staff!
1. Confirm the correct soellino of vour name and address, as well as vour correct phone number 
in the section above.
2. a Confirm vour aoe.
How old are you? (In order to be able to participate, you must be 25-45) ______
What is your date of birth? /  / 19___
2. b W hat is vour
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Weight (kg) Height (cm)
3. How did vou hear about our studv?
□  Poster a t:_________________ □  Newspaper □  Email □  Other
4. Are vou afraid of blood and/or needles? □  Yes □  No □  I don’t know
5. Have vou ever participated or are vou currentiv oarticioatina in another research studv or 
clinical trial?
□  Yes □  No If yes, please state what kind of study, where and w hen___________________
6. Do or did vou take anv recular medication (This includes any pills, creams, injections or 
anything you need a doctor’s prescription for)?
□  Yes □  No If yes, please state name, dosage, time and frequency of administration and date 
of last use
7. Do or did vou take anv recular ‘over the counter medication’ (medication for which no 
prescription was needed such as Aspirine, Paracetamol, Ibuprofen, medication for soar throats 
and colds or homeopathic medication such as St Johns Wort) or food supplements (such as 
vitamins /  minerals and fish oils)?2
□  Yes □  No If yes, please state name, dosage, time and frequency of administration and date 
of last use
8. The following is a list of medical conditions. Please, circle ‘ves’ if vou have or ever had anv of 
them.
Heart disease
Vascular disease
Blood Pressure
Gastrointestinal disorders
Endocrine disorders
Asthma
Liver disease
Arthritis
Diabetes
Cancer
Anaemia
Thyroid disorders
Any allergies e.g. for food or pollen (hay fever) 
Psychiatric conditions (i.e. depression/schizophrenia) 
Anything else?
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
9. Have vou ever smoked?
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□  Yes □  No
If yes: For how long have you been smoking/were you smoking? 
What do/did you smoke (cigarettes, cigars, pipe)?
How many units do/did you smoke a day?
10. Do vou drink /  did vou use to drink alcohol?
□  Yes □  No
If yes: For how long have you been drinking/were you drinking?
How much alcohol do you drink /did you drink on average (units per week)?
(1 pint = 2 units; 1 measure of alcohol = 1 unit)
None 1-4 units 5-14 15 or more
11 Do vou use /  have vou used recreational drucs?
□  Yes □  No If yes, please state name, dosage, time and frequency of administration and date 
of last use
Recreational drugs are prohibited throughout the study. You will be asked to provide a  urine 
sample for a drug screen at the start of the study, and possibly at other random times during 
the study. Would you consent on this?
□  Yes □  No
12. How manv c u d s  of tea/coffee or other caffeinated drinks (such as red bull or coke) do vou 
drink a dav?
None 1 -3 cups 4 or more cups
13. Would vou be able to refrain from smoking, alcohol, caffeine and/or taking the prescribed 
medication/'over the counter medication’/food supplements for some time before and during the 
studv?
□  Yes □  No
14. Have vou given more than 4 0 0  ml of blood in the oast 3 months?
□  Yes □  No
15 a What is vour occupation?
15 b What kind of shift patterns vou have been working u p  to now?
□ only day shifts □ permanent nights
□  only early and /  or late shifts □  other /  mixed
□ rotating shifts
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15 c Regarding the shift pattem(s) vou have ticked for question 15 b: for how manv months / 
vears have vou been working each of the patterns and when was it vou have worked these 
patterns?
16. Have vou crossed anv time zones in the past month?
□ Yes □ No If yes, where did you go and when did you return?_
17. We would like to know more about vour habitual sleep schedule.
What time are you currently going to bed during the week / when you are on day shifts?
What time are you currently waking up during the week / when you are on day shifts?
Are you waking up because you have to (i.e. to get to class or work or any other reason)? □ Yes 
□ No
So, you usually get about (calculate Average Sleep Duration)_______ hours of sleep per
night during the week / day shifts
What time are you currently going to bed during the weekend / days off?
What time are you currently waking up during the weekend / days off?
So, you usually get about (calculate Average Sleep Duration)_______ hours of sleep
per night during the weekend / days off?
How often do you wake up during the night?___________
When you awaken, how long are you awake for?
Thank you very much for completing this questionnaire!
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Brief overview of the study
The aim of the study is to investigate the effect of a night of total sleep deprivation (as is 
experienced during the first night of a night shift) on a range of metabolic, inflammatory and 
cardiovascular responses. Different groups of people (shift workers and non-shift workers) will 
be studied. The effect of a recovery nap and recovery sleep will also be investigated.
You will be asked to stay in the laboratory on one occasion for 4 nights and 4 days. After two 
nights of sleep, we will ask you to stay awake for one night, followed by a recovery nap and 
recovery sleep. During the study you will be in controlled conditions regarding dim light, body 
posture and food intake. Throughout the study we will need to take saliva samples and 
regular blood samples to investigate the above mentioned metabolic, inflammatory and 
cardiovascular responses. You are also asked to wear electrodes on your head, face and 
chest for sleep recordings. Furthermore, you will undergo ultrasound recordings of the artery 
in your upper arm (flow mediated dilatation (FMD)) to measure functioning of the blood 
vessels. These non-invasive methods are all painless and harmless. Mood, alertness and 
performance will also be measured.
As mentioned before, there are numerous pre-screening procedures. Before the study, you 
will be screened for drugs of abuse in urine, and a standard hematological and biochemical 
blood screen will also be done. We will write to your medical practitioner to ask whether 
he/she considers you suitable for the study and to request information about medications or 
medical disorders that may affect the study. If your medical practitioner considers that you 
should not, for whatever reason, participate in the study, we will be obliged to accept this 
advice.
Once we have considered you to be suitable to take part and you have decided to give your 
consent, you will be asked to collect a buccal swab (samples of cells lining the inside of the 
cheek). Samples of cheek cells will be used to provide a DNA sample for the sole 
measurement of specific genes involved in sleep and circadian rhythms. All research records 
including DNA samples will be assigned alphanumeric codes to ensure confidentiality and 
collected data will not be available to unauthorised persons.
Prior to the laboratory study, your sleep/wake cycle, diet, food supplements, medication and 
exercise will be strictly controlled. You will be required to keep a regular sleep-wake cycle for 
1 week prior to the study, to refrain from caffeine, alcohol, certain foods and heavy exercise 
the day before and during the laboratory session and from certain medication and food 
supplements for a certain wash out period. To ensure you are doing this, we will ask you to 
wear activity and light monitors, ring the lab-voice mail and complete a sleep-wake diary the 
week prior to the study. You will also be asked to record your consumptions and exercise 
pattern the week prior to the study.
Payment is £600. If you do not complete the study, you will be paid on a pro-rata basis.
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Appendix C Whole blood, serum and urine screening parameters
Parameter Reference range
Whole blood haematology
haemoglobin (Hb)
white blood cells (WBC)
platelets
packed cells volume (PCV)
mean cell/corpuscular volume (MCV)
mean cell/corpuscular haemoglobin (MCH)
red blood cells (RBC)
mean cell/corpuscular haemoglobin concentration (MCHC)
neutrophils
lymphocytes
monocytes
eosinophils
basophils
Serum biochemistry
sodium 135- 145 mmol/L
potassium 3.5 - 5.1 mmol/L
urea 2.6 - 6.5 mmol/L
creatinine 60- 120pmol/l
total bilirubin < 23 pmol/l
alkaline phosphatase 25-120 iu/l
alanine amino transferase (ALT) < 40 iu/l
albumin 34 - 48 g/l
cholesterol < 5 mmol/l
HDL > 1 mmol/l
Urine
opiates (morphine, codeine, dihydrocodeine, pholcodine)
amphetamines / ecstasy
methadone
barbiturates
benzodiazepines
cocaine
cannabis
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Appendix D Measurement of waist and hip circumference
waist
-  hip
thigh
Schematic presentation of the leveis at which the waist, hip and thigh circumferences should 
be measured.
According to the recommendations issued by the World Health Organization. Waist: midway between 
the lower rib margin and iliac crest; hip: widest over the great trochanters; thigh: highest level at the 
gluteal fold. From Van der Kooy & Seidell (1993).
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General health questionnaire
Appendices
UNIVERSITY OF
Subject Identification Code: Date:
Date o f Birth: Age:
Dominant hand: 
Height (cm):
Waist circumference:
Weight (kg):
Hip circumference:
Do vou do/have vou done shift work?
Yes/No (If yes: please, fill in the ‘standard shift work index’)
Do or did vou take anv regular medication (This includes any pills, creams, injections or anything 
you need a doctor’s prescription for)?
□  Yes □  No If yes, please state name, dosage, time and frequency o f administration and date 
of last use
Do or did vou take anv regular ‘over the counter medication’ (medication for which no 
prescription was needed such as Apirine, Paracetamol, Ibuprofen, medication for soar throats and 
colds or homeopathic medication such as St Johns Wort) or food supplements (such as vitamins /  
minerals and fish oils)?
?
□  Yes □  No If yes, please state name, dosage, time and frequency o f administration and date 
o f last use
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Do you have or have you had any major health problems?
Psychiatric conditions (i.e. depression/schizophrenia)
Migraine
Epilepsy
Heart disease
Vascular disease
Blood Pressure
Gastrointestinal disorders
Endocrine disorders
Asthma
Retinal disease
Kidney disease
Autoimmune disease
Liver disease
Arthritis
Diabetes
Cancer
Hernia
Tuberculosis
Lung problems
Anaemia
Thyroid disorders
Food or other allergies
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
Yes/No
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General sleep questionnaire
y ' /
UNIVERSITY O F
SURREY
Identification Code:.....................................  Date:
1. On a normal day how many times do you go outside?
< 1/day 1/day > 1/day
2. Would you regard your mobility as:
good fair poor
3. What time do you normally go to bed (h:min)?
4. How many hours per night do you sleep on average?
5. How long does it take you to fall asleep?
< 10 min 10-30 min > 30 min
6. How often do you wake up during the night?
7. How often do you get up during the night?
8. Why do you get up during the night?
9. What time do you normally wake up (himin)?
10. Do you go through phases o f getting to sleep earlier and earlier or later and later each 
night?
11. Do you have any difficulty getting up in the morning? Y/N  
If yes, what kind o f difficulty?
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12. Do you fall asleep during the day? Y/N  
If yes, how often and for how long?
13. Do you feel you have any problems sleeping? Y/N
If yes - What kind of problems?
14. Does it occur regularly?
15. Do you do anything to try and overcome this problem?
(i.e. sleeping pills, relaxation techniques, herbal remedies, routine)
16. Are these strategies effective?
17. How long have you had this sleep problem?
< 6 months 6-12 months >12 months
18. Do you ever skip a night’s sleep?
19. Is your sleep pattern different during work free periods (e.g. holidays, weekends)? 
If yes, how is it different?
20. Does your sleep pattern affect your social or occupational life? Y /N  If yes, how? 
If yes, in what way?
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Horne-Ôstberg questionnaire
UNIVERSITY OF
Identification Code: DATE;
This questionnaire will used to assess whether you are a “morning” type (i.e. a lark) or an
“evening” type (i.e. an owl) person.
a) Please read each question very carefully before answering.
b) Answer all questions
c) Answer questions in numerical order
d) Each question should be answered independently o f others. Do NO T go back and check 
your answers.
e) For some questions you are required to respond by placing a cross alongside your answer. In 
such cases, select O NE answer only.
f) Please answer each question as honestly as possible. Both your answers and results will be 
kept in strict confidence.
QUESTION 1
Considering only your own “feeling best” rhythm, at what time would you get up if you were entirely free 
to plan your day?
I I I I I I I I I
A M  5 10 11 12
QUESTION 2
Considering only your own “feeling best” rhythm, at what time would you go to bed if you were entirely 
free to plan your evening?
PM 8 10 11
I I
12 A M
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QUESTION 3
If there is a specific time you have to get up in the morning, to what extent are you dependent on being 
woken up by an alarm clock?
a. Not at all dependent [ ]
b. Slightly dependent [ ]
c. Fairly dependent [ ]
d. Very dependent [ ]
QUESTION 4
Assuming adequate environmental conditions, how easy do you find getting up in the morning?
a. Not at all easy [ ]
b. Not very easy [ ]
c. Fairly easy [ ]
d. Very easy [ ]
QUESTION 5
How alert do you feel during the first half hour after having woken in the morning?
a. Not at all alert [ ]
b. Slightly alert [ ]
c. Fairly alert [ ]
d. Very alert [ ]
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QUESTION 6
How is your appetite during the first half hour after having woken in the morning?
a. Very poor
b. Fairly poor
c. Fairly good
d. Very good
[ ]
[ ]
[ ]
[ ]
QUESTION 7
During the first half hour after having woken in the morning, how tired do you feel?
a. Very tired
b. Fairly tired
c. Fairly refreshed 
Very refreshed
[ ]
[ ]
[ ]
[ ]
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QUESTION 8
When you have no commitments the next day, at what time do you go to bed compared to your usual 
bedtime?
Seldom or never later [ ]
Less than one hour later [ ]
c. 1-2 hours later [ ]
d. More than 2 hours later [ ]
QUESTION 9
You have decided to engage in some physical exercise, A friend suggests that you do this one hour twice a 
week and the best time for him is between 0700 and OSOOh. Bearing in mind nothing else but your own 
inclinations, how do you think you would perform?
Would be on good form [ ]
Would be on reasonable form [ ]
c. Would find it difficult
d. Would find it very difficult
QUESTION 10
At what time in the evening do you feel tired and as a result in need of sleep?
U _1 I I I
PM 8 10
I I I
11
I I I I I
12 AM 1
I I I- I I I
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QUESTION 11
You wish to be at your peak for a test which you know is going to be mentally exhausting and lasting for 
two hours. You are entirely free to plan your day and considering only your own "feeling best" rhythm, 
which ONE of the four testing times would you choose?
a. 0800-1000  [ ]
b. 1100-1300 [ ]
c. 1500-1700 [ ]
d. 1900-2100 [ ]
QUESTION 12
If you went to bed at 2300h at what level of tiredness would you be?
a. Not at all tired [ ]
b. A little tired [ ]
c. Fairly tired [ ]
d. Very tired [ ]
QUESTION 13
For some reason you have gone to bed several hours later than usual, but there is no need to get up at any 
particular time the next morning. Which ONE of the following events are you most likely to experience:
a. Wake up at the usual time and not go back to sleep [ ]
b. Wake up at the usual time and doze [ ]
c. Wake up at the usual time and go back to sleep [ ]
d. Wake up later than usual [ ]
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QUESTION 14
One night you have to remain awake between 0400 and 0600h. You have no commitments the next day. 
Which ONE of the following suits you best:
a. Not to go to bed until 0600h [ ]
b. Nap before 0400h and sleep after 0600h [ ]
c. Sleep before 0400h and nap after 0600h [ ]
d. Sleep before 0400h and remain awake after 0600h [ ]
QUESTION 15
You have to do two hours of hard physical work. You are entirely free to plan your day and considering 
only your own "feeling best" rhythm which ONE of the following times would you choose?
a. 0800-1000 [ ]
b. 1100-1300 [ ]
c. 1500-1700 [ ]
d. 1900-2100 [ ]
QUESTION 16
You have decided to engage in some physical exercise. A friend suggests that you do this between 2200 and 
2300h twice a week. Bearing in mind nothing else but your own "feeling best" rhythm how well do you 
think you would perform?
a. Would be on good form [ ]
b. Would be on reasonable form [ ]
c. Would find it difficult [ ]
d. Would find it very difficult [ ]
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QUESTION 17
Suppose that you can choose your own work hours. Assume that you worked a FIVE hour day (including 
breaks)) and that your job was interesting and paid by results. Which FIVE CONSECUTIVE HOURS 
would you select:
12 1 2 3 4 5 6 7 
MIDNIGHT
9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12
NOON MIDNIGHT
QUESTION 18
At what time of day do you think that you reach your “feeling best” peak?
12 1 2 3 4 5 6 7 8 9 10 11 12 1 2 3 4 5 6 7 8 9 10 11 12
MIDNIGHT NOON MIDNIGHT
QUESTION 19
One hears of “morning” and “evening” types. Which do you consider yourself to be?
a. Morning type
b. More morning than evening
c. More evening than morning
d. Evening type
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Pittsburgh Sieep Quaiity index
U N IV E R S IIT  OF
SURREY
xuciiiiiicctuuii V.-UUC; Date:
Instructions;
The following questions relate to your usual sleep habits during the past month only. Your answers 
should indicate the most accurate reply for the majority of days and nights in the past month. Please answer 
all the questions.
1) During the past month, when have you usually gone to bed at night?
Usual bed time
2) During the past month, how long (in minutes) has it usually take you to fall asleep each night?
Number of minutes
3) During the past month, when have you usually got up in the morning?
Usual getting up time
4) During the past month, how many hours of actual sleep did you get at night? (This may be 
different from the number of hours spent in bed.)
Hours of sleep per night
For each of the remaining questions, check the one best response. Please answer all questions.
5) During the past month, how often have you had trouble sleeping because you.....
a) Cannot get to sleep within 30 minutes
Not during the Less than Once or twice
past month  once a week  a week_____________
Three or more 
times a week
b) Wake up in the middle of the night or early morning
Not during the Less than Once or twice
past month  once a week  a week_____________
Three or more 
times a week
c) Have to get up to use the bathroom
Not during the Less than
past month  once a week_
Once or twice 
a week_____
Three or more 
times a week
d) Cannot breathe comfortably
Not during the Less than
past month  once a week_
Once or twice 
a week_____
Three or more 
times a week
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e) Cough or snore loudly
Not during the Less than
past month.
f) Feel too cold
Not during the 
past month____
once a week
Less than 
once a week
Once or twice 
a week
Once or twice 
a week_____
Three or more 
times a week
Three or more 
times a week
g) Feel too hot
Not during the 
past month____
h) Had bad dreams
Not during the 
past month_____
i) Have pain
Not during the 
past month_____
Less than 
once a week
Less than 
once a week
Less than 
once a week
j) Other reason(s), please describe
Once or twice 
a week_____
Once or twice 
a week
Once or twice 
a week_____
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
How often during the past month have you had trouble sleeping because of this?
Not during the 
past month___
Less than 
once a week
Once or twice 
a week_____
Three or more 
times a week
6) During the past month, how would you rate your sleep quality overall?
Very good___________
Fairly good___________
Fairly bad____________
Very bad_____________
7) During the past month, how often have you taken medicine (prescribed or “over the counter”) to 
help you sleep?
Not during the 
past month___
Less than 
once a week
Once or twice 
a week_____
Three or more 
times a week
8) During the past month, how often have you had trouble staying awake while driving, eating meals, 
or engaging in social activity?
Not during the 
past month___
Less than 
once a week
Once or twice 
a week_____
Three or more 
times a week
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9) During the past month, how much of a problem has it been for you to show enthusiasm to get 
things done?
No problem at all_________
Only a very slight problem.
Somewhat of a problem___
A very big problem_______
10) Do you have a bed partner or roommate?
No bed partner or roommate?.
Partner/roommate in other room
Partner in same room, but not same bed. 
Partner in same bed_________
If you have a roommate or bed partner, ask him/her how often in the past month you have had).
a) Loud snoring
Not during the 
past month_____
Less than 
once a week
h) Long pauses between breaths while asleep
Not during the Less than
past month  once a week_____
c) Legs twitching or jerking while you sleep
Not during the Less than
past month  once a week_____
Once or twice 
a week_____
Once or twice 
a week_____
Once or twice 
a week
d) Episodes of disorientation or confusion during sleep?
Not during the Less than Once or twice
past month  once a week  a week_____________
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
Three or more 
times a week
e) Other restlessness while you sleep; please describe
Not during the 
past month___
Less than 
once a week
Once or twice 
a week_____
Three or more 
times a week
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Beck Depression inventory
UNIVERSITY OF
SURREY
Identification Code: Date:
Choose one statement from among the group of four statements in each question that best 
describes how you have been feeling during the past few days. Circle the number beside 
your choice.
0 1 do not feel sad.
1 1 feel sad.
2 1 am sad all the time and I can’t snap 
out of it.
3 I am so sad or unhappy that I can't 
stand it.
0 1 don't feel I am any worse than anybody 
else.
1 1 am critical o f m yself for my weaknesses or 
mistakes.
2 1 blame m yself all the time for my faults.
3 I blame m yself for everything bad that 
happens.___________________________________
0 1 am not particularly discouraged 
about the future.
1 1 feel discouraged about the future.
2 1 feel I have nothing to look forward 
to.
3 1 feel that the future is hopeless and 
that things cannot improve.__________
0 1 don't have any thoughts o f killing myself.
1 1 have thoughts o f killing myself, but I would 
not carry them out.
2 1 would like to kill myself.
3 1 would kill m yself if  I had the chance.
0 I do not feel like a failure.
1 1 feel I have failed more than the 
average person.
2 As I look back on my life, all I can 
see is a lot o f failure.
3 1 feel I am a complete failure as a 
person.____________________________
10 0 1 don't cry any more than usual.
1 1 cry more now than I used to.
2 1 cry all the time now.
3 1 used to be able to cry, but now I can't cry 
even though I want to.
0 1 get as much satisfaction out of 
things as I used to.
1 1 don't enjoy things the way I used 
to.
2 1 don't get any real satisfaction out 
o f anything anymore.
3 1 am dissatisfied or bored with 
everything.________________________
11 0 1 am no more irritated by things than I ever 
am.
1 1 am slightly more irritated now than usual.
2 1 am quite annoyed or irritated a good deal of  
the time.
3 I feel irritated all the time now.
0 1 don't feel particularly guilty.
1 1 feel guilty a good part o f the time. 
2 1 feel quite guilty most o f the time. 
3 I feel guilty all o f the time.
12 0 1 have not lost interest in other people.
1 1 am less interested in other people than I 
used to be.
2 1 have lost most o f my interest in other 
people.
3 I have lost all o f my interest in other people.
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0 1 don't feel I am being punished. 
1 1 feel I may be punished.
2 1 expect to be punished.
3 I feel I am being punished.
13 0 1 make decisions about as well as I ever 
could.
1 1 put o ff making decisions more than I used 
to.
2 1 have greater difficulty in making decisions 
than before.
3 1 can't make decisions at all anymore.______
0 1 don't feel disappointed in myself. 
I I  am disappointed in myself.
2 1 am disgusted with myself.
3 I hate myself.
14 0 1 don't feel that I look any worse than I used 
to.
1 1 am worried that I am looking old or 
unattractive.
2 1 feel that there are permanent changes in my 
appearance that make me look unattractive.
3 1 believe that I look ugly.___________________
15 0 1 can work about as well as before.
1 It takes an extra effort to get started 
at doing something.
2 1 have to push m yself very hard to 
do anything.
3 1 can't do any work at all.__________
19 0 1 haven't lost much weight, if  any, lately.
1 1 have lost more than five pounds.
2 1 have lost more than ten pounds.
3 I have lost more than fifteen pounds.
(Score 0 if  you have been purposely trying to 
lose weight.)______________________________
16 0 1 can sleep as well as usual.
1 1 don't sleep as well as I used to.
2 1 wake up 1-2 hours earlier than 
usual and find it hard to get back to 
sleep.
3 1 wake up several hours earlier than 
I used to and cannot get back to sleep.
20 0 1 am no more worried about my health than 
usual.
1 1 am owrried about physical problems such 
as aches and pains, or upset stomach, or 
constipation.
2 1 am very worried about physical problems, 
and it's hard to think o f much else.
3 1 am so worried about my physical problems 
that I cannot think about anything else._______
17 0 1 don't get more tired than usual.
1 1 get tired more easily than I used 
to.
2 1 get tired from doing almost 
anything.
3 I am too tired to do anything.
21 0 1 have not noticed any recent change in my 
interest in sex.
1 1 am less interested in sex than I used to be.
2 I am much less interested in sex now.
3 1 have lost interested in sex completely.
18 0 My appetite is no worse than usual.
1 My appetite is not as good as it used 
to be.
2 My appetite is much worse now.
3 1 have no appetite at all anymore.
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Epworth Sleepiness Scale
UNIVERSITY OF
Identification Code:.....................................  Date;
Use the following scale to choose the most appropriate number for each situation:
0 = would never doze or sleep.
1 = slight chance of dozing or sleeping
2 = moderate chance of dozing or sleeping
3 = high chance of dozing or sleeping
Situation
Chance of 
Dozing or 
Sieeping
Sitting and reading
Watching TV
Sitting inactive in a public place
Being a passenger in a motor vehicle for
an hour or more
Lying down in the afternoon
Sitting and talking to someone
Sitting quietly after lunch (no alcohol)
Stopped for a few minutes in traffic while
driving
Total score
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Standard Shift work index
UNIVERSITY OF
SURREY
(N.B. Only those questions used to assess shift work duration and schedules are included in this
appendix due to space constraints)
We are an independent research team engaged on a research programme looking at the problems which people 
may experience as a result of working shifts. We have no particular "axe to grind" within an organisation.
Throughout this questionnaire the terms "Morning", "Afternoon" and "Night" shifts are used. Please ignore the 
fact that these terms may differ from the ones used in your organisation. For example, you may call your 
"Morning" shift an "Early" one, while your "Afternoon" shift may be referred to as a "Late", "Evening" or 
"Swing" shift.
It is possible that completing this questionnaire may draw your attention to problems you experience as a result of 
shiftwork. If you are worried that these are serious we would advise you to contact your GP (see back page).
Thank you for your co-operation.
Developed by the:
Shiftwork Research Team,
MRC/ESRC Social and Applied Psychology Unit 
Professor Emeritus Simon Folkard D.Sc.
224
Appendices
1. Your General Biographical Information
Please answer the following questions as accurately as possible. Please note that the information you 
give will be treated in strictest confidence.
1.10 How long have you worked altogether?
1.11 How long have you worked in your present shift system?
1.12 How long altogether have you been working shifts?
1.13 On average, how many hours do you work each week 
excluding overtime?
1.14 On average, how many hours paid overtime do you work 
each week?
1.15 On average, how many hours unpaid overtime do you work 
each week, (e.g. over-run of shifts)?
1.16 Do you have a second paid job in addition to your main one? 
(tick one)
1.17 If you have taken a career break (or breaks), how long was this 
for in total?
years 
. years.
, years.
. hours
. hours
. hours 
.yes
years
months 
_ months
minutes
minutes
minutes
no
months
Your Shift Details
1.18 For each of the shifts that you normally work, at what time do they start and finish? (Please use 24h 
time, e.g. 21:30 or clearly indicate "am" or "pm").
START FINISH
(a) Morning (or early) shift
(b) Afternoon (or late, evening or swing) shift
(c) Half-day shift
(d) Night shift
(e) Other...............
(please specify)
1.22 For each of the shifts that you normally work, on average how many successive shifts of the same kind 
do you normally work before changing to another shift or having some days off?
NUMBER
(a) Number of successive morning shifts
(b) Number of successive afternoon shifts
(c) Number of successive night shifts
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(d) Total number of successive shifts 
(of any kind) before days off
(e) Other................
(please specify)
1.23 What is the maximum number of shifts of any kind you have 
worked between days off in the past month?
1.24 On average, how many days off in succession do you normally have?
1.25 In general, when changing from one type of shift to another, what type of shift is each shift or day off 
followed by?
(a) Morning shifts are normally followed by: __________
(b) Afternoon shifts are normally followed by: __________
(c) Night shifts are normally followed by: __________
(d) Other..........................  are normally followed by: __________
(e) Days off are normally followed by: __________
1.26 On average how many nights do you work per year?
1.27 How are these night shifts organised?
(please tick the one which best describes your night work)
(a) permanent nightshift
(b) a single block of night duty per year
(c) occasional blocks of night duty per year
(d) a block of nights each month
(e) one or two nights each week
(0 any other? (please specify) _________________
1.28 On average how many weekends do you have off per 28 days?
1.29 How regular is the shift system you work?
(please tick one)
(a) REGULAR i.e. a fixed roster which is repeated when 
the cycle of shifts finishes, even if occasional 
variations occur to meet special requests.
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(b) IRREGULAR i.e. the duty roster does not cycle 
or repeat in any regular manner and individual 
preferences are not taken into account.
(c) FLEXIBLE i.e. where the individuals concerned 
are consulted about their preferred duty hours 
before the duty roster is drawn up.
1.30 If your shift system is regular, over how many weeks 
does the cycle run before it is repeated?
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Appendix F Subject demographics
TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- TSD- 
subjectlD C-2 C-5 C-9 C-10 C-12 C-13 15 16 21 23 25 26 28 32 S-1 S-2 S-3 S.6 S-8 S-9 17 18 29 34 35
group_________NSW NSW NSW NSW NSW NSW NSW NSW NSW NSW NSW NSW NSW NSW SW SW SW SW SW SW SW SW SW SW SW
participation 2 6 - 1 4 - 12 - 28 25 - 28 20 - 20 - 22 - 2 6 -  1 2 - 14 - 1 8 - 18 - 28
dates 8 -1 2  4 - 8 8 - 1 2  30 18 16 Ju ly- 29 Sept- 8 - 1 2  24 24 26 8 -1 2  4 - 8  30 16 18 22 22 J u ly - 25-29 22-26 2-6 2-6
(laboratory Nov Sept Nov Nov Dec Feb 1 Aug Aug 2 Oct Dec Oct Oct Nov Dec Sept Nov Feb Dec Jan Jan 1 Aug Aug Nov Feb Feb
study) 2007 2007 2007 2007 2007 2008 2008 2008 2008 2008 2008 2008 2008 2008 2007 2007 2008 2007 2008 2008 08 08 08 09 09
current t  ^  ^  ^  g  n  &  g
I U  M .  1 u  M
currently ~  S ’ % > g -§ % i  g |  S
unemployed 8 . 8 . 8 .  = 8 ® 8  =  6  §  E
i |
1 A
shift work
(years) 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 5 5.6 5.1 5 7 7 18.5 6.3 5 16.7 15
time since last
shift (months) 60 0 0 0 0  18 0 0 0 0 0 0
age (years) 29 32 28 42 28 30 26 25 37 30 42 41 27 38 38 44 31 25 38 25 38 29 37 45 43
weight (kg) 72.8 82.3 77 67.8 84 68 84.4 93.4 94.4 68 100.9 72.8 109 97.2 82.9 84.2 91.6 97.6 91.8 83.8 117 85.2 92.6 99 82
height (m) 1.75 1.78 1.69 1.7 1.81 1.66 1.75 1.85 1.78 1.78 1.84 1.81 1.79 1.82 1.76 1.75 1.71 1.71 1.83 1.91 1.81 1.79 1.73 1.87 1.83
BMI (kg/mZ) 23.9 26.0 27.0 23.5 25.6 24.7 27.6 27.3 29.8 21.5 29.8 22 2  34.0 29.3 26.8 27.5 31.3 33.4 27.4 23.0 35.7 26.6 30.9 28.3 24.5
circumference(cm) 81 89.5 91 82 86 91.4 92 91 103 76 103 83 107 101 93.5 94 97 100 104.1 91 110 90 102 105 91
circumference
(cm) 97 99 99 91 93 96.5 104 103 108 88 107 97 114 108 105 101 103 108 106.8 98 114 105 113 113 95
WHR 0.84 0.90 0.92 0.90 0.92 0.95 0.88 0.88 0.95 0.86 0.96 0.86 0.94 0.94 0.89 0.93 0.94 0.93 0.98 0.93 0.96 0.86 0.90 0.93 0.96
currently smoke
(units/day) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
past smoked
(units/day) 0 15 0 0 10 0 5 0 15.5 0 0 0 5 0 7.5 0 0 0 15 0 12.5 5 9 0 0
smoking
duration (years) 0 8 0 0  14 0 2 0 8 0 0 0 5 0 7 0 0 0  20 0 8 8 5 0 0
time since last
smoked
(months) 60 10 0.5 5 14 0 18 36 6 132
alcohol
consumption
(category) 0 1 0 2 2 1 2 1 0 2 2 1 2 1 0 2 2 0 1 1 2 2 1 0 2
caffeine
consumption
(cups/day) 0 1 0.14 4 1.5 1 2 5.5 1 2 1 2 0.2 2 7.5 4 2.5 0 5.5 0 4 2 2 1 4
HÔ 72 56 58 55 53 60 56 51 61 70 64 63 61 63 75 51 62 45 71 42 50 60 52 69 34
PSQI 2 4 3 1 5 2  3 6 3 5 4 7 2 7 2 6 4® 8^  6 3 10* 6 11 * 5 10
GDI 3 2 3 0 2 1  0 9 9 4 1  6 5 1  3 3 5 * 6  17 2 3 0  10 4 4
ESS 8 11 4 3 4 2 4 5 8 1  1 6 2 10 7 11 10 * 10 7  2 9 2 12® 6 3
cholesterol
(mmol/L) 4.1 3.9 5 4.4 5.2 4.6 5.3 4.4 4.7 4.5 5.3 4.5 5.5 5 6 3 4.2 3.8 5.4 5.1 6.3 4 4.4 6.5 5.5
serum HDL
(mmol/L) 1.3 1.6 0.8 1.3 1.4 1 1.4 1.1 1.2 1.4 1.2 1.3 1.3 1.3 1.1 1.6 1.2 1.1 1.2 0.9 1.1 1.2 1.6 2.4 1.5
genotype 44 44 45 44 44 55 44 44 44 45 44 44 45 44 44 44 45 44 45 44 45 45 45 44 55
serum sodium
(mmol/L) 141 141 140 140 138 139 140 140 140 140 138 139 136 137 141 142 140 141 143 140 140 141 136 139 141
potassium
(mmol/L) 4.5 NA 4.2 4.4 4.8 4.1 4.5 4.7 4.5 4.3 5 4.3 4.7 4.5 5.4 4.2 4.1 4 4.9 4.4 4.5 5.1 4.8 4.8 5
serum ALT
(lU/L) 23 15 20 14 18 22 30 9 75 14 23 20 40 25 47 33 14 35 28 24 45 37 30 20 21
whole blood
WBC(X10’/L) 5.19 5.64 7 6.19 6.32 5.62 5.38 5.62 5.86 3.95 6.57 3.97 5.48 6.33 10.14 7.27 6.68 5.1 3.97 4.97 7.38 5.86 6.16 8.89 5
scheduled bed
time (decimal h) 24 22.5 23.5 23 24 23.5 23.5 23.5 23 23.5 23.5 23 23 23 22 23.5 24 23.5 24 24 23 23 23.5 23 23.5
scheduled get 
up time
(decimal h) 7.5 6 7 7 8 7 7.5 7.5 7 7.5 7.5 7 7 7 5.5 7.5 7.5 7.5 7.5 8 7 7 7.5 7 7.5
scheduled time 
in bed (decimal
ji]____________ 7.5 7.5 7.5 8 8 7.5 8 8 8 8 8 8 8 8 7.5 8 7.5 8 7.5 8 6 8 8 8 8
Superscripts Indicate values from the second assessment prior to the study (see section 2.2)
Alcohol categories: 0 :0  units/week, 1 :1 -4  units/week, 2 :5 -1 4  units/week, 3: >14 units/week
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Appendix G Shift work schedules
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Appendix H Procedures 2 days prior to the laboratory session
UNIVERSITY OF
SURREY
Steps to be taken on the 2 days prior to study (from waking up):
1. Do not take:
• Caffeine (e.g. tea, coffee, coke, red bull, chewing gum and chocolate.) Drinks 
that do not contain caffeine and are allowed include: herbal tea, 7-up, ginger 
ale and sprite
• Drinks and foods containing high levels of antioxidants (see table below for 
more details)
• Bananas
• Foods containing nitrate/nitrites listed below:
o Green vegetables especially spinach, broccoli, green beans, peas and 
lettuce
o Processed meats such as spam, bacon, ham, hot dogs, com beef, 
burgers 
o Oysters
• Alcohol
• Tobacco
• Recreational drugs
2. Do not take:
a. Prescribed medication
b. ‘Over the counter’ medication e.g. non-steroidal anti-inflammatory dmgs 
(NSAIDS) such as aspirin, ibuprofen and antihistamines, medication for 
soar throats and colds or homeopathic medication such as St John’s Wort. 
An exception is Paracetamol which is allowed because it is NOT a NSAID
c. Food supplements e.g. vitamins / minerals, fish oil, protein supplements, 
anabolic steroids, antioxidant tablets
3. Do not take part in any heavy exercise
4. Do not apply lip balm; plain vaseline is ok.
5. Continue keeping your event diary (which will be provided) recording all the 
foods and drinks that you consume that day. Also continue wearing your light and 
activity monitors and keeping your sleep and light diary.
6. 5 h before your scheduled study time (following lunch on the day you are 
scheduled to start the study) you must fast. This means no food or drink other than 
water. E.g. if you are scheduled for 6 pm you must eat your lunch between 12:00 
and 13:00 and not eat anything after 13:00.
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Table. Details on antioxidant contents of vegetables and fruits.
Please avoid taking vegetables and fruits listed in the ‘NO’ column, since they 
are high in antioxidants! If you do want to eat vegetables and fruits, please 
chose from those listed in the ‘YES’ column.
NO YES
Fresh vegetables Fresh vegetables
Red cabbage White potato
Beets Red potato
Mushrooms Cauliflower
Broccoli flowers Carrots
Spinach Yellow onions
Brussels sprouts Tomato
Sweet com Green cabbage
Peas Cucumber
Green beans Celery
Head lettuce
Fresh fruits Fresh fruits
Red plum Orange
Black plum Pear
Red grape Cantaloupe
Red apple Honeydew melon
Green grape Watermelon
Nectarine
Banana
Kiwi
Pineapple
Sweet cherry
Berries
Other
Dried fruit
Fruit juices
If you are unsure about any of the restrictions, do not 
hesitate to contact us!
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Appendix I Protocol PER3 genotyping in human buccal swabs
Methods are according to an established protocol (Ebisawa etal. 2001), with some modifications 
(Vandewalle et al. 2009)
Use only sterile pipette tips
TNES solution (in RNase free water)
-1 0  mM Tris at pH 7.65
- 400 mM NaCI
- 1 0 0  mM EDTA (inactivates metal-dependent enzymes that can damage DNA)
- 0.6%  SDS (opens up the cellular membrane)
Example for a 10 ml solution
- 1 0 0  pH  M TRIS
- 800 pi 5M NaCI
- 2 ml 0.5M EDTA  
- 6 0 0  pi 10% SDS
- Complete up to 10 ml with DNase free water 
Isolation protocol
- Thoroughly dissolve tissue from the buccal swab in 400 pi TNES
- Add 23 pi Proteinase K (10 mg/ml) and incubate for 1 hour at 55 °C 
This will digest the cells
- Add 111 pi 5 M NaCI and turn to mix (do not shake; SDS will foam) and leave 2 min
- Spin down for 10 minutes at max speed and transfer supernatant to new tube 
The salt has precipitated the peptides which are left in the pellet
- Add 1 volume (= 400 + 111 pi) -2 0 °C 95%  EtOH and tumble to mix until clear
- Spin down for 5 minutes (or up to 12 if a smaller centrifuge is used) at max speed and discard 
supernatant
The EtOH has precipitated the DNA
- Wash the pellet in 180 pi -2 0 °C 70%  EtOH; spin down at max speed for 5 minutes 
This will clean up the sample (remove hydrophilic impurities)
- Remove supernatant and dry to air for 5 -1 0  minutes at 55 °C
- Resuspend in 200 pi DNase free water
- Vortex 2 X 20 seconds
Make sure to resuspend very thoroughly, the DNA is now attached to the tube
- Store at -20 °C until further processing or run PCR immediately
PGR protocol 
Primers:
- Primer 1 = Xis AF
- Primer 2 = Xis AR
10 pM primer stocks;
- Add 20 pi primer to 180 pi nuclease free water (not frozen)
- Vortex and spin down
- Vortex GoTAQ (gently heat to thaw and then keep on ice)
- Make PCR mix in 0.5 ml tube (N = # samples + 1 ):
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- Add N * 8 pi nuclease free water (from frozen)
- Add N * 15 pi GoTAQ (2 times conc. solution)
GoTAQ is always 50% of the end volume Including sample DNA
- Add N * 2 pi first primer (10 pM stock)
- Add N * 2 pi second primer (10 pM stock)
- Mark PCR tubes high on the side, not on the lid
- Add 27 pi of PCR mix to each tube
- Add 3 pi purified sample DNA to each tube and put on ice
- Add 3 pi nuclease free water (frozen) to blank (X) tube and put on ice
- Spin down samples and blank (and then keep on ice)
- Run PGR (do not add tubes until 95‘C is reached):
-3min-95°G
- Repeat 40 times:
1 min-95°C 
1 min-58°C 
1 min-72°C 
5 min -72°C 
00 at 4°C
Blotting protocol:
No sterile pipette tips needed
- Prepare 2% agarose-TaE gel
- 0.5 gram agarose in 25 ml TaE buffer + 1 pi ethidum bromide
-or-
- 2 grams agarose in 100 ml TaE buffer + 5 pi ethidum bromide
Microwave to dissolve until clear and than cool so that It can be held In hand, then add 
ethldlum bromide and swirl to suspend
- Pour gel
- Place gel in electrophoresis chamber, submerge in TaE buffer and remove combs
- Load the samples
- Attach black (negative) pole to top (comb side) of setup
- Attach red (positive) pole to bottom of setup
- Set voltage to 120 V (or 65 V for small gel)
DNA Is negatively charged and will move towards the positive pole 
Voltage Is always volt/cmF; too high voltage = too warm gel
- Run gel for ~3 hours (until yellow dye has ran off the end of the gel)
- Visualize gel under UV light (do not look into the light)
- Photograph gel
Use settings 2 and 8 on camera
Pull strip and than photo (gently and at constant speed) from camera 
Walt one minute and pull photo from developer strip
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Appendix J Meal composition for the laboratory session
Meal Quantity Unit
Energy
(Kcai) Protein (g) Fat (g)
Carbohy 
drates (g)
Breakfast
Cornflakes (Kelloggs) 40 g 148.8 2.8 0.4 33.6
Semi skimmed milk (Tesco) 125 ml 58.8 4.3 2.0 6.1
Croissant (Tesco full butter, 8 per pack) 1 unit 225.0 6.2 12.7 21.5
Butter (Country Life spreadabie) 10 g 68.9 0.0 7.6 0.0
Strawberry cream yogurt (Tesco finest) (150 g) 1 unit 206.0 5.0 10.4 25.2
Sugar (Silverspoon) in 100 ml water 20 g 80.0 0.0 0.0 20.0
Double cream (Tesco) 20 ml 89.0 0.3 9.6 0.5
Orange squash (Robinsons High Juice Orange
Squash Drink) + 200 ml water 50 ml 91.0 0.2 0.1 22.0
Total breakfast 967.5 18.8 42.7 129.0
%composlt!on 7.8 39.7 53.3
Lunch
Slices of white bread (Hovis Granary 2 = 88g) 2 slice 203.0 8.1 1.5 39.4
Cheese (Tesco vaiue mild) 50 g 410.0 25.0 34.5 0.1
Butter (Country Life spreadable) 15 g 103.4 0.0 11.4 0.0
Crisps (Tesco Ready Salted) 34.5 g 184.6 1.8 11.9 17.5
Orange squash (Robinsons High Juice Orange
Squash Drink) + 200 ml water 50 ml 96.0 0.2 0.1 23.2
Total lunch 996.9 35.1 59.4 80.3
% composition 14.1 53.6 32.2
Dinner
Tesco vegetarian lasagne (629 gm) 1 unit 629.0 27.0 34.5 52.2
Strawberry cream yogurt (Tesco finest) (150 g) 1 unit 225.0 4.4 11.7 25.5
Orange squash (Robinsons High Juice Orange
Squash Drink) + 200 mi water 50 ml 96.0 0.2 0.1 23.2
Total dinner 950.0 31.6 46.3 100.9
%composition 13.3 43.9 42.5
Snack
Frijj (strawberry) 250 ml 160.0 9.0 2.3 25.8
Biscuits (McVitie’s digestives, 15 g each ) 2 unit 140.0 2.2 6.2 18.6
Total snack 300.0 11.2 8.5 44.4
%composition 14.9 25.4 59.1
Overall Total 3214.4 96.6 156.9 354.5
Overall % composition 12.0 43.9 44.1
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Appendix K Metabolite reaction equations
Glucose (Oxidase) (ILTestTM, catalogue number 0018250840, instrumentation Laboratory, 
Warrington, UK)
Enzymatic end point analysis, Trinder methodology:
B-D-Glucose + O2 + H2O > GOD Gluconic acid + H2O2
2 H2O2 + phenol + 4-aminoantipyrine — >quinoneimine + 4 H2O 
Glucose oxidase (GOD) / Peroxidase (POD)
The increase in absorbance as generated by the red quinoneimine dye is proportional to the 
glucose concentration in the sample. Primary measurements are taken at 510 nm. On the ILab 
600, a blanking reading is taken at 600 nm.
Triglycerides (ILTestTM, catalogue number 0018255640, Instrumentation Laboratory)
Enzymatic end point analysis:
triglycerides /Wmfe/n /ypase  ^ glycerol + fatty acids
glycerol + ATP > glycerol-3-phosphate + ADP
glycerol-3-phosphate + O2 — glycerophosphate oxidase  ^ dihydroxyacetone phosphate + H2O2 
H2O2 + 4-chlorolphenol + 4-aminoantipyrine — peroxidase—  ^ quinoneimine + H2O2
The concentration of red quinoneimine dye generated in the reaction is proportional to the 
concentration of triglyceride in the sample. Absorbance measurements are taken at a reading and 
a blanking wavelength: ILab 600/900/1800:510/700 nm.
Cholesterol (ILTestTM, catalogue number 0018250540, Instrumentation Laboratory)
Enzymatic end point dichromatic analysis:
cholesterol ester + H2O — cholesterol esterase cholesterol + fatty acids
cholesterol + O2  cholesterol oxidase  ^ cholestenone + H2O2
2 H2O2 + 4-aminoantipyrine + phenol — peroxidase—  ^ quinoneimine + 4 H2O
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Red quinoneimine production is proportional to the cholesterol concentration in the sample. 
Absorption measurements are taken at a primary wavelength of 510 nm and a blanking 
wavelength of 700 nm.
HDL-choiesteroI (catalogue number CH2652, Randox Laboratories Ltd., Crumlin, UK)
The assay consists of 2 distinct reaction steps:
1. Elimination of chylomicron, VLDL-cholesterol and LDL-cholesterol by cholesterol 
esterase, cholesterol oxidase and subsequently catalase.
cholesterol ester — cholesterol esterase  ^ cholesterol + fatty acids 
cholesterol + O2 — cholesterol oxidase  ^ cholestenone + H2O2 
2 H2O2 — > 2 H2O + O2
2. Specific measurement of HDL-cholesterol after release of HDL-cholesterol by detergents 
in reagent 2.
cholesterol ester — cholesterol esterase cholesterol + fatty acids
cholesterol + O2 — cholesterol oxidase  ^ cholestenone + H2O2
2 H2O2 + 4-aminoantipyrine + N - (2- hydroxy -  3 sulfopropyl) -  3,5 - dimethoxyaniline 
— —> quinoneimine + 4 H2O
The intensity of the red quinoneimine dye produces is directly proportional to the cholesterol 
concentration when measured at 600 nm.
In the second reaction catalase is inhibited by sodium azide in Enzyme reagent 2.
The assay uses a Rate method and a single point calibration.
NEFA (catalogue number FA115, Randox Laboratories Ltd.)
NEFA + ATP + CoA  acyl CoAs s y n t h e t a s e Acyl CoA + AMP + PPi
Acyl CoA + O2 — ecyicoAs oxidase  ^ 2,3,-trans-onoyl-CoA + H2O2 
2 H2O2 + 4-aminoantipyrine + N - ethyl -  N - (2- hydroxy -  3 sulfopropyl) m-toluidine 
— > purple adduct + 4 H2O
236
_____________________________________________________________________________ Appendices
Appendix L Plasma insulin assay procedure
Kit protocol (catalogue number HI-14K, Millipore Ltd., Watford, UK)
For optimal results, accurate pipetting and adherence to the protocol are recommended.
Assay Set-Up, Day One
1. Pipet 300 pL of Assay Buffer to the Non-Specific Binding (NSB) tubes (3-4), 200 pi to 
Reference (Bo) tubes (5-6), and 100 pi to tubes 7 through the end of the assay.
2. Pipet 100 pL of Standards and Quality Controls in duplicate.
3. Pipet 100 pL of each Sample in duplicate. (NOTE: Smaller volumes of sample may be used 
when insulin concentrations are anticipated to be elevated or when sample size is limited. 
Additional Assay Buffer should be added to compensate for the difference so that the volume is 
equivalent to 100 pL, e.g., when using 50 pL of sample, add 50 pL of Assay Buffer). Refer to 
Section IX for calculation modification.
4. Pipet 100 pL of hydrated 1251-Insulin to all tubes. Important: For preparation, see Section III, 
Part C.
5. Pipet 100 pL of Human Insulin antibody to all tubes except Total Count tubes (1-2) and NSB  
tubes (3-4).
6. Vortex, cover, and incubate overnight (20-24 hours) at room temperature (22-25 °C).
Day Two
7. Add 1.0 mL of cold (4 'C ) Precipitating Reagent to all tubes (except Total Count tubes).
8. Vortex and incubate 20 minutes at 4°C.
9. Centrifuge, 4°C, all tubes [except Total Count tubes (1-2)] for 20 minutes at 2,000-3,000 xg. 
NOTE: If less than 2,000 xg is used or if slipped pellets have been observed in previous runs, the 
time of centrifugation must be increased to obtain a firm pellet (e.g., 40 minutes). Multiple 
centrifuge runs within an assay must be consistent.
Conversion of rpm to xg: 
xg = (1.12 X 10-5) (r) (rpm)2
r = radial distance in cm (from axis of rotation to the bottom of the tube) 
rpm = revolutions per minute
10. Immediately decant the supernate of all tubes except Total Count tubes (1-2), drain tubes for 
at least 15-60 seconds (be consistent between racks) and blot excess liquid from lip of tubes. 
NOTE: Invert tubes only one time. Pellets are fragile and slipping may occur.
11. Count all tubes in a gamma counter for 1 minute. Calculate the pU/mL of Human Insulin in 
unknown samples using automated data reduction procedures.
Conversion to SI units: 1 pU Insulin / mL = 6 pM
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Appendix M Karolinska Sleepiness Scale
r'"" U N IV E R S IT Y  O Fîu. SURREY
Identification code: 
Date: ____
Time of rating:
Please indicate your sleepiness during the 10 minutes before this rating.
Very alert 1
2
Alert -  normal level 3
4
Neither alert nor sleepy 5
6
Sleepy, but no effort to keep awake 7
8
Very sleepy, great effort to keep awake 9
238
Appendices
Appendix N Case study subject S8
Subject 88  is 38 years of age, worked night shifts for 7 years, but quit shift work 1.5 years ago. 
Some of his screening results are: PER^'^, HO: 71, PSQI: 6, BDI: 17, ESS: 7 (see appendix F for 
more details)
The saliva melatonin profiles before and after baseline sleep suggest that subject S8 is phase 
advanced (Figure 1). However, the week prior to the study, get up time and actual bed time are 
fairly regular and correspond to the agreed times (Figure 2). Moreover, the subject has called the 
lab voicemail every day at the correct times, indicating he was awake at these times. The agreed 
bed time was 24:00 h and the subject’s habitual bed time was 23:00. The agreed wake up time 
was 7:30 h although the subject says he often wakes up around 4:00 h. However, the subject 
reports he is ‘unable to get 8 h’ since he quit shift work and is keen on trying a regular sleep/wake 
cycle with bed time at 24:00 and a 7.5 h sleep opportunity. Despite his efforts to try and adhere to 
the agreed sleep/wake cycle, the subject indicates in his sleep diary the week prior to the 
laboratory session that he woke up almost every day around 5:30 h but did not get up until 7:30 h. 
In addition, on the majority of the days the subject wrote down he would like to have napped 
between 20:30 and 21 :30 h but was unable to (probably because this was outside the designated 
‘napping-window’). This agrees with the low level of activity in the actograms around this period.
These observations indicate that subject S8 may be an ‘early type’ but does not have an habitual 
sleep/wake cycle according to this, either as he may not know what his optimal cycle is because 
of former shift work or due to social commitments.
SB
80-1
2 6 0 -
o 40-
n 20-
20 21 22 23 2431
Figure 1. Saliva melatonin profiles of subject SB.
On the evening before baseline sleep (from 4 -  0.5 h before bed time) and in the morning 
following baseline sleep (from 0 -  4.75 h after waking).
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Figure 2 A. Actogram from the wrist actiwatch from subject S8 the week prior to the 
laboratory session.
The actogram is double plotted with the time of day on the x-axis and the height of the vertical 
bars indicating the amount of activity (black) and light exposure (yellow) on the y-axis.
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Figure 2 B. Actogram from the neck actiwatch from subject S8 the week prior to the 
laboratory session.
The actogram is double plotted with the time of day on the x-axis and the height of the vertical 
bars indicating the amount of activity (black) and light exposure (yellow) on the y-axis.
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